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 1
1 Introduction 
1.1 Introduction to carotenoids 
1.1.1 Occurrence and function 
The term “carotenoid” encompasses a diverse family of naturally occurring pigment 
molecules belonging to the terpenoid class. Some of the most strikingly obvious and 
best known examples of the natural occurrence of carotenoids are provided by the 
yellow-orange colors of flowers (e.g., sunflower, marigold), the orange-red colors of 
fruit (e.g., tomato, orange), and the orange roots of carrots.  
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Figure 1 – Structure of lycopene 1, β,β-carotene 2 and some structural diversities 
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To date, more than 600 naturally occurring carotenoids are known, all derived from the 
same basic C40 isoprenoid skeleton by modifications such as cyclization, substitution, 
elimination, addition, rearrangement and oxidation. The basic structure is illustrated by 
lycopene 1, β,β-carotene 2 and the diversity of structures by further examples in figure 
1. The remarkably long chain of conjugated double bonds explains the most evident 
properties: the intense color ranging from the yellow tones to the deep red.  
 
Carotenoids are widely distributed in nature. They are commonly thought of as the 
pigments in plants such as fruits, flowers and vegetables, but in fact they also occur 
widely in microorganisms and animals. Apart from their occurrence in phototrophic 
bacteria, carotenoids are often responsible for the yellow, orange or red colors in non-
phototrophic bacteria, yeasts and moulds. The importance of the carotenoids in these 
micro-organisms lies mainly in protection against damage by light and oxygen. 
 
The greatest production of carotenoids occurs within the photosynthetic tissues of 
plants and algae. Here, carotenoids are found universally in the photosynthetic 
apparatus, though their presence is often masked by the green colour of chlorophyll and 
revealed only when chlorophyll is degraded as, for example, in autumn leaves. The 
annual natural production of carotenoids has been estimated to be in the order of 100 
million tons, of which some single carotenoids contribute upwards of 10 million tons 
each. 
 
Animals appear to be incapable of biosynthesising carotenoids, but many animals are 
colored by carotenoids that originate from their diet. Some eye-catching examples are 
provided by bird feathers (e.g., ketocarotenoids in the pink feathers of flamingos) and 
the skin and flesh of some fish (e.g., salmon). Coloration by carotenoids is not normally 
seen in mammals, although humans ingesting large amounts of carotenoids, either as 
dietary supplements or as “tanning agents”, may show slight yellow or orange color in 
the skin. 
 
Carotenoids do not only act as pigments. However, their biological relevance is based 
mainly on their role in the photosynthetic process with the double function of 
harvesting energy from light and protecting the reaction center from excess irradiation 
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and unwanted side reactions (e.g., with singlet oxygen). Carotenoids also fulfil the 
essential function as precursors of vitamin A in animals.[1] 
 
1.1.2 Carotenoids and nutrition 
The presence of a fat soluble principle, essential for life, was discovered in foods such 
as egg yolk and butter fat in the early part of the twentieth century. Fish oils proved to 
be the most important source of this factor, which was named vitamin A (retinol 7). 
The link between vitamin A and carotenoids was established when it was shown that 
crystalline β,β-carotene possesses high vitamin A activity[1] and that, in the rat, β,β-
carotene is metabolised to vitamin A which is stored in the liver.[2] In 1931, the 
structure of vitamin A was established by Karrer et al (figure 2).[3, 4] 
 
OH
retinol 7
O
retinal 8  
 
    Figure 2 – Structure of vitamin A (retinol) and retinal 
 
The most important nutritional role of carotenoids, particularly β,β-carotene 2, is as 
pro-vitamin A. The involvement of vitamin A aldehyde-retinal 8, as the chromophore 
of the visual pigment in the eye, is essential to the process of vision.[5] Vitamin A 
deficiency is still a major nutritional problem in many parts of the developing world 
where its consequences, xerophthalmia, blindness and premature death are still 
common, particularly in children. Vitamin A also has important systemic functions in 
maintaining growth, reproductive efficiency and plays a critical role in the maintenance 
of epithelial tissues by preventing their keratinisation. The importance of the latter 
effect has led to the synthesis of a wide range of related compounds, the retinoids, and 
to the evaluation of these substances for therapeutic use to treat skin problems such as 
acne, and also as cancer-prevention agents.[6-9] 
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Carotenoids are also important in the protection against disease via their role as 
antioxidants. Extreme sensitivity to light, seen in humans suffering from erythropoietic 
protoporphyria, an abnormality in porphyrin metabolism, has long been treated by the 
administration of β,β-carotene to prevent singlet oxygen formation. Most current 
research is focused on a proposed role for carotenoids as lipid antioxidants which are 
able to protect against oxidation and other destructive processes mediated by free 
radicals,[10-12] though more specific effects on the immune system are still under 
investigation.[13, 14] 
 
1.1.3 Mechanistic aspects of the production of retinal from β,β-
carotene: central cleavage or excentric cleavage 
In 1930, Moore experimentally recognized the production of vitamin A,[2] the structure 
of which was not fully confirmed at that time, in vitamin A deficient rats fed with a 
β,β-carotene dietary suppliment. Later, the resemblance of the structure of vitamin A[3] 
to half of the β,β-carotene molecule suggested that retinol might have been formed 
from β,β-carotene by central cleavage, providing two molecules of retinal (scheme 1). 
 
OH
7
O
8
2
central cleavage
 
 
Scheme 1 - β,β-Carotene 2 as a precursor for vitamin A 7 (central cleavage pathway) 
 
However, as early as 1960, Glover suggested an excentric cleavage pathway in which, 
as shown in scheme 2, the double bond next to the β-ring of β,β-carotene reacts first, 
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followed by sequential oxidative removal of fragments containing between two and 
five carbon atoms to provide 1 molecule of retinal.[15] Two observations supported this 
idea: i) the biological activity of β,β-carotene was always inferior when compared to 
that of retinol; ii) apo-β-carotenals also showed high biological activity. 
 
O
8
2
excentric cleavage
O
8'-apo-β-carotenal 9  
 
Scheme 2 – Proposed excentric cleavage pathway 
 
Before the discovery of the enzymatic activity in vitro, only speculative explanations 
were proposed for the mechanisms of the cleavage reactions. Two schools of thought 
have both been argued over the most important pathway to yield vitamin A: i) 
proceeding over the central cleavage producing two moles of retinal from each mole of 
β,β-carotene, or ii) if the excentric cleavage was biologically more relevant.  
 
1.1.3.1 β,β-Carotene-15,15’-monooxygenase: the enzyme for the 
central cleavage of β,β−carotene 
The in vitro central cleavage to retinal was independently reported in rat liver and 
intestine by two research groups in 1965.[16, 17] In both studies the production of other 
aldehydes, e.g., apo-β-carotenals, was not observed. The activity was almost totally 
localized in the cytosolic fraction, with very little catalytic activity in the membranes. 
Only two years later, an enzyme which was responsible for the central cleavage was 
identified.[18] Although complete characterization was not possible at that time, this 
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enzyme was admitted into the Enzyme Handbook with the name β,β-carotene-15,15’-
dioxygenase (CDO) under the E.C. number 1.13.11.21.  
 
The features of the enzyme had already been investigated in 1965.[16] Molecular oxygen 
is required for the cleavage, and the presence of a metallic binding site was suspected 
due to the activity inhibition by iron complexing substances, such as EDTA, 
phenanthroline and α,α’-dipyridine. A mechanism, involving a [2+2] cycloaddition to 
the central bond to afford a dioxetan, which is further cleaved to two molecules of 
aldehyde, was postulated as shown in scheme 3. 
 
R
R R
R
O
O
+ FeII - O2 2 R-CHO
 
 
Scheme 3 – Proposed mechanism of cleavage 
 
The enzyme activity was shown to increase upon addition of thiols (mercapto ethanol, 
cystein) to the incubation mixture and was inhibited by SH-specific reagents (N-
ethylmaleinimide, iodo acetamide, p-hydroxy mercury benzoic acid), indicating that the 
enzyme contains SH-groups essential for activity. Different detergents, lipid and bile 
salt were tested to mimic the conditions in the intestinal mucosa, a tissue from which 
the enzyme is largely expressed. These additives are probably important for the 
solubilization of the lipophilic substrate. The optimal pH for CDO was determined to 
be 7.7. 
 
In 1969, the discovery of CDO’s activity in other animals (e. g., rabbit) was published 
again by Olson.[19] The sole product of the enzymatic assay was found to be retinal, 
confirming the central cleavage. During the course of this study, the enzyme activity 
towards apo-β-carotenals was also tested. Surprisingly, 10’-apo-β-carotenal 10 reacted 
11 times faster than β,β-carotene, and the rate increased with decreasing length of the 
substrate. However, this result was not reproducible. 
 
The distribution of enzyme activity in the different animals was the subject of a 
publication in 1972.[20] The cleavage of β,β-carotene had been reported as important in 
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herbivores (guinea pig, rabbit), normal for omnivores (tortoise, freshwater fish, 
chicken); the meat eaters showed low activity; and the cat showed no ability at all to 
produce vitamin A from carotenoids. 
 
In 1989, Lackshman reported the production of retinal as the main product of a 45-60% 
acetone precipitation protein from the intestinal mucosa of rat and rabbit.[21] The 
postulated role of iron (II) in the catalysis was confirmed by increasing activity of the 
enzyme in the presence of 1mM FeSO4. Traces of apo-β-carotenals were found in the 
same order of magnitude from incubation of β,β-carotene with the denaturated enzyme, 
excluding that these side products arose from an enzymatic reaction. 
 
An interesting report appeared in 1994, including several aspects of the understanding 
of retinal production.[22] Cytosolic homogenate from guinea pig intestinal mucosa was 
found responsible for the production of retinal from β,β-carotene with a stoichiometric 
value between 1.5-2. Starting from [15,15’-14C,3H]-β,β-carotene, the same amount of 
14C and 3H was detected in the metabolite, additionally supporting the central cleavage 
theory because an excentric cleavage, followed by β-oxidations, would result in the 
loss of the 3H at C(15). Butylhydroxytoluene (BHT) was used in order to avoid 
oxidation of the cleavage products during extraction, and the procedure was shortened 
so that the products would not stay for a long time in solution.  
 
The control of reaction stoichiometry, and perhaps definitive results about the central 
cleavage, were published in 1996.[23] Using cytosolic and membrane fractions of pork, 
Nagao and co-workers calculated a stoichiometric conversion of 1.88±0.08. By-
products, originating from non-enzymatic reactions, were only found in trace quantities. 
The addition of formaldehyde, which could concur with retinal in the formation of 
Schiff-Base complex with protein, increased the rate of retinal isolated from 50% to 
90%. The concentration of the biomolecule is important; working with 3.7mg of 
protein per ml (10 times higher than usual), the isolation of retinal decreased to 80%, 
despite the addition of formaldehyde. The ability to cleave 8’-apo-β-carotenal 9 was 
reported again, but only traces of 8’-apo-β-carotenal (< 2.1%) were cleaved to retinal. 
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In 2000, two research groups independently succeeded in cloning the key enzyme in 
vitamin A formation from chicken and the fruit fly Drosophila melanogaster.[24-26] For 
the first time, Woggon and Wirtz et al. established a purification protocol for the 
enzyme isolated from chicken intestinal mucosa, which led to the identification of the 
catalytically active protein.[24, 25] Sequencing and expression of the hexa-His-tagged 
protein in Escherichia coli and BHK (baby hamster kidney) cells gave, after affinity 
chromatography, a catalytically active, cytosolic enzyme (60.3 kDa), which cleaves 
β,β-carotene to retinal as the only product. Iron was identified as the only metal ion 
associated with the over-expressed protein in a 1:1 stoichiometry, and since a 
chromophore is absent in the protein, heme coordination and iron complexation by 
tyrosines can be excluded. Even without X-ray crystallography, it could be predicted 
that the active site contains a mononuclear iron complex, presumably consisting of 
histidine and carboxylic acid residues. Subsequently, the substrate specificity of the 
enzyme was investigated.[27] It was revealed that any deviation from the rodlike 
structure of β,β-carotene is not tolerated by the enzyme, implicating a rather rigid 
substrate binding pocket. Via hydrophobic interaction of amino acids with the methyl 
groups of β,β-carotene, the substrate is bound such that only the central double bond  
can be attacked. Substrates with only one functional group in either carotenoid end 
group are cleaved.  
 
In 2001, a publication from the same group provided a strong evidence that oxidative 
cleavage at the central double bond is catalyzed in a monooxygenase mechanism via a 
transient carotene epoxide but not by a dioxygenase mechanism.[28] Incubation of α-
carotene 11 with the enzyme in 85% 17O2 and 95% H218O revealed equal enrichment of 
the 17O- and 18O-label in both derivatives of metabolites 12 and 13. This result proves 
the incorporation of one 17O atom of molecular oxygen and the concomitant 
incorporation of 18O from labeled water (scheme 4). Experimental evidence accounts 
for a monooxygenase-type mechanism in which the first step is an epoxidation of the 
central double bond of 11, followed by unselective ring opening by water and final diol 
cleavage to yield the aldehydes 12 and 13. This sequence implies a high-valent non-
heme oxoiron species as the reactive intermediate. 
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Scheme 4 – Enzymatic cleavage of α-carotene 11 in the presence of 17O2 and H218O[28] 
 
Since the mechanism was suggested as monooxygenase process, a more appropriate 
term, BOC or BOC I (β,β-carotene-15,15’-monooxygenase), has been widely accepted 
instead of CDO. (for BOC II, please see next section) 
 
Subsequently, BOC genes from mouse and human were identified and the recombinant 
proteins biochemically characterized in several laboratories.[29-32] Mammalian BOC 
catalyzed the cleavage of carotenoid substrates with at least one unsubstituted β-ionone 
ring, such as β,β-carotene and β-cryptoxanthin, and there was no observed cleavage of 
lycopene 1 and zeaxanthin 3.[32] The Km values for β,β-carotene were estimated to be in 
the range of 1-10μM.[26, 29, 30, 32] BOC exhibits a slightly alkaline pH optimum, and 
enzymatic activity is sensitive to chelating agents such as o-phenanthroline and α,α’-
bipyridyl, indicating that it depends on ferrous iron. Thus, the purified recombinant 
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BOCs share biochemical properties which have already been described for the native 
BOCs. 
 
1.1.3.2 Excentric cleavage 
As early as 1960, Glover had proposed the excentric cleavage pathway of β,β-carotene 
as the most relevant biological mechanism for the production of vitamin A.[15] 
Comparison of the biological activity of retinal with β,β-carotene was a motive in 
supporting this theory. The pro-vitamin A activity of these two compounds was 
identical and it was therefore deduced that only one molecule of retinal is generated 
from each molecule of β,β-carotene, i.e., the compound is cleaved excentrically. This 
observation constitutes the evidence for excentric cleavage followed by degradation of 
the product(s). However, today, this assumption must be rectified according to the 
bioavailability of carotenoids. The absorption of β,β-carotene and retinal in intestines 
do not proceed quantitatively and thus they can not be compared to each other. Also, 
the observed effect could be due to the formation of retinoic acid. 
 
Glover compared the reactivity of the double bonds against chemical reagents. The 
central double bond was found to be less reactive, whereas, in contrast, the first double 
bond C(7)-C(8) of the polyene chain is easily cleaved. However, the relevance of this 
to an enzymatic reaction is questionable. The real support for this alternative 
metabolism would have been the in vivo detection of apo-β-carotenals, but this was 
never observed during the first investigation. Thus, it led to the conclusion that they are 
present in an active form, which is either water-soluble or tightly bound to the protein.  
 
An excentric cleavage requires a second fragmentation reaction (or a series of 
shortenings). A formal β-oxidation was proposed by Glover. Analogous to fatty acid, 
the β-oxidation would cleave the double bond next to the acid function of an apo-β-
carotenoic acid, derived from the oxidation of the corresponding aldehyde. This process 
should be stopped by the presence of the methyl group at C(13). (scheme 5) 
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Scheme 5 – Possible metabolic pathways for β,β-carotene 2 
 
Direct evidence for the excentric pathway emerged from the in vivo isolation of apo-β-
carotenals 9, 10, 14 from chicken intestine.[33] Sharma et al. suggested a double 
mechanism: i) central cleavage catalyzed by a cytosolic enzyme (BOC) and ii) 
excentric cleavage to apo-β-carotenals catalyzed by the membrane fraction. The total 
amount of apo-β-carotenals produced was less than detected for retinal. The difference 
was also explained by the dependence on cofactors. The presence of NAD+ or NADP+ 
did not influence the activity of BOC, on the other hand, the oxidative excentric 
cleavage was stimulated by these cofactors. Feeding rats with 8’-apo-β-carotenal 9 
allowed the isolation of 8’-apo-, 10’-apo- and 12’-apo-β-carotenoic acid, thus 
supporting the theory of β-oxidation. 
 
Within the last decade of the twentieth century, the most assiduous promoter of the 
excentric cleavage was the group of Krinsky.[34-38] Incubating β,β-carotene with 
homogenate from different tissues (liver, kidney, lungs and feet) of ape, human, ferret 
and rat, they detected a NAD+-dependent production of apo-β-carotenals, retinal, 
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retinoic acid 16 and, for the first time, one shorter metabolite-13-apo-β-carotenone 
17.[34, 35] DTT (dithiothreitol) concentration strongly influenced the reaction, and SH-
specific reagents like disulfiram could inhibit the cleavage. The studies were performed 
using a membrane fraction; pH optimum lying between 6.5 and 7 was definitively 
lower than that for the central cleavage. The β-oxidation degradation mechanism was 
suggested because of the time dependent decrease of 8’-apo-β-carotenal 9, the 
metabolite that was the main product at the beginning of the reaction. The total 
production of apo-β-carotenals was 6-15 times higher than that of retinoids. The 
concomitant existence of 14’-apo-β-carotenal 15 and 13-apo-β-carotenone 17 (scheme 
6) was the first direct evidence of an excentric cleavage.  
 
O
O
excentric cleavage
14'-apo-β-carotenal 15 13-apo-β-carotenone 17
β,β-carotene 2
14'
13'
 
 
Scheme 6 – The excentric cleavage of β,β-carotene 2 at C(14’)-C(13’) double bond 
 
Two further elegant publications validated the excentric pathway because retinoic acid 
was found in an incubation assay with β,β-carotene or apo-β-carotenoic acid as 
substrate, whereas the oxidation of retinal to the acid was inhibited by citral (an 
inhibitor of oxidation of retinal).[36, 38] The detection of retinoic acid among the 
metabolites means that the origin of these retinoids must be associated with an 
alternative metabolism for β,β-carotene, supporting the mechanism of the excentric 
cleavage followed by β-oxidations.  
 
In 2001, direct evidence of excentric cleavage was reported by von Lintig and co-
workers.[39] They identified a cDNA from mouse encoding a type of carotene 
oxygenase (532 amino acids) (β,β-carotene-9’,10’-oxygenase, BOC II) which catalyzes 
exclusively the asymmetric oxidative cleavage of β,β-carotene at the C(9’)-C(10’) 
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double bond, resulting in the formation of 10’-apo-β-carotenal 10 and corresponding 
fragment-β-ionone 18 (scheme 7). Besides β,β-carotene, lycopene 1 is also oxidatively 
cleaved by this enzyme. The deduced amino acid sequence shares 39% sequence 
identity with the BOC I of mouse. Several highly conserved stretches of amino acids 
and six conserved histidines probably involved in binding the cofactor iron(II) were 
found, indicating that the encoded protein belongs to the same class of enzymes. Later, 
they also succeeded in cloning cDNAs encoding this new type of enzyme from human 
and zebrafish.  
 
O O
β,β-carotene-9',10'-oxygenase
(BOC II)
2
10 18
9'
10'
 
 
Scheme 7 – The excentric cleavage catalyzed by β,β-carotene-9’10’-oxygenase 
 
In 2005, another striking result was reported by Al-Babili and co-workers.[40, 41] They 
characterized a novel carotenoid oxygenase (apocarotenoid-15,15’-oxygenase, ACO) 
from the cyanobacteria Synechocystis sp. PCC 6803.[40] Surprisingly, in contrast to the 
β-oxidation mechanism proposed by Glover, this enzyme could directly cleave 
apocarotenals to retinoids.  Later, the crystal structure of enzyme was published.[41]  
 
The ACO was expressed in Escherichia coli inclusion bodies and (re)natured with 
yields of ~ 2 mg purified enzyme per liter culture. It is activated upon addition of 
iron(II) ions. As shown in figure 3A, ACO consists of a seven-bladed β-propeller with 
four histidine residues at the propeller axis, holding the iron(II) ion and thus marking 
the active center. A tunnel, lined with numerous nonpolar residues, runs perpendicular 
to the propeller axis and extends to the active center (figure 3B). 
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Figure 3 – Crystal structure of ACO (with substrate)[41] 
 
Comparing the sequence of ACO with six other members of the carotenoid oxygenase 
family, the author presumed that the carotenoid oxygenase family shares a common 
chain fold and possess similar active center since the four active center histidines are 
strictly conserved and their environment is well conserved. 
 
As shown in scheme 8, investigation of the substrate specificity of ACO revealed that 
only all-trans homologs a, b, c and d as alcohols or aldehydes with and without the 3-
hydroxy group could be cleaved, consisting with the substrate fit of binding tunnel. 
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Scheme 8 – The enzymatic cleavage catalyzed by ACO 
 
1.1.3.3 Summary 
Following such intense research activity of the investigation of the metabolisms of 
carotenoids, finally, the debate has been settled as both pathways are demonstrated to 
be important in nature. Each pathway is used preferentially in mammalian β,β-carotene 
metabolism, depending on the specific tissue. 
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1.2 Supramolecular chemistry and enzyme mimics 
1.2.1 What is supramolecular chemistry? 
A precise definition of “Supramolecular Chemistry” is difficult to summarize. One of 
the foremost exponents of supramolecular chemistry, Jean-Marie Lehn, has described 
the term in the following manner:[42] Supramolecular Chemistry can be defined as 
chemistry beyond the molecule, referring to the organised entities of higher complexity 
that result from the association of two or more chemical species held together by 
intermolecular forces. However, this rather broad and loose description is nevertheless 
accurate.  
 
Indeed, supramolecular chemistry does cover a broad area of scientific research and 
discovery. It is a highly interdisciplinary field, extending over organic chemistry, 
coordination chemistry, physical chemistry and the experimental/theoretical studies of 
interactions. Thus, supramolecular chemistry sits at the crossroads of physics, 
chemistry and biology, drawing on the physics of organised condensed matter and 
expanding, through “classical” chemistry, to the biological properties of very large 
molecular assemblies. 
 
Lehn’s decsription fails to give the appropriate weight to “intermolecular forces”. 
However, in a sense, it might be regarded as noncovalent interactions such as Coulomb 
forces, hydrophobic interactions and hydrogen bonding. These noncovalent interaction 
are the basis of many biological processes such as receptor-ligand binding, enzyme-
substrate complex formation, antibody-hapten binding, and cell surface recognition. 
Accordingly, supramolecular chemistry has provided, and is likely to continue to 
provide, insight into these phenomena through the investigation of artificial 
synthesizable molecular assemblies. 
 
1.2.2 Application of supramolecular systems to enzyme mimics 
Enzymes and receptors are supramolecular systems by their very definition. It is 
therefore easy to conceive mimicking their behaviour with smaller, designed entities 
which incorporate the features (binding site and reactivity) necessary for the activity of 
the native enzyme. Such molecules are the targets of many supramolecular chemists 
and are often described as artificial enzymes or more accurately as enzyme mimics. 
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Figure 4 – A cyclophane based transaminase model (left)[43] and a calixarene based ribonuclease model  
                  (right)[44]. 
 
The first property that a potential enzyme mimic must have, is a binding domain. In a 
native enzyme this is provided by the tertiary structure of the protein, which generates a 
specific microenvironment for substrate binding and subsequent catalysis in aqueous 
media. To incorporate this property into a synthetic system, one needs to look towards 
macrocyclic compounds which exhibit guest-inclusion capability, such as cyclodextrins, 
cyclophanes and calixarenes. Among those, cyclodextrins seem to be the most 
important candidate for the following reasons. 
 i) They are seminatural products, produced from a renewable natural material, starch, 
by a relatively simple enzymatic conversion.  
ii) They are produced in thousands of tons per year by environmentally friendly 
technologies. As a result, the prices have dropped to levels where they become 
acceptable for most industrial purposes.  
iii) Through their inclusion complex forming ability, important properties of the 
complexed substances can be modified significantly. This unprecedented “molecular 
encapsulation” is widely utilized in many industrial products, technologies, and 
analytical methods.  
iv) Any toxic effect is of secondary character and can be eliminated by selecting the 
appropriate cyclodextrin type, derivative or mode of application, so they can be 
consumed by humans as ingredients of drugs, foods, or cosmetics. 
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1.2.3   The cyclodextrins 
1.2.3.1   Chemical structures 
The cyclodextrins (CDs) are a family of cyclic oligosaccharides comprising α-1,4-
linked glucopyranose units. The family is made up of three major and well-known CDs, 
α−, β−, and γ-CD, containing six, seven and eight glucose subunits respectively 
(example as figure 5), and of rare minor cyclic oligosaccharides which contain up to 
fourteen such sugar residues.  
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Figure 5 – The structure of　β-cyclodextrin (β-CD) 19. The glucose residues are labelled as A – G. 
 
As a consequence of the 4C1 conformation of the glucopyranose units, all secondary 
hydroxy groups are situated on one of the two edges of the ring, the so called secondary 
face. The seven primary hydroxy groups thus form the opposite primary face. The 
openings at the two faces are slightly different in size: the secondary opening is the 
larger. Thus the ring is more accurately a conical cylinder, which is frequently 
characterised as a doughnut or wreath shaped truncated cone. The cavity is lined by the 
C(3)-, C(5)-hydrogen atoms and the glucosidic oxygen bridges, lending it hydrophobic 
character in contrast to the hydrophilic nature of the outer surface. The nonbonding 
electron pairs of the glycosidic oxygen bridges are directed towards the inside of the 
cavity, producing a high electron density and lending to it some Lewis base character. 
The characteristic structural features and the dimensions of β-CD 19 are shown in 
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schematic form in figure 6. This schematic representation of 19 will be used to denote 
the full cyclodextrin structure. 
 
primary face
secondary face
apolar cavity 7.8 Å
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Figure 6 – Functional scheme of β-CD torus 
 
The C(2)-hydroxy group of one glucopyranoside unit can form a hydrogen bond with 
the C(3)-hydroxy group of the adjacent glucopyranose unit as the proton donor, lending  
C(2)-hydroxy group the most acidic (pKa ~ 12). In the β-CD molecule, a complete 
secondary belt is formed by these hydrogen bonds, so that β-CD is a rather ridig 
structure. 
 
1.2.3.2   Cyclodextrin based enzyme mimics 
CDs have been widely employed as the substrate-recognition moieties in enzyme 
models, mainly due to i) their high water solubility; ii) their ability to accommodate a 
wide variety of guest molecules; iii) their well defined molecular structure iv) the 
regular arrangement of the hydroxyl groups around the rim of the cavity allowing a 
variety of functional/catalytic residues to be introduced. All of these properties have 
made the molecular design of CD-based enzyme mimics successful and fruitful. For 
recent comprehensive reviews of this field see refs.[45-47]  
 
Attachment of a simple catalytic group to a CD can afford interesting enzyme mimics. 
For instance, a system which has been mimicked by CDs is that of chymotrypsin. At 
the active site of serine proteases, carboxylate (aspartate), imidazole (histidine) and 
hydroxy (serine) residues form a triad charge relay system. It was proposed that a 
proton relay from the serine to histidine is accompanied by proton transfer from the 
histidine to aspartate, which is the key to the enormous catalytic activities of these 
enzymes. As a mimic of this charge relay system, the effect of 2-benzimidazoleacectic 
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acid on the α-CD catalyzed hydrolysis of m-tert-butylphenyl acetate was examined.[48] 
A 10 fold acceleration, ascribable to cooperation of the carboxylate, imidazole, and 
hydroxy residues of α-CD, was observed. Later, an even better mimic for the charge 
relay system, appended CD-derivative 20, was reported (scheme 9).[49, 50] Both 
carboxylate and imidazole were attached to the secondary face of α-, β-, and γ-CDs. 
The kinetic parameters reported for ester hydrolysis by the β-CD based enzyme mimic 
are comparable with the values of chymotrypsin. The specificities are dependent on the 
nature of CDs. α- and β-CD based models are better than the γ-CD based system in 
phenyl ester hydrolysis, whereas the γ-CD system hydrolyses tryptophane ethyl ester 
faster than the other two. In the same way as chymotrypsin, the enzyme mimics show 
presteady-state acylation and steady-state deacylation and turnover. 
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Scheme 9 - Mechanism of ester hydrolysis by a chymotrypsin mimic (a modified CD involving the 
charge relay system of hydroxyl, imidazolyl, and carboxylate residues).[49, 50] 
 
Alternatively, the serine-histidine-aspartate catalytic triad has been introduced as a 
tripeptide (Ser-His-Asp) to the primary face of β-CD.[51] 
 
The models mentioned above, as in the enzyme they mimic, require the substrate to be 
bound before reaction and subsequently released. However, CDs bind typical substrates 
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in water with binding constants of ca. 104 M-1 or less (a recent exception is lithocholic 
acid, whose binding constant to β-CD exceeds 106 M-1).[52] This binding is not as strong 
as that of most enzymes, which typically bind several substrate segments to give 
cooperative binding effects. Thus it is of interest to make artificial enzymes that use 
two or more CDs to bind substrates well. It would be expected that a substrate that 
binds to both CD cavities could have a binding constant exceeding 108 M-1. Simple 
additivity of the binding free energies would lead to 108 M-1, while the entropy 
advantage of the chelate effect should lead to an even larger binding constant than that. 
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Table 1 
 
It has been shown by Breslow et al.,[53] and more recently by Nolte et al.[54] that 
substrates bearing two hydrophobic segments can be bound very tightly by dimeric CD 
systems. It has also been shown that guests displaying the correct size and geometry 
can be bound with binding constants in the range of 106  - 108 M-1 with single linked 
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CD dimers (21 and 22 in table 1) and up to 1010 M-1 with double linked systems such as 
23 (table 1).[55] Heterodimers have also been made linking two different CDs[56, 57] and 
even CD tetramers.[58, 59] 
 
If a CD dimer has a catalytic group in the linker, one might observe strong catalysis in 
complexes where a substrate functional group is held directly above the catalytic linker 
group. An early example of this, reported by Breslow et al.[60, 61] is the esterase model 
27 which contains a 2,2’-bipyridyl subunit as a chelation centre (scheme 10).  
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Scheme 10 – Esterase function of a metallo-CD-dimer.[60-62] 
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Substrate 28 was hydrolysed with at least 50 turnovers in water at pH 7, the products, 
acid 29 and nitrophenol 30, being detected by gas chromatography. The catalyst 27 
gives an acceleration of 2 × 105 fold over uncatalysed hydrolysis, but is not effective 
for unactivated alkyl esters. This challenge was overcome by an Cu(II) complex of a β-
CD dimer 31 linked on the secondary faces, leading to 1000-fold acceleration for 
substrate 32.[62]  
 
The Cu(II) ion was later replaced by La(III) to provide a catalyst, 27-La(III), for the 
cleavage of phosphate esters in the presence of H2O2 (figure  7).[63] 
 
S
S
N N
La
O
P
O
O-OO2N
NO2O
O3+
27-La (III) + substrate
-
 
 
Figure 7 – H2O2 mediated cleavage of phosphate esters by a La3+ modified CD-dimer.[63] 
 
Breslow first mentioned the possibility of including two known catalytic residues, 
namely metallosalens and metalloporphyrins, into CD-dimers as early as 1994,[64] 
however, no results were published and this was purely a claim to the field. In 1996, the 
first publication regarding β-CD containing porphyrin and salen linkers appeared.[59] 
Accordingly, porphyrin linked β-CD derivatives 35, 36 and 37, and salen linked β-CD-
dimer 38 were synthesized (figure 8).  
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Figure 8 – The structures of β-CD dimers or tetramers containing porphyrin and salen linkers[59] 
 
The porphyrin containing derivatives were used to selectively epoxidize stilbene 
derivative 39 in competition experiments with “worse fitting” stilbene 40 (scheme 11). 
Adamantane-1-carboxylic acid is used as a face protection agent. When the substrate is 
bound to the catalyst on one face of the porphyrin, there is the possibility that the oxo 
group goes to the other face and performs unselective epoxidation. The adamantane 
carboxylate could coordinate to that face and prevent such non-selective oxidation. It is 
large enough not to be tolerated on the same face as bound substrate, whereas 
experiments with acetate ion showed no such face selectivity and reduced the 
selectivity of the reaction. 
 25
H
N
N
H
O
O
CO2H
HO2C
39
H
N
N
H
O
O OH
O
HO
O
H
N
N
H
O
O
CO2H
HO2C
H
N
N
H
O
O OH
O
HO
O
O
40
42
37, PhIO,
adamantane-1-carboxylic acid
41
O
98%
2%
 
 
Scheme 11 – Competition epoxidation with β-CD-dimer 37, selectivity was a factor of 50 higher for 39  
                      over 40.[59] 
 
The epoxidations with 35 and 37 were run with up to 40 turnovers, although it was 
reported that the reaction slowed down after some time. This was due to product 
inhibition, such that the reaction product, epoxide 41, can still bind with an appreciably 
high binding constant to the receptor. It can of course be expected if that the endgroups, 
as the major recognition sites of the substrate, have not been altered during the reaction 
and can thus show the same cooperative binding effects when present in epoxide 41. 
 
A further development in the regiospecific catalytic capabilities of porphyrin linked CD 
systems was the selective catalytic hydroxylation of a steroid derivative by a 
cytochrome P-450 enzyme mimic.[65-67] Thus, CD-tetramer 35 (10 mol%) was 
incubated with derivatised steroid 43 in water for 2h with PhIO as the oxygen source 
(scheme 12). 40% conversion of 43 was observed after ester hydrolysis and 
quantification of the triol 44. The regioselectivity of the reaction was shown to be 
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complete. The reaction was also stereospecific, yielding only the equatorial C(6)-
alcohol. The catalyst was capable of only 4 turnovers before being oxidatively 
destroyed. 
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Scheme 12 – Regioselective hydroxylation of steroid by a cytochrome P-450 mimic.[65, 66] 
 
The system was later improved by increasing the stability and reactivity of the catalyst 
through introduction of fluorine to the free aromatic positions of the porphyrin linker, 
β-CD-tetramer 45 (figure 9).[67, 68] In contrast to 4 turnovers from catalyst 35, 45 was 
used in 1 mol% and gave 100% conversion of 43 to 44 (95 turnovers). However, 
reaction with 0.1 mol% gave only 18.7% of product but with 187 turnovers, indicating 
that at the high conversion case there might be some inhibition by product binding to 
the catalyst. 
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Figure 9 – Improved P-450 mimic[68] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 28
1.2.4 β-CD based enzyme mimic of β,β-carotene-15,15’-moooxygenase: 
the essential contributions from “Woggon group”[69-76] 
Supramolecular systems, and especially CD based enzyme mimics, have been used to 
catalyse a range of reactions with good selectivity. The hydrophobic pocket of CDs is a 
good “artificial receptor” moiety, and has been shown in CD dimer/tetramer systems to 
be useful in the cooperative binding and subsequent geometric control of specific 
substrates. However, few of the current works on these more complicated enzyme 
mimics have been devoted to the conversion of natural substrates to biologically 
important metabolites.  
 
As previously mentioned, Woggon et al. have been able to purify the enzyme, which is 
able to centrally cleave β,β-carotene, from chicken’s intestinal mucosa. Further 
investigation showed that, in contrast to earlier belief, this enzyme is not a dioxygenase 
but operates by a monooxygenase mechanism in which the first step is an epoxidation 
of the central C(15)-C(15’) double bond.  
 
Parallel to efforts to purify and investigate the native protein, for the first time, they 
have developed a supramolecular system 46 which mimics the enzymatic cleavage of 
carotenoids (scheme 13).[69-73, 75, 76] This enzyme mimic consists of two β-CD moieties 
linked with a ruthenium porphyrin on the primary face. Each of the β-CDs is shown to 
be capable of binding one of the cyclohexenoid endgroups of β,β-carotene, leaving the 
porphyrin to span the polyene chain. Based on the MOLOC program calculation, it was 
estimated that approximately half of β,β-carotene would be included in the β-CD 
cavities and that the C(15)-C(15’) double bond would be perfectly placed under a 
corresponding oxo-ruthenium complex.  
 
To apply such system to catalyse the cleavage of β,β-carotene, a biphasic system was 
established, in which β,β-carotene was extracted from a 9:1 mixture of hexane/ 
chloroform into the water phase containing the catalyst 46 and cooxidant tert.-butyl 
hydroperoxide (TBHP). The reaction products, released from the catalyst, were then 
extracted back to the organic phase, aliquots of which were subjected to HPLC measure 
without workup. It was reasonable that this kind of biphasic system could efficiently 
avoid the product-inhibition effect. 
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Scheme 13 – The proposal binding mode of 46 and 2, and the cleavage result with TBHP as cooxidant in  
                      biphasic reaction system.[69-73, 75] 
 
The results from cleavage catalyzed by 46/TBHP showed that β,β-carotene is not only 
cleaved at the central double bond (~40%) but also at excentric double bonds to give 
12’-apo-β-carotenal 14 and 10’-apo-β-carotenal 10. It was suggested that lateral 
movement of β,β-carotene within the hydrophobic cavity of β-CD is responsible for the 
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unselective cleavage. Using 17-nor-φ,β-carotene 47 as substrate, the cleavage was 
indeed very regiospecific since only retinal and the corresponding fragment 48 were 
detected. (scheme 14) This suggested that the stronger hydrophobic interaction between 
the aromatic endgroup of 47 and β-CD cavity was responsible for stabilizing the 1:1 
inclusion complex, leaving the central double bond under the reactive ruthenium center 
in contrast to β,β-carotene. 
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Scheme 14 – Selectively central cleavage of 17-nor-φ,β-carotene 47[69-71, 73, 75] 
 
It should be noted that the first step in the cleavage of the double bond is epoxide 
formation catalyzed by the active oxo-ruthenium porphyrin species, which is followed 
by ruthenium porphyrin/TBHP mediated fragmentation yielding the aldehydes as 
shown in scheme 15.[74, 76] 
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Scheme 15 - Catalytic cycle with TBHP as cooxidant[74, 76] 
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2 Aim of the project 
To date, the debate between central or excentric cleavage of β,β-carotene should be 
settled as both pathways are important in nature. Each pathway is used preferentially in 
mammalian β, β-carotene metabolism, depending on the specific tissue. 
 
However, the enzymes catalyzing the excentric cleavage of β,β-carotene and their 
mechanism of action have not been unambiguously characterised. As β,β-carotene-
15,15’-monooxygenase, these enzymes also present a challenge to the synthetic 
chemist in the ability to attack a single double bond in a polyene substrate. The goal of 
this work was to prepare supramolecular enzyme mimics which are capable of binding 
β,β-carotene 2 and can selectively cleave the excentric double bonds to yield 
apocarotenals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 33
3 Results and Discussion 
3.1 A rigidly linked Ru(II)-porphyrin-bis-β-CD complex 58, the first 
enzyme mimic for regioselective cleavage of carotenoids 
3.1.1 Design of the Ru(II)-porphyrin-bis-β-CD complex 58 
As mentioned before, a Ru(II)-porphyrin-bis-β-CD complex 46 has been developed in 
our group to mimic the enzymatic central cleavage of carotenoid.[69-72]  In this structure, 
β-CD moieties act as hydrophobic hosts to bind two cyclohexenoid endgroups of 
carotenoid, leaving porphyrin to span the polyene chain. With TBHP as cooxidant, the 
central C(15)-C(15’) double bond, which in a static view sits under the active 
ruthenium center, could be selectively cleaved. Encouraged by this good result, we 
wanted to construct a new supramolecular system to mimic the excentric cleavage of 
carotenoid.  
 
Based on the binding mode of 46/β,β-carotene 2, for mimicking the excentric cleavage, 
it was easy to conceive that the ruthenium-porphyrin moiety could be retained as active 
catalytic center, whereas the binding mode of β,β-carotene to supramolecular host 
should be reconstructed. To achieve the excentric cleavage, one could envisage that an 
extended hydrophobic cavity, inside which β,β-carotene could be bound more deeply, 
would drive the excentric double bonds under the active ruthenium center of the 
porphyrin (figure 10). 
 
A receptor model 49 has been suggested by MOLOC calculation to be an excellent 
candidate for binding β,β-carotene. It was shown that β,β-carotene could be bound into 
the longer cavity produced by a dimeric β-CD moiety which was linked on secondary 
face with a rigid 1,3-diamidephenyl spacer, leaving the porphyrin moiety to span the 
polyene chain over excentric double bonds (figure 10).[74]  
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Figure 10 – Computer generated binding mode of 49/β,β-carotene 2 
 
The synthesis of 49 was carried out by P. Holzer as part of his Ph. D. thesis (scheme 
16).[74] Treatment of dry β-CD 19 with tert.-butyldimethylsilyl chloride (TBDMSCl) in 
dry pyridine furnished TBDMS-β-CD 50. After mono-tosylation at C(2)-hydroxy 
group of 50, the resulting β-CD 51 was refluxed in the solution of NaOEt in ethanol to 
provide the corresponding epoxide 52 as intermediate. Without work-up, the solution of 
52 in ethanol was saturated with ammonia, and then refluxed to provide 3-deoxy-mono-
amino-β-CD 53 in 80% yield calculated from 51. Coupling of 53 with isophthalic di(N-
hydroxysuccinimide)ester in refluxing THF furnished β-CD dimer 54 in 64% yield, 
followed by deprotection with TBAF. Mono-tosylation of 55 was carried out with equal 
equivalent of p-TsCl in pyridine to provide 6-mono-Ts-β-CD dimer 56 in 42% yield 
after purification by preparative HPLC. It should be noted that 56 was a mixture of 
isomers resulted from unselective mono-tosylation of primary hydroxyl groups. Further 
separation of isomers was difficult. It was postulated that the binding models of β,β-
carotene towards isomers were not much different, so that the mixture of 56 was 
directly used for the next step without isolation.  Treatment of porphyrin 57 with NaH 
and 2 equivalents of 56 in DMF furnished 49 in 6% isolated yield.  
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Scheme 16 – Synthesis of supramolecular receptor 49 
 
With the receptor in hand, it was logical to directly introduce ruthenium into 49 to 
obtain the corresponding ruthenium-porphyrin complex. However, in a similar case as 
shown in scheme 17, it was found that the β-CD moiety was degraded, via a ruthenium 
mediated decomposition, under the standard reaction condition required for insertion of 
ruthenium (excess ruthenium dodecacarbonyl, 190oC, 4h).[69]  
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Scheme 17 – Degradation of porphyrin-CD complex under standard ruthenium insertion reaction 
 
Alternatively, one could conceive that the synthesis of the corresponding ruthenium 
complex of 49 may be achieved by coupling of 56 with Ru(II)-57. However, owing to 
the poor reactivity of 57, this protocol was unreliable. Yield of coupling of 56 with 57 
is only 6%. After introduction of ruthenium into 57, NMR of the resulting Ru(II)-57 
showed that protons of phenol ring shifted to low field, suggesting its nucleophilicity 
would be less than that of 57. According to this finding, it could be predicted that the 
yield of coupling reaction would be lower than 6% in the presence of ruthenium. 
Furthermore, since the preparation of 56 was difficult (4.6% overall yield from β-CD 
with 6-step sequence), use of a large excess of 56 to increase the yield of coupling was 
unaffordable.  
 
In view of these problems, complex 58 has to be synthesized by using porphyrin 59 as 
precursor since thiophenol is a good nucleophile (scheme 18).  
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Scheme 18 – Synthesis of complex 58 from porphyrin 59 
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3.1.2 Synthesis of Ru(II)-porphyrin-bis-β-CD complex 58 
Since β-CD dimer 56 has been already prepared by P. Holzer (scheme 16), the crucial 
synthetic task of this project is the synthesis of Ru(II)-porphyrin 59 and the sequent 
coupling to obtain complex 58.  
 
3.1.2.1 The first attempt for synthesis of Ru(II)-porphyrin 59 via 
Pummerer rearrangement 
A previous investigation revealed that 5-methylthiophenyl-10,15,20-tri(methylphenyl)-
porphyrin 60 was extremely labile under the standard condition for ruthenium insertion 
(scheme 19). The problem might arise from the binding of sulfur to ruthenium and 
consequent degradation.   
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Scheme 19 
 
It was envisaged that the corresponding methylsulfoxy porphyrin 61 might be less 
likely to bind to ruthenium, and thus might survive under the harsh reaction condition. 
In addition, to the best of our knowledge, Pummerer rearrangement[77-79] is efficient for 
converting methylsulfoxy precursors to the corresponding thiol compounds under mild 
reaction conditions. Thus, porphyrin 61 was chosen as the precursor of 59. 
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3.1.2.1.1 Retrosynthetic analysis 
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Scheme 20 – Retrosynthetic analysis of 59 with 61 as intermediate (Pummerer rearrangement) 
 
As illustrated in scheme 20, 59 could be generated from porphyrin 62 via Pummerer 
rearrangement. In principle, 62 could be accessible from free base porphyrin 61 by 
insertion of ruthenium. The latter porphyrin 61 could be prepared from p-
tolyldipyrromethane 63, p-methylbenzaldehyde 64 and p-(methylsulfoxy)benzaldehyde 
65 which could be accessible from p-(methylthio)benzaldehyde 67 by simple functional 
group manipulations.[80-82]  
 
3.1.2.1.2 Synthesis 
The synthesis of the porphyrin 61 was achieved by acid catalyzed condensation of p-
tolyldipyrromethane 63[83, 84] with p-methylbenzaldehyde 64 and p-(methylsulfoxy)- 
benzaldehyde 65. Thus, treatment of a solution of 63, 64 and 65 in CH2Cl2 with 
trifluoroacetic acid (TFA) at room temperature, followed by oxidation of the crude 
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porphyrinogen products with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ), afforded a 
mixture of porphyrins 61, 68-70 (scheme 21).[85] This mixture was the result of 
competing acid catalyzed “scrambling” which occurs during the condensation. The 
proposed mechanism of this reaction is shown in scheme 22.[86] The reaction allows the 
production, from 63 via I, of rogue intermediate III which can then substitute for 
species II to produce a mixture of porphyrinic products. Column chromatography of 
the mixture afforded pure porphyrin 61 in 17% yield. 
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Scheme 21 - Porphyrin condensation reaction 
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Scheme 22 - Mechanism of the scrambling reaction which leads to porphyrin mixture 
 
Attempt to introduce ruthenium into 61 under the standard condition was unsuccessful, 
leading to a mixture of porphyrins without methylsulfinyl group (scheme 23). 
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Scheme 23 – Attempt to insert ruthenium to 61 under standard condition 
 
Further investigations on the reaction conditions revealed that the same result was 
obtained even in refluxing toluene. In contrast, porphyrin 61 survived without reaction 
at 90oC. It was thus postulated that this undesired result could be due to the same 
reason suggested in the case of porphyrin 60 at high temperature. 
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At this stage, it was reasonably expected that the addition of another ligand of 
ruthenium in the reaction system would block the coordination of methylsulfoxy group 
and thus inhibit the ruthenium mediated degradation. To achieve this strategy, the 
ligand should possess appropriate binding constant to ruthenium, leading to a 
competitive inhibition. On the other hand, it should be easily removed by simple work-
up. After a number of attempts, compound 66 was found to be an ideal scavenger. 
Using 12 equivalents of 66 in refluxing DMF furnished 62 in 67% isolated yield 
(scheme 24). 
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Scheme 24 – Sucessful insertion of ruthenium to porphyrin 61 
 
Once the precursor 62 was obtained, it was now required to convert to Ru(II)-porphyrin 
complex 59. Breslow reported a similar procedure to produce a porphyrin-CD complex 
71 via Pummerer rearrangement.[59] As illustrated in literature (scheme 25), treatment 
of porphyrin 72 with trifluoroacetic anhydride (TFAA) in CH2Cl2 provided a porphyrin 
dithioacetal acetate 75, which was labile and used immediately for the next step. The 
corresponding bis-(p-thiophenyl)porphyrin could be generated from 75 in situ with 
MeOH/Et3N, which was then directly coupled with 6-deoxy-mono-iodo-β-CD to 
furnish complex 71. 
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Scheme 25 - Synthesis of complex 71 via Pummerer rearrangement[59] 
 
Despite a number of attempts, 62 could not be converted directly to 59 or by means of 
“in situ” to 58. Exposure of 62 to TFAA only led to decomposition judged by TLC and 
ESI-MS. In contrast, the free base porphyrin 61 could provide the corresponding 
coupling product verified by ESI-MS. (scheme 26) 
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Scheme 26 – The conversion of free base porphyrin 61 to β-CD complex via procedure reported by 
Breslow.[59] 
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3.1.2.2 The second attempt for synthesis of Ru(II)-porphyrin 59 via 
Newman-Kwart rearrangement 
3.1.2.2.1 Retrosynthetic analysis 
Because of the failure of the first strategy, the attention was turned to phenol 
substituted porphyrin 57. It was known that Newman-Kwart rearrangement could 
efficiently convert phenol to thiophenol.[87] Thus, phenols are readily converted into the 
corresponding O-aryl dialkylthiocarbamates in high yield by treatment with 
dialkylthiocarbamyl chloride, which is then pyrolyzed to S-aryl dialkylcarbamates 
under “neat” reaction condition or in solvents with high boiling points. It was proposed 
that the pyrolysis involved intramolecular nucleophilic attack of the sulfur at the carbon 
holding the oxygen. The desired polarization is assisted by the dialkylamino group 
(scheme 27). In turn, S-aryl dialkylcarbamates could be hydrolysed to the 
corresponding aryl mercaptans easily.  
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Scheme 27 - Mechanism of Newman-Kwart rearrangement 
 
Therefore, a new strategy was planned to achieve the target porphyrin 59. The 
retrosynthesis is outlined in scheme 28. The crucial thiophenol-Ru(II)-porphyrin 59 
could arise from  prophyrin 57 via the sequence of Newman-Kwart rearrangement, 
followed by insertion of ruthenium and subsequent deprotection. Porphyrin 57 should 
be accessible from p-tolyldipyrromethane 63, anisyldipyrromenthane 80 and p-
methylbenzaldehyde 64, followed by cleavage of methoxy group. 
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Scheme 28 – Retrosynthetic analysis of 59 with 57 as intermediate (Newman-Kwart rearrangement) 
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3.1.2.2.2 Synthesis 
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Scheme 29 – Synthesis of porphyrin 77 via Newman-Kwart rearrangement 
 
Porphyrin 79 was achieved by acid catalysed condensation, followed by cleavage of the 
methoxy group.[69] Thus, treatment of a solution of 63, 64 and 80[83, 84] in CH2Cl2 with 
3.56 equivalents of TFA at room temperature, followed by DDQ oxidation, gave a 
mixture of porphyrins. After column chromatography, the second band was collected 
and afforded porphyrin 79 in 15.8% yield, which was subsequently converted to 57 in 
96% yield with large excess of AlCl3/ethanethiol in CH2Cl2 at room temperature over 
night. In turn, after deprotonation with sodium hydride, porphyrin 57 was converted to 
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the corresponding O-aryl dimethylthiocarbamated porphyrin 78 in 89% yield by 
treatment with dimethylthiocarbamyl chloride in DMF at 80oC. By means of neat 
reaction at 280oC, 78 rearranged to S-aryl dimethylcarbamated porphyrin 77 
quantitively (scheme 29). 
 
Unfortunately, attempts to introduce ruthenium into 77 under the standard condition 
only afforded the free base porphyrin as sole product (scheme 30). The similar 
methodology used for preparation of ruthenium porphyrin 62 also led to the same result. 
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Scheme 30 - The result of insertion of ruthenium into 77 under the standard condition 
 
At this stage, based on the lesson learned from previous works, it was reasonable to 
suggest that the introduction of ruthenium should be done as early as possible to avoid 
the degradation of sulfur functional group mediated by ruthenium. Thus, the attention 
was turned to β-carbonyl [5-phenol-10,15,20-tri(methylphenyl)-porphyrinato] 
ruthenium 81 as the precursor of 59. 
 
Under the standard condition, phenol porphyrin 57 provided the corresponding 
ruthenium complex 81 quantitively. Treatment of 81 with sodium hydride in DMF, and 
then dimethyllthiocarbamyl chloride at 80oC provided dimethylthiocarbamated 
porphyrin 82 in 71% yield. The following Newmann-Kwart rearrangement was firstly 
tested under neat condition (280oC), leading to 76 (25-27%) along with unreacted 82 
and a number of unidentified side products. Several solvents with boiling points within 
120-180oC were screened to elicit the rearrangement but failed without reaction. 
Remarkably, using sulfolane as solvent finally provided a workable solution, furnishing 
the product of rearrangement, porphyrin 76, in 86-88% yield (scheme 31). 
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Scheme 31 – Preparation of porphyrin 76 
 
With the crucial precursor 76 in hand, it was now required to convert to porphyrin 59 
for coupling with β-CD dimer 56. Thus, porphyrin 76 was subjected to the reduction 
with LiAlH4 to remove the dimethylcarbamate protecting group. Despite a number of 
attempts, Ru(II)-porphyrin 59 could not be obtained. Closer investigation suggested 
that 59 was extremely unstable to dioxygen. A sequent oxidation might happen to 
produce a dimeric porphyrin with disulfur linker even with traces of dioxygen, which 
was confirmed by ESI-MS (scheme 32). To this point, separation of 59 was impossible.  
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Scheme 32 – Oxidation of 59 with traces of oxygen 
 
Eventually, an “in situ” procedure was developed to avoid separation of 59 as shown in 
scheme 33. Thus, porphyrin 76 was treated with 3 equivalents of LiAlH4 in refluxing 
THF under argon to afford deprotonated 59. Water and oxygen free methanol was 
added to quench the reaction, and then evaporated under vacuo at room temperature. 
The resulting residue was dissolved in a degassed solution of 2 equivalents of 56 in 
DMF together with 100 equivalents of pyridine. The reaction mixture was heated at 
80oC under argon for 24h. This procedure furnished the desired supramolecular 
complex 58 in 67% yield after purification by semi-preparative HPLC.  The same 
procedure was also applied to produce a mono-β-CD complex 83 in 57% yield.  
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Scheme 33 – Preparation of supramolecular complex 58 and 83 
 
It should be noted that pyridine was used to avoid the self-assembling of 59 since 
coordination of thiol group to ruthenium would block the coupling (scheme 34).  
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Scheme 34 – Self-assembling of 59 
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3.1.3 Reactivity of supramolecular complex 58/TBHP towards β,β-
carotene 
For the catalytic cleavage of β,β-carotene 2, initial reactions were carried out under 
identical biphasic conditions as R. French reported.[69] Thus, a round bottomed flask 
which had been purged with argon and fitted with an appropriately sized egg shaped 
magnetic stir bar was charged with a solution of 58 in water (75nM/ml). TBHP (70% in 
water) (300 equivalents to 58) was added. β,β-Carotene was added to the reaction flask 
as a solution in chloroform/hexane (1:9) (750nM/ml) to produce a biphasic system. The 
reaction was closed and stirred vigorously to ensure good mixing of the two phases at 
room temperature. At intervals, stirring was stopped to allow phase separation. 
Aliquots (20μl) of the organic phase were taken and subjected to HPLC analysis.  
 
β,β-Carotene was fully consumed after 18h and six products of the reaction could be 
identified: 13-apo-β-carotenone 17 (peak a), retinal 8 (peak b), 14’-apo-β-carotenal 15 
(peak c), 12’-apo-β-carotenal 14 (peak d), 10’-apo-β-carotenal 10 (peak e), 8’-apo-β-
carotenal 9 (peak f, traces) by means of UV/Vis, LC-MS or co-injection with authentic 
standards. (figure 11) It should be noted that 15 and 17 were only verified by UV/Vis[35] 
and LC-MS but could not be quantified since the corresponding authentic standards 
were not available.  
 
Upon quantification of the three “cleavage” products (8, 10, 14), the combined yield 
from the reaction at 10.5h (the time point when concentration of 10 and 14 reached 
maximum) was 8.5%, which is similar to the results from complex 46 (7%) as R.  
French reported.[69] The selectivity for the cleavage is similar to that of 46 as well. It 
should be noted that the yield of the reaction is based on the fact that one molecule of 
β,β-carotene would be cleaved to give two molecules of retinal, but the cleavage to 
apo-β-carotenals would only give one molecule of these products.  But, for comparing 
with reported results of 46, the selectivity is demonstrated as product ratio [C (apo-β-
carotenal, nmol/ml)/C (retinal, nmol/ml)]. 
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Figure 11 – HPLC chromatogram of reaction of 2 with 10% 58 after 10.5h (λdet = 380nm) and product  
                     ratio (compared with the result of 46) 
 
For practical reasons, a modified procedure was developed. The solution of β,β-
carotene (265nmol/ml) in hexane/chloroform (9:1) was added into the flash containing 
a solution of 58 (75nmol/ml, 30%) in water, to which 300 equivalents of TBHP (wrt 58) 
had been added. The biphasic system was stirred vigorously at 31oC. Under this 
reaction condition, the combined yield (7.3%) of 8, 10, 14 and the cleavage selectivity 
a
b
c
d
e 
f
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were similar to that obtained before (figure 12). However, the reaction time was 
reduced to 8h, making reaction control much easier.  
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Figure 12 – Product ratio of reaction of 2 with 30% 58 at 31oC (λdet = 380nm) 
 
Suprisingly, the results shown in figure 11 and 12 are very similar to those observed 
using complex 46, the catalyst designed for the central cleavage of β,β-carotene 
(scheme 13). It was postulated that one of two phenomena, degradation of apo-β-
carotenals to retinal and/or motion of β,β-carotene within the binding pocket, were 
occurring during the reaction to cause this anomalous result. These two postulates and 
the manner in which they were addressed will be discussed in the following section. 
 
3.1.3.1 Degradation of apo-β-carotenals to retinal or mobility of 
binding? 
3.1.3.1.1 Cleavage of apo-β-carotenals by complex 58/TBHP 
During the catalytic cleavage reaction, it was observed that the apo-β-carotenals were 
sensitive to the reaction condition and they might be continuously degraded to retinal. 
Therefore, degradations of apo-β-carotenals by complex 58 was investigated under the 
identical modified procedure for cleavage of β,β-carotene (30% 58 at 31oC). 
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Scheme 35 – Degradations of apo-β-carotenals by complex 58 
 
Reactions of 58/apo-β-carotenals with TBHP as cooxidant showed that: i) 8’-apo-β-
carotenal could not be cleaved to 10’- and 12’-apo-β-carotenal, but to retinal in 0.8% 
yield; ii) 10’-apo-β-carotenal could not be cleaved to 12’-apo-β-carotenals, and both of 
them could not be degraded to retinal (scheme 35). Since only traces of 8’-apo-β-
carotenal was produced during the cleavage reaction, the effect of conversion could be 
omitted. 
 
3.1.3.1.2 Is β,β-carotene mobile when bound to the complex? 
If β,β-carotene is mobile when bound to the complex, then this phenomenon must be 
related to the interaction between the endgroup of β,β-carotene and β-CD cavity, such 
that a lateral movement of β,β-carotene within the binding pocket would expose several 
double bonds to the reactive ruthenium center.[69] Thus, if the answer is “yes”, one 
would expect a carotenoid with modified endgroup(s) to increase the binding constant 
to β-CD cavity would demonstrate a different selectivity in cleavage. For this purpose, 
a synthetic carotenoid 84[88] with 2,6-dimethylphenyl as endgroups was chosen as 
substrate (figure 13). The hydrophobic interaction between the aromatic endgroup of 84 
and β-CD cavity would be much stronger than that from cyclohexane endgroup of β,β-
carotene, stabilizing the 1:1 inclusion complex as expected from the cleavage results of 
carotenoid 47 using catalyst 47/TBHP (section 1.2.4).   
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Figure 13 – Lateral movement of 2 in β-CD cavity and the structure of endgroup modified carotenoid 84 
 
Accordingly, the profile of synthetic carotenoid 84 was investigated under the identical 
condition (30% 58 at 31oC). The HPLC chromatogram (C-30) for this reaction is 
shown in figure 14. Four products were identified by means of UV/Vis: 13-apo-φ-
carotenone 85 (peak a, Rt = 5.3min, λmax = 340nm, further assignment see section 3.2.4 
and 3.2.5), φ-retinal 86 (peak b, Rt = 6.2min, λmax = 380nm)[69], 14’-apo-φ-carotenal 87 
(peak c, Rt = 9.8min, λmax = 405nm) and 12’-apo-φ-carotenal 88 (peak d, Rt = 18.5min, 
λmax = 425nm).  Surprisingly, the main product is φ-retinal 86 from central cleavage but 
not apocarotenals. Furthermore, a similar result was obtained with the mono-β-CD 
complex 83 as shown in figure 14. 
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Figure 14 – HPLC chromatogram (C-30): A) 30% 58 at 31oC after 4h; B) 30% 83 at 31oC after 4h  
 
Based on these results, it was suspected that only the first β-CD directly linked to the 
porphyrin was used for binding carotenoids. At this stage, two postulates were 
suggested (figure 15): i) the dimeric β-CD moiety does not provide a rigid, extended 
cavity due to the conformational flexibility of the linker and/or due to the small driving 
force for the dimethylphenyl group to slip from the first CD unit into the second one 
and ii) each β-CD unit binds a carotenoid molecule and that a 2:1 complex is produced. 
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d
 56
S
O
NH
O
NH N
N N
N
Ru
CO
another carotenoid
 
 
Figure 15 – Two possible binding modes of 58/84  
 
3.1.4 The crystal structure of the dimeric β-CD moiety 55 
To date, no crystal structure of CD dimer linked via the secondary face has been 
reported. However, fortunately, a single crystal of the β-CD dimer 55 was obtained 
from water/acetone by means of solvent diffusion. The corresponding crystal structure 
is shown in figure 16 (for details see experiment part). 
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Figure 16 – Crystal structure of 55 : A) side view B) top view from the primary face 
 
Obviously, in the solid state the β-CDs of the dimer are perfectly aligned, forming an 
extended cavity which is organized by hydrogen-bonding network between two 
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secondary faces. But, unexpectedly the diamide linker is placed in the axis of the 
molecule between two β-CD cavities, preventing the binding of carotenoids by both 
hydrophobic cavities. As a consequence the ruthenium complex 58/TBHP behaves in 
the same way as 46/TBHP or 83/TBHP with respct to the regioselective oxidation of 
carotenoids. 
 
Actually, the structure is unusual. In the sequence of modification to prepare this dimer 
(scheme 36), the C(2)-tosylated unit of CD (α-D-glucopyranose, 4C1-conformation) 
was first transformed into the 2,3-manno-epoxide, which was then subjected to a 
nucleophilic attack by ammonia, leading to the diaxial 1,2-amino alcohol. Since the 
resulting 4C1 modified α-D-altrose unit is unfavourable, it usually flaps to the more 
stable 1C4 conformation, in which both C(2)-OH and C(3)-NH2 are in favourable 
equatorial position.[89]  
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Scheme 36 – The sequence for modification at C(3) 
 
However, in this special case, the X-ray structure of 55 reveals that the modified α-
altrose unit stays in less stable 4C1 conformation. This conformation is essential for 
self-assembling the secondary faces since the resulting distance between these two β-
CDs is appropriate for interaction by hydrogen-bonding. In addition, the formation of 
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hydrogen-bonding between oxygen atoms of the linker-amides and adjacent C(3)-OHs 
is another driving force.  It could be concluded that the free energy gained by self-
assembling in water is sufficient to compensate for the conversion of the altrose unit 
from 1C4 to the less stable 4C1 conformation. 
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3.2 A flexibly linked Ru(II)-porphyrin-bis-β-CD complex, the second 
enzyme mimic for the excentric cleavage of carotenoids 
3.2.1 Design of a C6-flexibly linked Ru(II)-porphyrin-bis-β-CD 
complex 89 
From the first generation supramolecular complex 58 and corresponding references,[56, 
89-93] it is now clear that, if the β-CD dimer is produced by C(3)-modification via 2,3-
manno-epoxide, there is one of two phenomena which were not favourable for the 
binding  of carotenoids:  
i) If the modified altrose unit is in an unfavourable 4C1 conformation, the entry 
of β-CD cavity is partially blocked since the amide group of the linker 
occupies an axial position and thus is directed towards the interior of the 
cavity. (sheme 35, 4C1 conformation of altose)  
ii) If the modified altrose unit is in a favourable 1C4 conformation, the shape 
and size of the β-CD cavity changes to a distorted ellipsoid, more narrow 
than that of the unmodified β-CD and hence unfavourable for binding of 
carotenoids (example as shown in figure 17).[94]  
 
 
 
 
 
 
 
 
 
 
 
Figure 17 - mono[3-(2-Imidazolythio)]-altro-β-cyclodextrin (right) and the corresponding crystal  
                  structure (middle)[94] 
 
Thus, to avoid these problems mentioned above, C6-flexibly linked Ru(II)-porphyrin-
bis-β-CD complex 89 was designed as shown in figure 18.  
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Figure 18 - Designed second generation enzyme mimic 89 
 
It has been known that C(2)-OH is the most acidic hydroxyl group of β-CD (pKa ~ 12). 
Thus, direct introduction of linker into C(2) would not result in conformational changes 
of β-CD.[93, 95-98] On the other hand, since C(2)-OH is in an equatorial position, this 
flexible C6 linker might stay outside the cavity. It might act as a loop,[99] and thus these 
two β-CDs of the dimer could self-assemble to produce an extended cavity via a 
hydrogen-bonding network on the secondary faces as suggested from the crystal 
structure of the β-CD dimer 55. 
 
3.2.2 Testing the principle 
To the best of our knowledge, it was still possible that the flexible linker could be self-
included into the cavity of β-CD in aqueous environment if it was long enough.[93, 98] 
To exclude this possibility, β-CD dimer 93 was prepared and then subjected to 2D 
NOE measurement (for details of synthesis, please see next section).  In theory, if the 
linker was self-included inside the cavity, NOEs between protons of the linker and CD-
C(3, 5)-Hs, which point into the cavity, should be observed. 
 
The NMR spectra of dimer 93 in D2O showed that dimer was symmetric. Examination 
of the coupling constants revealed that J1,2 (3.6 Hz) and J2,3 (9.9Hz) of the modified 
glucose unit (A) were similar to those of free β-CD 19, suggesting the conformation of 
this unit was retained. Moreover, NOEs were not observed between the protons of the 
linker and protons at C(3, 5), indicating that the linker stayed outside the cavity as 
desired. (figure 19) 
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Figure 19 - Result of NOE measurement for β-CD dimer 93 
 
3.2.3 Synthesis of the flexibly linked Ru(II)-porphyrin-bis-β-CD 
complex 89 
Complex 89 was synthesized as shown in scheme 37. TBDMS-β-CD 50 was selectively 
deprotonated at C(2)-OH with one equivalent of LiH in THF, and then reacted with 
tosylated diol 90[100] in refluxing THF for 5 days.[101] After column chromatography, a 
mixture of dimer 92 and monomer 91 was obtained, but further separation by normal or 
reversed phase column chromatography was impossible. After a lot of attempts, 
eventually, the separation was carried out easily with column chromatography on 
charcoal (ethyl acetate/CH2Cl2 = 2:1) to furnish pure dimer 92 in 22% yield. After 
deprotection with TBAF in refluxing THF, free β-CD dimer 93 was obtained 
quantitively, which was mono-tosylated at the primary face with one equivalent of p-
TsCl in dry pyridine at room temperature. It should be noted that the resulting mono-
tosyl-β-CD dimer 94 is a mixture of isomers, generated from the unselective tosylation 
of one of the primary hydroxyl groups. This mixture could not be separated further and 
was directly used for the next step. Then, following the similar procedure used for 
preparation of complex 58, compound 89 as a mixture of isomers was obtained in 
26.4% yield, identified by UV/Vis (H2O, λmax = 412nm) and ESI-MS (3171 [M+Na]+, 
1597.3 [M+2Na]2+/2, 1573.9 [M-2H]2-/2). 
 
 62
O
OO
HO OH
OTBDMS
7
O
O OT
BD
M
S7
7TBDMSO
TsO(CH2)6OTs (90)
O
OTs
7TBDMSO
TBAF / THF
LiH / THF
(22%)
O
O
(97%)
50
92
91
93
TsCl / Py
(34%)
O
O
94
OTs
(mixture of 7 isomers)  
 
N
N
N
N
S
Ru
CO
O O
89
(mixture of 7 isomers, 26.4%)
1. LiAlH4 (3eq.) / THF
2. MeOH
3. 94(2eq.) / Py (100eq.) / DMF
N
N
N
N
Ru
CO S C
O
N(CH3)2
76
 
 
Scheme 37 - Synthesis of complex 89 
 
3.2.4 Reactivity of complex 89/TBHP towards carotenoids 
For the catalytic cleavage, initial reaction was carried out with β,β-carotene 2 as 
substrate under the modified conditions described in section 3.1.3 
(catalytic/substrate/TBHP = 1:3.5:300, @ 31oC). β,β-carotene was completely 
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consumed after 8h. As shown in figure 20, it was observed that the ratio of 13-apo-β-
carotenone 17 (Rt = 10.1min)/retinal 8 (Rt = 10.5min) decreased over the reaction time, 
and the final result was similar to those with complex 58 as catalyst and β,β-carotene as 
substrate (figure 11).  
 
A) 
min0 2 4 6 8 10 12 14 16
mAU
0
50
100
150
200
250
300
 DAD1 B, Sig=380,8 Ref =of f  (HAO2\H-257-01.D)
  A
rea
: 3
3.8
49
4
 1
0.
10
2
  A
rea
: 2
1.8
70
8
 1
0.
48
7
 
B) 
min0 2 4 6 8 10 12 14 16
mAU
-10
0
10
20
30
40
50
60
 DAD1 B, Sig=380,8 Ref =of f  (HAO2\H-257-06.D)
  A
rea
: 1
61
.47
8
 1
0.
11
1
  A
rea
: 2
54
.90
9
 1
0.
49
3
  A
rea
: 8
4.9
03
1
 1
1.
39
4   A
rea
: 1
29
.27
9
 1
2.
13
5
  A
rea
: 3
8.1
78
5
 1
2.
26
1
 
 
Figure 20 - A) HPLC chromatogram (RP-18) of reaction of 89/2 after 1h (λdet = 380nm); B) HPLC  
                   chromatogram after 8h (λdet = 380nm): Peak a and b are from 13-apo-β-carotenone 17 and       
                   retinal 8 respectively. 
 
The cleavage was further examined with 17,17’-dinor-φ,φ-carotene 84 as substrate. As 
expected, the reaction time was reduced to 5h. Interestingly, a “de-centralized” 
cleavage was observed (figure 21 and scheme 38). The main peak a (Rt = 5.18min, λmax 
= 340nm) was verified to be 13-apo-φ-carotenone 85 by co-injection with synthetic 
authentic standard (for synthesis of 85, please see next section). Peak c and d were 
identified as 14’-apo-φ-carotenal 87 (Rt = 10.7min, λmax = 402nm) and 12’-apo-φ-
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carotenal 88 (Rt = 18.5min, λmax = 425nm) according to their UV/Vis spectra. Peak b 
(Rt = 6.25min) was a mixture containing φ-retinal 86 (λmax = 380nm). 
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Figure 21 – A) HPLC chromatogram (C-30) of reaction of 89/84/TBHP (λdet = 380nm) after 5h; B) 
UV/Vis spectra of peak a; C) UV/Vis spectra of peak b 
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Scheme 38- Reaction of synthetic carotenoid 84 with complex 89 under the  modified condition 
 
However, in contrast to the first supramolecular complex 58, the combined yield of 
cleavage products was extremely low. A similar result was obtained even if the ratio of 
catalyst to substrate (84/89) is 10:1. It was possible that the cleavage products were 
bound by 89 in aqueous phase as well as 84 since the endgroup with strong interaction 
with β-CD was not been altered, and then they were continuously degraded to some 
other small fragments. To exclude this possibility, CHCl3/hexane (2:3) was used as 
organic phase for the cleavage reaction to increase the efficiency of product-extraction. 
Surprisingly, the substrate was completely consumed after 3h, but the yield of 13-apo-
φ-carotenone 85 (figure 22) was similar to that with CHCl3/hexane (1:9).  
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Figure 22 - HPLC chromatogram (C-30) of cleavage of 84 with CHCl3/hexane (2/3) after 3h (λdet = 
380nm). Peak (Rt = 6.67min) was from φ-retinal 86 as UV/Vis suggested. 
 
3.2.5 Synthesis of 13-apo-φ-carotenone 85 
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Scheme 39 - Synthesis of 13-apo-φ-carotenone 85 
 
As shown in scheme 39, 13-apo-φ-carotenone 85 was synthesized starting from 2,6-
dimethylbenzaldehyde 95.[88, 102, 103] Catalyzed by NaOH (aq. 2M), 95 reacted with 
acetone at room temperature to give ketone 96 in 77% yield.[88] The selective formation 
of (E)-96 is due to steric hindrance of the aromatic methyl groups. Using Wittig-Horner 
conditions, ketone 96 was converted to the ester 97 obtained as a mixture of EE/ZE = 
4:1 according to 1H-NMR. Employing di(iso-butyl)aluminum hydride (DIBALH), ester 
97 was reduced to the alcohol 98.[103] After column chromatography, the all-E isomer 
O
13-apo-φ−carotenone 85
O
φ−retinal 86
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of 98 was obtained in 56.3% yield. It should be noted that ethyl acetate could not be 
used as solvent for column chromatography since alcohol 98 was acylated to the ester 
100 catalyzed by silica gel or basic alox (scheme 40).  
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Scheme 40  - Acylation of alcohol 98 by ethyl acetate 
 
Alcohol 98 was then oxidized with an excess of MnO2 in hexane to furnish the 
corresponding (all-E)-aldehyde 99 in 58.7% yield, which was then converted to ketone 
85 in 84.7% yield with acetone catalyzed by NaOH (2M).  The all-E configuration of 
85 was verified by 1H-NMR and 2D COSY and NOE experiments as shown in figure 
23. 
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Figure 23 – The all-E configuration of 85 confirmed by NMR examinations 
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3.2.6 Argument of the cleavage results from complex 89 
The cleavage of 17,17’-dinor-φ,φ-carotene 84 catalyzed by the enzyme mimic 89 is 
selective at C(13’)-C(14’) double bond of the polyene chain. However, the result is not 
as expected from our design (figure 24). In contrast to the results from complex 58 or 
83, the “de-centralized” cleavage corresponds to a shift of oxo-ruthenium attack by 
only 2-2.5Å, suggesting that the second β-CD unit does not participate in 
binding/orienting the substrate. 
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Figure 24 
 
There may be, however, other reasons why 89 seemingly fails to show truly excentric 
cleavage. In order to discuss this aspect one has to consider two important facts. i) The 
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HPLC of the reaction mixture of 89/TBHP/84 (see figure 21/top) shows quite a number 
of peaks (Rt = 22-32min) displaying a retinyl chromophore (λmax = 320-380nm), 
suggesting the presence of carotenoid-epoxides which have not been cleaved to 
aldehydes. This observation is related to ii) The mechanism of oxo-ruthenium/TBHP 
supported double bond cleavage (see scheme 15) comprises a fast epoxidation and a 
very slow ring opening fragmentation in which the ruthenium porphyrin must 
participate.[74, 76] This two-step mechanism poses a problem that was actually not 
considered when the supramolecular enzyme model for excentric cleavage was 
designed.  
 
In fact we expect a “successful” system that the “initial” epoxide stays bound to oxo-
ruthenium, does not move to expose another double bond for epoxidation or de-
complex and has to be rebound for cleavage. Further, we anticipate that the cleavage of 
ruthenium-bound epoxide is insensitive to steric hindrance, i.e., trisubstituted epoxides 
are cleaved with the same rates as disubstituted ones. However, for all these aspects a 
clear-cut knowledge is not available. 
 
The situation is further complicated by the possibility that the “initial” epoxide may 
undergo ruthenium catalyzed reactions other than TBHP assisted ring opening and 
fragmentation. It was indeed shown by M. Kundu in our group (scheme 41) that the 
“central” epoxide of β,β-carotene 101 undergoes rearrangement/isomerization to the 
dihydro-oxepin 102 which displays a retinyl-like chromophore (λmax = 332nm).[76] In 
these experiments it was demonstrated that it was impossible to isolate the central 
15,15’-epoxy carotene. Accordingly the bulk of compounds visible in HPLC (figure 21) 
with long retention times probably comprise carotenoid epoxides and their 
rearrangement products. 
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Scheme 41 – Ru-assisted transformation of the central epoxide 101 to the dihydro-oxepin 102 
 
In summary it looks that we asked too much from complex 89. Obviously, for a 
“successful” excentric cleavage system the two reactions must be separated, i. e., a 
complex must be found to catalyze epoxidation without performing fragmentation, then 
analysis of the epoxides provides the required information regarding regioselectivity. In 
a separate reaction, the mixture of epoxides can then be subjected to 
cleavage/fragmentation in order to obtain the aldehydes. 
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3.3 A Ru(II)-porphyrin-mono-β-CD complex, the third enzyme mimic 
for the excentric cleavage of carotenoids 
3.3.1 Design of complex 103 
As mentioned in section 3.1, it has been found that the mono-β-CD complex 83 could 
act as catalyst for the central cleavage of carotenoids. As shown in figure 25, the 
binding mode of 83/84 suggests that one of dimethylphenyl endgroups of carotenoid 84 
binds inside the cavity of β-CD, leaving the C(15)-C(15’) double bond exposed to the 
active ruthenium center.  
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Figure 25 – Design of the third enzyme mimic 103 
 
Based on this hypothesis, it is reasonable to conceive that introduction of a rigid spacer 
between β-CD and the porphyrin moiety of complex 83 could make one of the 
excentric double bonds of 84 under active ruthenium center. Therefore, Ru(II)-
porphyrin-mono-β-CD complex 103 was designed to mimic the excentric cleavage of 
carotenoids. 
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As shown in figure 24, β-CD and porphyrin moieties of 101 are linked by a biphenyl 
spacer. Due to free rotation at benzylic position, it is expected that complex 101 could 
self-adjust to the favourable conformation for the cleavage of carotenoids when the 
rod-like substrate binds to the β-CD receptor. 
 
3.3.2 Synthesis of mono-β-CD complex 103 
 The first synthetic strategy was examined as shown in scheme 42 below. 
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Scheme 42 - First synthetic strategy of complex 103 
 
Treatment of ruthenium porphyrin 81 with bromide 104 (prepared by S. Gabutti[104]) in 
the presence of Cs2CO3 as base in DMF afforded porphyrin 105 in 85.3% yield. 
Subsequent deprotection with hydrazine in EtOH/toluene (2:1) furnished free amino-
porphyrin 106 in 82.9% yield. Pyridine was used to avoid coordination of the terminal 
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amino group to ruthenium. However, the reaction of porphyrin 106 with 6-mono-tosyl-
β-CD did not afford the coupling product-complex 103. 
 
To investigate the reaction condition of coupling, a series of reactions between p-
phenylbenzylamine 107 and 6-mono-tosyl-β-CD was examined, revealing that 
treatment of 6-mono-tosyl-CD with 2 equivalents of 107 in DMF for 46h at 70oC 
indeed provided the product 108 in 62% yield. (scheme 43) 
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Scheme 43 – Results of mode reactions 
 
However, under the same reaction condition, coupling of 106 with 6-mono-tosyl-β-CD 
did not give the desired product 103, even if 100 equivalents of pyridine was used to try 
to exclude coordination of the amino group to ruthenium. This result was not 
understood till it was found that ruthenium porphyrin “inhibited” the coupling reaction: 
treatment of 6-mono-tosyl-CD with 2 equivalents of 107 in the presence of 2 
equivalents of ruthenium meso-tetraphenylporphyrin 109 in DMF only provided traces 
of 108. (scheme 43) 
 
It was concluded that this “inhibition” was still due to the coordination of the amino 
group to ruthenium. Thus, a reversed strategy was investigated as shown in scheme 44 
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since, owing to steric hindrance, 6-deoxy-mono-amino-β-CD might not coordinate to 
ruthenium.  
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Scheme 44 - Second synthetic strategy of complex 103 
 
Treatment of 81 with excess of dibromide 110 (prepared by S. Gabutti[104]) at room 
temperature yielded benzylbromide 111. However, the subsequent coupling reaction 
only provided benzylalcohol 112 probably due to hydrolysis of 111 by traces of water 
associated to β-CD. 
 
3.3.3 Design and synthesis of an alternative mono-β-CD complex 113 
The synthetic problems to attach the ruthenium porphyrin moiety to the primary face of 
β-CD led us to consider an alternative complex 113, in which the porphyrin moiety was 
linked to the secondary face of β-CD.  
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The synthetic strategy is outlined in scheme 45. TBDMS-β-CD 50 was chosen as 
starting material because: 
i) TBDMS-protecting groups crowded around the primary face are expected to 
block the entry of biphenyl group into the cavity of β-CD from the primary 
face. 
ii) As mentioned before, C(2)-OH is the most acidic hydroxyl group, which 
can be selectively deprotonated to act as a strong nucleophile for coupling. 
Further, the possible deprotonation of several C(2)-OH groups prevents the  
biphenyl group to enter the cavity of β-CD from the secondary face. 
 
Thus, TBDMS-β-CD 50 was deprotonated by 7 equivalents of LiH, and then reacted 
with 0.1 equivalent of bromoporphyrin 111 in refluxing THF for 40h under argon to 
afford protected complex 114 in 63.7% yield (calculated from 111). During reaction, no 
alcohol 112 was observed. After deprotection with excess of TBAF in refluxing THF, 
the desired complex 113 was obtained in 80% yield. 
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Scheme 45 - Synthesis of complex 113 
 
3.3.4 Reactivity of supramolecular complex 113/TBHP towards 
carotenoids 
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Since complex 113 is insoluble in water, initial reactions were carried out in DMF. 
Thus, a solution of 113, 17,17’-dinor-φ,φ-carotene 84 (10 eq.) and TBHP (300 eq.) in 
DMF was stirred at 31oC under argon. At intervals, aliquots of the reaction mixture 
were subjected to HPLC analysis (C-30). Surprisingly, the result turned out to be 
central cleavage as shown in figure 26. 
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Figure 26 – HPLC chromatogram (C-30) of reaction of 84 with 10% 113 in DMF after 3h (λdet =  
                    380nm). Peak a-e are 13-apo-φ-carotenone 85, φ-retinal 86, 14’-apo-φ-carotenal 87, 12’-apo-    
                    φ-carotenal 88 and substrate 84 respectively. 
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In contrast, a de-centralized cleavage was obtained under biphasic reaction conditions 
afterwards. It was found that MeOH could be a co-solvent to increase solubility of 
complex 113 in water. Thus, to a solution of complex 113 in MeOH/H2O (1:9) was 
added the solution of carotenoid 84 in hexane/CHCl3 (9:1) to produce a biphasic system. 
With TBHP (300 eq. to 113) as cooxidant, this biphasic mixture was stirred vigorously 
at 31oC. The HPLC analysis is shown in figure 27. 
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Figure 27 – HPLC chromatogram (C-30) of reaction of 84 with 10% 113 in biphasic system (λdet =  
                     380nm). Peak a, c, d are 85, 87 and 88 respectively. Peak b is from 86 together with others. 
 
These results revealed that the cleavage catalyzed by complex 113 is solvent dependent. 
The cleavage result obtained in DMF was suggested by NMR spectra of 113 in DMSO-
D6 (figure 28). NOEs were observed between the spacer and the meta-protons of the 
adjacent phenyl ring of porphyrin unit. It is suspected that, due to the rotation of C-O 
ether bond, spacer-porphyrin moiety of complex 113 stays in a partially folded but not 
a rodlike conformation in DMF, reducing the distance between ruthenium center 
(reactive site) and β-CD (substrate binding site) so that complex 113 acts as a catalyst 
for the central cleavage of carotenoids in DMF. Further, this hypothesis was confirmed 
by computational calculation of a model structure 115 with the Titan program, 
revealing that the distance between protons (marked in red) is 4.5 Å. 
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Figure 28 – NOEs between spacer and adjacent phenyl ring of porphyrin unit in 113 (DMSO-D6) and     
                     computational calculation of 115 
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4 Summary 
All naturally occurring vitamin A derives from enzymatic oxidative cleavage of β,β-
carotene or other carotenoids with pro-vitamin A activity. Two metabolic pathways of 
β,β-carotene to retinal (vitamin A aldehyde) have been proposed: the central cleavage 
providing 2 mol of retinal, and the excentric cleavage yielding apo-β-carotenals first, 
which are subsequently transformed into retinal. Each pathway is used preferentially in 
mammalian β,β-carotene metabolism, depending on the specific tissue. 
 
Due to their unusual reactivity to regioselectively cleave one double bond in a 
conjugated polyene of very hydrophobic substrates, these enzymes present a formidable 
challenge to chemists interested in enzyme catalysis. 
 
Regarding the central cleavage of carotenoids, considerable progress has been 
accomplished both with respect to the identification/isolation of the proteins from 
various tissues/species and concerning the synthesis of structural remote enzyme 
models which effectively mimic the enzymatic reaction. 
 
The excentric oxidative cleavage of carotenoids is not only significant to mammals but 
even more important in the plant kingdom providing metabolites used as fragrances and 
for defensive mechanism. 
 
The latter research area is overall less advanced than the former in particular no 
enzyme mimics have been available at the outset of this thesis. 
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Scheme 46 – The central cleavage of β,β-carotene 2 to retinal 8 can be mediated by the β-CD based  
enzyme mimic 46. 
 
Encouraged by the success of complex 46 as an enzyme mimic for central cleavage of 
carotenoids (scheme 46), we decided to develop related supramolecular models to 
mimic the reactivity and selectivity of the enzymes catalyzing the excentric cleavage of 
carotenoids. Within this context, three β-CD linked ruthenium porphyrin complexes 
have been designed and synthesized.  
 
The first generation enzyme mimic, complex 58, designed by computer modelling, 
comprises a rigidly linked dimeric β-CD moiety as the substrate recognition site and a 
ruthenium porphyrin,  attached to one of the primary faces of  β-CDs, as site of 
reactivity.   
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Scheme 47 – The reactivity of 58/TBHP towards 17,17-dinor-φ,φ-carotene 84 
 
However, the reactivity of complex 58 towards 17,17’-dinor-φ,φ-carotene 84 reveals 
that this supramolecular model actually mimics the central cleavage pathway (scheme 
47), which is consistent with the crystal structure of β-CD dimer moiety obtained later 
(figure 29). Owing to the modification of β-CD via 2,3-manno-epoxide and 
intramolecular self-assembling by hydrogen-bonding network, the diamide linker sits 
between β-CDs, blocking the entrance of the substrate to the second β-CD unit. 
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Figure 29 – Crystal structure of dimeric β-CD moiety of 58 
 
In order to avoid “capping” of β-CD by the linker, the second complex 89 was 
designed and synthesized (scheme 48). The dimeric β-CD moiety is linked by a C6-
flexible chain directly on C(2). It is conceived that the linker might act as a loop outside 
the dimeric β-CD moiety, holding β-CDs together via a hydrogen-bonding network to 
produce an extended cavity as the substrate binding site. The results with 89/TBHP 
reveals that this complex cleaves carotenoids at C(13’)-C(14’) double bond, mimicking 
excentric cleavage to a certain extent.  
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Scheme 48 – Cleavage of carotenoid 84 to 13-apocarotenone 85 can be mediated by β-CD based enzyme  
                      mimic 89 
 
The fact that mono-β-CD complex 83 could mimic the central cleavage of carotenoids 
was then used to design and prepare complex 113 which contains a rigid biphenyl 
linker, attached to the secondary face of β-CD, to increase the distance between the β-
CD unit and the ruthenium porphyrin moiety (figure 30).  
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Figure 30 – Structures of complexes 83 and 113 
 
The reactivity of complex 113/TBHP towards carotenoid 84 is solvent dependent. A 
central cleavage was observed in DMF, whereas an excentric cleavage at C(14’)-C(13’) 
double bond was observed in the biphasic system. NOE spectra and computational 
calculation suggests that complex 113 adopts a partial folded conformaion in DMF, 
reducing the distance between β-CD and active ruthenium center. 
 
In conclusion the work presented here comprises the synthesis of several new 
monomeric and dimeric β-CD-ruthenium porphyrin complexes which in the presence 
of TBHP show the reactivity required to cleave conjugated double bond to aldehydes, 
depending on the relative orientation/distance of the substrate binding site (β-CD) to 
the reactive site (Ru=O). These complexes, binding carotenoids in a supramolecular 
fashion, cleave the symmetric polyolefins either at the central C(15)-C(15’) or slightly 
excentric C(13’)-C(14’) double bond. As such, these complexes mimic to a certain 
extent both classes of enzymes which metabolize carotenoids in nature. 
 
 
 
 86
5 Experimental Part 
5.1 General 
Solvents and Reagents 
Reagents were used as received from Fluka AG, and Aldrich Chemie unless otherwise 
stated. Chemicals of the quality purum, purum p. a. or >98% were used without further 
purification. Retinal 8, 12’-apo-β-carotenal and 14’-apo-β-carotenal for HPLC 
reference were obtained as a gift from F. Hoffman - La Roche AG. 6-O-monotosyl-β-
CD and 6-monodeoxy-6-monoamino-β-CD hydrochloride were purchased from 
CycloLab Ltd (Budapest, Hungary). 
 
Solvents for chromatography and extractions were distilled prior to use. Dry 
dichloromethane (CH2Cl2) and dimethylformamide (DMF) and decalin were distilled 
from CaH2, diethyl ether (Et2O) and tetrahydrofuran (THF) from Na/benzophenone, 
MeOH from Mg, pyridine from KOH. All freshly dried solvents were stored over 
activated molecular sieves (4Å). Further solvents used for reactions corresponded to the 
quality puriss p. a., abs., over Molecular Sieves from Fluka AG. HPLC-grade solvents 
were purchased and used for analytical or semi-preparative RP-HPLC. Degassed 
solvents for reactions under oxygen-free condition were obtained by three freeze-
pump-thaw cycles in high-vacuum. 
 
For an inert atmosphere Argon 56 (< 4 ppm other gases) from Carbagas AG (Lenzburg, 
Switzerland) or Argon 6.0 (<1.5 ppm other gases) from PanGas AG (Dagmersellen, 
Switzerland) were used. 
 
Materials and Instruments 
Solvents were removed with a Büchi (Switzerland) rotary evaporator (Waterbath 461, 
Rotavapor RE 111 and Vauum Controller 168) and a MZ 2C membrane pump 
(Vacuubrand). For cooling a mixture of EtOH and water was kept at 0oC with a UKW 
300 thermostat (Vacuubrand). 
 
For weighing compounds and reagents Mettler (Switzerland) balances P1200 (>1g), AE 
163 (<1g), and AX205 (<100mg) were used. 
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A high-vacuum pump D5E from Trivac (Köln, Germany) was used for drying 
compounds and degassing solvents.  
 
Slow addition of reagents to a reaction mixture was achieved with a Precidor 5003 
syringe pump (Informs HT, Switzerland). 
 
For all non-aqueous reactions glassware was flame dried either under vacuum or argon 
overpressure, and the atmosphere was exchanged by three cycles of evacuating and 
flushing with argon. 
 
Melting points (mp) were determined on a büchi 510 apparatus and are uncorrected. 
For the porphyrins and CDs, the melting points are > 250oC and were not determined. 
 
Chromatographic Methods 
Analytical thin layer chromatography (TLC) was performed on 0.25 mm precoated 
glass plates (5×10 cm, silica gel 60 F254, Merck AG, Germany), 0.25mm precoated 
glass plates (5×10 cm, aluminium oxide 60 F254, Merck AG, Germany), or on 0.25 mm 
precoated glass plates (5×10 cm, RP-18 F254s, Merck AG, Germany). Compounds were 
detected at 254 nm (UV) or at 366 nm (fluorescence). For carbohydrates, compounds 
were visualized by p-anisaldehyde dip. Description: TLC (solvent): Rf. 
 
For normal phase column chromatography silica gel 60 from Merck (0.040-0.063 mm, 
230-400 mesh) or aluminum oxide 90 from Merck (standardized (activity II-III), 0.063-
0.2 mm, 70-230 mesh) were used. For reversed phase column chromatography, RP-18 
silica gel (fully endcapped) from Fluka (0.040-0.063mm, 230-400 mesh) was used. For 
ion-exchange column chromatography, Amberlite CG-50 from Fluka (weak acidic, H+-
Form, 100-200 mesh) was used. Flash chromatography was performed under pressure 
from N2. 
 
Analytical reversed phase HPLC (synthesis) was performed on LiChrospher® 100 
RP-18 silica gel from Merck (5 μm particle size, 4×250 mm column) with nanopure 
water and HPLC-grade solvents. Analytical reversed HPLC (enzyme mimic reactions) 
was performed on LiChrospher® 100 RP-18 silica gel from Bischoff (Leonberg, 
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Germany) (5 μm particle size, 4.6×125 mm column) or YMC C30 from YMC Europe 
GMBH (Schermbeck, Germany) (3 μm particle size, 4.6×250 mm column) according to 
substrate. Semi-preparative HPLC was performed on LiChrospher® 100 RP-18 silica 
gel from Merck (10 μm particle size, 10×250 mm column). HPLC-System: 1) Merck 
Hitachi LaChrom system (analytical for synthesis or semi-preparative) with Solvent 
degasser L-7612, Pump L-7100, UV detector L-7400, Interface D-7000; 2) Agilent 
1100 Series 1100 HPLC system (analytical for synthesis and enzyme mimic reaction) 
with Solvent degasser G1322A, BinPump G1312A, Autosampler G1313A, 
Thermostatic column housing G1316A, Diode array UV detector G1315B).  
 
Spectroscopic Methods 
Ultra violet-Visible absorption spectra (UV/Vis) were recorded on an Agilent 8453 
Diode Array spectrophotometer using optical 110 QS Hellma cuvettes (10 mm light 
path). Description: UV/Vis (solvent): wavelength of maxima (λmax) in nm (relative 
extinction coefficient in %). 
 
Infrared spectra (IR) were measured on a Perkin-Elmer 1600 series FTIR 
spectrometer in KBr or on a FTIR-8400S from SHIMADZU. Description: IR (medium): 
wavenumbers of transmission maxima in cm-1. 
 
Electron impact mass spectra (EI-MS) and fast atom bombardment mass spectra 
(FAB-MS) were measured by Dr. H. Nadig on a Finnigan MAT 95Q spectrometer and 
Finnigan MAT 8400 spectrometer in the mass spectrometry laboratory of the 
department. As matrix for FAB-MS m-nitro-benzenealcohol (NBA) or glycine (GLY) 
was used. Electron spray ionization mass spectra (ESI-MS) was record on a Bruker 
Esquire 3000plus. For matrix-assisted laser desorption/ionization mass spectra in 
conjunction with time of flight mass analysis (MALDI-TOF-MS) a Perspective 
Biosystems Vestec Mass Spectrometry Products VoyagerTM Elite BiospectrometryTM 
Research Station was used. As matrix for MALDI-TOF-MS, 0.1M of 2,5-
dihydroxybenzoic acid in MeCN/H2O/EtOH = 50:45:5 was used. Description: MS 
(solvent): mass peaks in m/z (relative intensity in %). Peaks with an intensity of less 
than 5% were not considered. 
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1H-Nuclear magnetic resonance spectroscopy (1H-NMR) was performed using either 
a Bruker av250 (250MHz), Bruker DPX-NMR (400MHz), Bruker DRX-500 (500MHz) 
or Bruker DRX-600 (600MHz) spectrometer. Solvents for NMR were obtained from 
Cambridge Isotope Laboratories (Andover, MA, USA). CDCl3 was filtered through 
basic alumina prior to use. All spectra were recorded at room temperature. If necessary 
for the interpretation correlated spectra like COSY, TOCSY, NOESY and ROESY 
were recorded also. Descripition: 1H-NMR (frequency, solvent): δH in ppm relative to 
TMS or residual solvent peaks (peak multiplicity: s = singlet, d = doublet, t = triplet, q 
= quartet, m = multiplet, br = broad; coupling constants J in Hertz). 
 
13C-Nuclear magnetic resonance spectroscopy (13C-NMR) was 1H-decoupled and 
recorded on a Bruker DPX-NMR (100MHz), Bruker DRX-500 (125 MHz) 
spectrometer. For the assignment of carbons ATP, DEPT, HETCOR, HMQC and 
HMBC experiments were carried out if essential. Descripition: 13C-NMR (frequency, 
solvent): δC in ppm relative to residual solvent peaks. 
 
LC-MS analysis was preformed on LiChrospher® 100 RP-18 silica gel from Bischoff 
(Leonberg, Germany) (5 μm particle size, 4.6×125 mm column), using the combination 
of Agilent 1100 Series 1100 HPLC system and Bruker Esquire 3000plus ESI-MS system. 
  
Single crystal X-ray structures were determined by Dr. Markus Neuburger and Dr. 
Silvia Schaffner in the chemical crystallography laboratory of the department. Data 
collection was carried out on a Nonius KappaCCD diffractometer using the COLLECT 
software suite. The usual corrections were applied. No absorption correction was 
determined. The structures were solved by direct method using the program DIRDIF-
99. Anisotropic least-squares refinement was carried out on all non-hydrogen atoms 
using the program CRYSTALS. Hydrogen atoms were in calculated positions. 
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5.2 Synthesis 
2-[4-(Methylsulfoxy)phenyl]-5,5’-dimethyl-1,3-dioxane 66[80] 
 
O
O
S
O
O
O
SS
O
 
 
To a solution of 4-(methylthio)benzaldehyde 67 (11.42g, 75mmol) and neopentyl 
glycol (8.59g, 82.5mmol) in toluene (150ml) was added p-toluenesulfonic acid (95mg, 
0.5mmol). The resulting suspension was heated at reflux with a Dean-Stark trap for 2h. 
At room temperature, the reaction mixture was washed with saturated NaHCO3 (aq.) 
and water, dried over Na2SO4 and evaporated in vacuo to afford crude product, which 
was recrystallized from hexane to give 2-[4-(methylthio)phenyl]-5,5’-dimethyl- 1,3-
dioxane (16.2g, 91%) as white needle crystals.  
 
mp: 73.8-74.8oC (Lit.[80] 74-75oC) 
TLC (ethyl acetate/hexane =1:2 + 1% Et3N): Rf = 0.75  
1H-NMR (400MHz, CDCl3): 7.35 (AA’BB’, 4H, Ar-H), 5.36 (s, 1H, ArCH), 3.75 
(AB/2, J = 11.1, 2H, CH2), 3.64 (AB/2, J = 11.1, 2H, CH2), 2.48 (s, 3H, CH3S), 1.29 (s, 
3H, CH3), 0.79 (s, 3H, CH3) 
13C-NMR (100MHz, CDCl3): 139.6, 135.6, 127.0, 126.9, 101.8, 78.1, 30.6, 23.5, 22.3, 
16.3 
EI-MS: 238.2 [M]+. (44), 152.2 (100), 124.2 (20), 109.1 (14) 
 
A solution of 2-[4-(methylthio)phenyl]-5,5’-dimethyl-1,3-dioxane (1g, 4.2mmol) in 
CH2Cl2 (8ml) was cooled to -15oC and stirred vigorously and a suspension of m-CPBA 
(1.2g, 4.7mmol) in CH2Cl2 (6ml) was added in portions. The mixture was stirred at 0oC 
for 2h. Ca(OH)2 and Na2SO4 were added and stirring was continued for 1h at room 
temperature. After filtration and evaporation, the resulting colorless oil was purified by 
column chromatography (SiO2, ethyl acetate/hexane = 2:1) to give the title compound 
(0.9g, 85%) as white needle crystals. 
 
mp: 116.9-117.4oC (Lit.[80] 116-117oC) 
TLC (ethyl acetate): Rf = 0.4  
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1H-NMR (400MHz, CDCl3): 7.7-7.64 (m, 4H, Ar-H), 5.44 (s, 1H, ArCH), 3.78 (AB/2, 
J = 11.1, 2H, CH2), 3.67 (AB/2, J = 11.1, 2H, CH2), 2.69 (s, 3H, CH3S), 1.29 (s, 3H, 
CH3), 0.81 (s, 3H, CH3) 
13C-NMR (100MHz, CDCl3): 146.7, 141.9, 127.7, 123.8, 101.2, 78.1, 44.5, 30.7, 23.4, 
22.2 
EI-MS: 254 [M]+. (100), 239 (68), 168 (50), 153 (37), 124 (50), 69 (27), 41 (16) 
 
4-(Methylsulfoxy)benzaldehyde 65 
 
O
S
O
 
 
To a suspension of acetal 66 (0.63g, 2.5mmol) in water (2ml) was added TFA (6.5ml). 
The resulting solution was stirred overnight at room temperature and then poured into 
water (40ml) and extracted with toluene. The combined extractions were washed with 
water and evaporated in vacuo. The residue was purified by column chromatography 
(SiO2, ethyl acetate) to give the title compound (0.34g, 80%) as white solid. 
 
mp: 87.4-88.4oC (Lit.: 81-82oC,[82] 85-86oC[81]) 
TLC (ethyl acetate): Rf = 0.29  
1H-NMR (400MHz, CDCl3): 10.1 (s, 1H, CHO), 7.94 (AA’BB”, 4H, Ar-H), 2.8 (s, 3H, 
CH3) 
13C-NMR (100MHz, CDCl3): 191.5, 152.9, 138.6, 130.8, 124.6, 44.2 
EI-MS: 168 [M]+. (100), 153 (43), 125 (15), 121 (10), 97 (9), 77 (9) 
  
p-Tolyldipyrromethane 63[83, 84] 
 
NH N
H  
To a solution of p-tolylaldehyde (1.85ml, 15.6mmol) in pyrrole (27ml, 390mmol) was 
added TFA (0.12ml, 1.56mmol). The reaction was stirred at room temperature in dark 
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under argon for 4.5h and then quenched with saturated NaHCO3 (aq., 50ml). The 
resulting mixture was extracted with CH2Cl2 and the combined extractions were 
washed with brine, dried over Na2SO4 and evaporated in vacuo to afford a dark oil. 
Column chromatography (SiO2, ethyl acetate/hexane = 1:2 + 1% Et3N) gave crude 
product, which was recrystallized from ethyl acetate/hexane to afford the title 
compound (2.3g, 62%) as prey solid. 
 
TLC (ethyl acetate/hexane = 1:2): Rf = 0.38  
1H-NMR (400MHz, CDCl3): 7.9 (brs, 2H, NH), 7.12 (m, 4H, Ar-H), 6.69 (m, 2H, pyro-
H2), 6.15 (m, 2H, pyro-H4), 5.92 (m, 2H, pyro-H3), 5.44 (s, 1H, meso-H), 2.33 (s, 3H, 
CH3) 
13C-NMR (100MHz, CDCl3): 139.5, 137, 133.1, 129.7, 128.7, 117.5, 108.8, 107.5, 44, 
21.4 
ESI-MS (CH2Cl2/MeOH): 259.0 [M+Na]+ 
 
[5-(p-Methylsulfoxy)phenyl-10,15,20-tri(p-methylphenyl)]porphyrin 61 
 
N
N
H
NH
N
S
O
5
10
15
20
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6'
2''
6''
2'''
6'''
 
 
To a solution of 63 (200mg, 0.85mmol), 65 (71mg, 0.42mmol) and p-tolylaldehyde 
(51mg, 0.42mmol) in CH2Cl2 (80ml) was added TFA (0.12ml, 1.5mmol). The reaction 
was stirred for 2h at room temperature under argon and then the solution of DDQ 
(300mg, 1.32mmol) in THF (3ml) was added. The resulting mixture was heated at 
reflux for 1h. The reaction mixture was filtered through silica gel (CH2Cl2+1%Et3N, 
then CH2Cl2/MeOH = 2:1) to afford the crude product (second band), which was 
further purified by column chromatography (basic alox, CH2Cl2) to give the title 
compound (43.1mg, 14.2%) as purple solid.  
 
 93
TLC (basic alox, CH2Cl2): Rf = 0.25  
UV/Vis (MeOH, λ): 415 (100, Soret), 513 (4) 
1H-NMR (500MHz, CDCl3): 8.90 (d, J = 4.8, 2H, C(2, 8)-H), 8.88 (s, 4H, C(12, 13, 17, 
18)-H), 8.76 (d, J = 4.8, 2H, C(3, 7)-H), 8.38 (AA’BB’, J = 8.3, 2H, C(2’, 6’)-H), 8.10 
(d, 6H, C(2’’, 6’’, 2’’’, 6’’’)-H), 8.03 (AA’BB’, J = 8.1, 2H, C(3’, 5’)-H), 7.56 (d, 6H, 
C(3’’, 5’’, 3’’’, 5’’’)-H), 3.05 (s, 3H, CH3S), 2.71 (s, 9H, ArCH3), -2.75 (s, 2H, NH) 
13C-NMR (125MHz, CDCl3): 145.59 (C(1’)), 145.23 (C(4’)), 139.27 (C(1’’’)), 139.23 
(C(1’’)), 137.60 (C(4’’)), 137.58 (C(4’’’)), 135.41 (C(2’, 6’)), 134.65 (C(2’’, 6’’, 2’’’, 
6’’’)), 132-130 (brs, C(2, 3, 7, 8, 12, 13, 17, 18)), 127.61 (C(3’’, 5’’)), 127.59 (C(3’’’, 
5’’’)), 122.17 (C(3’, 5’)), 120.91 (C(15)), 120.61 (C(10, 20)), 117.81 (C(5)), 44.19 
(CH3S), 21.67 (ArCH3) 
MALDI-TOF-MS: 718.9 [M], 702.9 [M-16] 
ESI-MS (CH2Cl2/MeOH): 741.0 [M+Na]+, 719.0 [M+H]+, 717.2 [M-H]- 
 
β-Carbonyl [5-(p-methylsulfoxyphenyl)-10,15,20-tri(p-methylphenyl)-porphyrinato] 
ruthenium 62 
 
N
N
N
N
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2'''
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CO
 
 
To a solution of porphyrin 61 (43.9mg, 0.061mmol) and acetal 66 (0.196mg, 
0.733mmol) in DMF (25ml, degassed) was added trirutheniumdodecacarbonyl (78.1mg, 
0.122mmol). The reaction was heated at reflux for 3h under argon. After evaporation of 
DMF in high vacuo, the resulting residue was purified by column chromatography 
(SiO2, CH2Cl2/acetone = 20:1) to give the title compound (33.6mg, 67%) as red solid. 
 
TLC (CH2Cl2/MeOH = 20:1): Rf = 0.29  
UV/Vis (CH2Cl2, λ): 414 (100, Soret), 531 (10) 
IR (neat, ν/cm-1): 1932.5 (νCO), 1008.7 [Ru (II) oxidation state marker band] 
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HPLC (LiChrospher® 100 RP-18 (5μm) 250×4, 80% MeOH to 100% MeOH in 13min, 
then @ 100% MeOH till 30min, flow 1ml/min, λdet = 413nm, T = 40oC): Rt = 15.29min 
1H-NMR (500MHz, CDCl3/MeOH-D4): 8.63 (d, J = 4.9, 2H, porphyrin-H), 8.61 (s, 4H, 
porphyrin-H), 8.48 (d, J = 4.9, 2H, porphyrin-H), 8.32 (d, J = 7.6, 1H, C(2’ or 6’)-H), 
8.25 (d, J = 7.6, 1H, C(2’ or 6’)-H), 8.01 (m, 3H, C(2’’, 2’’’ or 6’’, 6’’’)), 7.95-7.89 (m, 
5H, C(3’, 5’) and C(2’’, 2’’’ or 6’’, 6’’’)-H), 7.47-7.43 (m, 6H, C(3’’, 5’’, 3’’’, 5’’’)-H), 
3.0 (s, 3H, CH3S), 2.61 (s, 9H, ArCH3) 
13C-NMR (125MHz, CDCl3/MeOH-D4): 180.71 (CO), 146.41 (C(1’)), 
144.27/144.19/144.07/143.20 (C(1, 4, 6, 9, 11, 14, 16, 19)), 143.49 (C(4’)), 139.54 
(C(1’’’)), 139.51 (C(1’’)), 136.99 (C(4’’)), 136.97 (C(4’’’)), 135.11/134.85 (C(2’, 6’)), 
134.24/133.77 (2’’, 2’’’ and 6’’, 6’’’)), 132.0/131.74/131.63/130.74 (C(2, 3, 7, 8, 12, 
13, 17, 18)), 127.33/127.12 (C(3’’, 3’’’ and 5’’, 5’’’)), 122.29/121.75 (C(3’, 5’)), 
122.04 (C(10, 15, 20)), 119.30 (C(5)), 43.52 (CH3S), 21.4 (ArCH3) 
MALDI-TOF-MS: 818.2 [M-CO], 802.1 [M-CO-16] 
ESI-MS (CH2Cl2/MeOH): 869.03 [M+Na]+ 
 
5-(p-Methoxyphenyl)dipyrromenane 80[83, 84] 
 
NH N
H
OCH3
 
To a solution of ansialdehyde (3.4ml, 28.8mmol) in pyrrol (50ml, 720mmol) was added 
TFA (0.23ml, 2.88mmol). The reaction was stirred under argon at room temperature in 
dark for 30min and then quenched with saturated NaHCO3 (aq., 80ml). The resulting 
mixture was extracted with ethyl acetate. The combined extractions were washed with 
brine, dried over Na2SO4 and evaporated in vacuo to afford a dark oil. Column 
chromatography (SiO2, ethyl acetate/hexane = 1:2 + 1% Et3N) gave crude product as 
orange oil, which was recrystallized from ethyl acetate/hexane to afford the title 
compound (5.4g, 74%) as prey solid. 
 
mp: 97-98oC (Lit.[84] 99oC) 
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TLC (ethyl acetate/hexane = 1:2): Rf = 0.44 
1H-NMR (400MHz, CDCl3): 7.90 (brs, 2H, NH), 7.13 (AA’BB’, 2H, C(3’, 5’)-H), 6.86 
(AA’BB’, 2H, C(2’, 6’)-H), 6.69 (m, 2H, pyro-H2), 6.16 (dd, J = 5.8, 2.8, 2H, pyro-H3), 
5.91 (m, 2H, pyro-H4), 5.43 (s, 1H, ArCH), 3.80 (s, 3H, ArCH3) 
13C-NMR (100MHz, CDCl3): 158.7, 134.3, 133, 129.5, 117.2, 114.1, 108.5, 107.2, 55.4, 
43.3 
ESI-MS (CH2Cl2/MeOH): 253.0 [M+H]+, 275.0 [M+Na]+, 251.2 [M-H]- 
 
5-(p-Methoxyphenyl)-10,15,20-tri(p-methylphenyl)-porphyrin 79 
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To a solution of 63 (100mg, 0.42mmol), 80 (107mg, 0.42mmol) and p-tolylaldehyde 
(102mg, 0.85mmol) in CH2Cl2 (85ml) was added TFA (0.120ml, 1.51mmol). The 
reaction was stirred for 1h at room temperature under argon and then the solution of 
DDQ (480mg, 2.1mmol) in THF (5ml) was added. The resulting mixture was heated at 
reflux for 1h and Et3N (0.85ml) was added. The mixture was directly filtered through 
silica gel (CH2Cl2+1%Et3N) to afford a mixture of porphyrins, which was separated by 
column chromatography (SiO2, CH2Cl2/hexane = 2:1, second band) to give the title 
compound (45.8mg, 15.8%) as purple solid.  
 
TLC (CH2Cl2/hexane = 3:1): Rf = 0.51 
UV/Vis (CH2Cl2, λ): 420 (100, Soret), 517 (5) 
1H-NMR (500MHz, CDCl3): 8.86 (d, 8H, porphyrin-H), 8.13 (AA’BB’, J = 8.4, 2H, 
C(2’, 6’)-H), 8.10 (d, 6H, C(2’’, 6’’, 2’’’, 6’’’)-H), 7.56 (d, 6H, C(3’’, 5’’, 3’’’, 5’’’)-H), 
7.29 (AA’BB’, J = 8.4, 2H, C(3’, 5’)-H), 4.10 (s, 3H, OCH3), 2.71 (s, 9H, ArCH3), -
2.76 (s, 2H, porphyrin-NH) 
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13C-NMR (500MHz, CDCl3): 159.50 (C(4’)), 139.45 (C(1’’, 1’’’)), 137.45 (C(4’’, 
4’’’)), 135.72 (C(2’, 6’)), 134.80 (C(1’)), 134.66 (C(2’’, 6’’ and 2’’’, 6’’’)), 131 (brs, 
C(1, 2, 3, 4, 6,7, 8, 9, 11 12, 13, 14, 16, 17, 18, 19)), 127.55 (C(3’’, 5’’ and 3’’’, 5’’’)), 
120.22 (C(10, 20)), 120.18 (C(15)), 119.88 (C(5)), 55.71 (OCH3), 21.68 (ArCH3) 
ESI-MS (CH2Cl2/MeOH): 687.2 [M+H]+ 
 
5-(p-Hydroxyphenyl)-10,15,20-tri(p-methylphenyl)-porphyrin 57 
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To a solution of porphyrin 79 (266.7mg, 0.297mmol) in CH2Cl2 (21.2ml) was added 
ethanthiol (21.2ml, 286mmol) followed by AlCl3 (2.12g, 15.87mmol). The reaction 
was stirred at room temperature overnight and then quenched by the slow addition of 
saturated NaHCO3 (aq., 200ml). The biphasic mixture was extracted with 4 portions of 
CH2Cl2 and then the combined extractions were washed with brine, dried over Na2SO4 
and evaporated in vacuo. The resulting residue was purified by column 
chromatography (SiO2, CH2Cl2+1% Et3N and then ethyl acetate/hexane = 2:1) to give 
the title compound (251mg, 96%) as purple solid. 
 
TLC (ethyl acetate/hexane = 1:2): Rf = 0.45 
UV/Vis (CH2Cl2, λ): 419 (100, Soret), 517 (4) 
HPLC (LiChrospher® 100 RP-18 (5μm) 250×4, 80% MeOH to 100% MeOH in 10min, 
then @ 100% MeOH till 30min, flow 1ml/min, λdet = 420nm, T = 40oC): Rt = 20.99min 
1H-NMR (500MHz, CDCl3): 8.86 (m, 8H, porphyrin-H), 8.10 (d, 6H, C(2’’, 6’’, 2’’’, 
6’’’)-H), 8.06 (AA’BB’, J = 8.5, 2H, C(2’, 6’)-H)), 7.55 (d, 6H, C(3’’, 5’’, 3’’’, 5’’’)-
H), 7.16 (AA’BB’, J = 8.5, 2H, C(3’, 5’)-H), 2.71 (s, 9H, ArCH3), -2.76 (s, 2H, 
porphyrin-NH) 
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13C-NMR (500MHz, CDCl3): 155.50 (C(4’)), 139.43 (C(1’’, 1’’’)), 137.46 (C(4’’, 
4’’’)), 135.82 (C(2’, 6’)), 134.95 (C(1’)), 134.66 (C(2’’, 2’’’, 6’’’, 6’’’)), 131.2 (brs, 
C(2, 3, 7, 8, 12, 13, 17, 18)), 127.55 (C(3’’, 3’’’, 5’’, 5’’’)), 120.25 (C(10, 20)), 120.23 
(C(5)), 119.71 (C(5)), 113.78 (C(3’, 5’)), 21. 67 (ArCH3) 
ESI-MS (CH2Cl2/MeOH): 673.2 [M+H]+, 671.4 [M-H]- 
 
5-(p-O-dimethylthiocarbamylphenyl)-10,15,20-tri(p-methylphenyl)-porphyrin 78 
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To a solution of porphyrin 57 (5mg, 7.44μmol) in dry DMF (1ml) was added NaH 
(60% in oil, 0.9mg, 22.32μmol). The resulting suspension was stirred vigorously at 
room temperature for 15min and then a solution of dimethylthiocarbamylphenyl 
chloride (1.1mg, 8.27μmol) in DMF (1ml) was added. The reaction was heated at 80oC 
for 2h and then quenched with water (5ml). The biphasic mixture was extracted with 
ethyl acetate and the combined extractions were washed with 1M NaOH (aq.), brine, 
dried over Na2SO4 and evaporated in vacuo. Purification by column chromatography 
(SiO2, ethyl acetate/hexane = 1:4) gave the title compound (5.03mg, 89%) as purple 
solid.  
 
TLC (ethyl acetate/hexane = 1:3): Rf = 0.37 
UV/Vis (CH2Cl2 + 1% Et3N, λ): 419 (100, Soret), 516 (4) 
1H-NMR (400MHz, CDCl3): 8.9 (d, J = 4.8, 2H, porphyrin-H), 8.88 (d, J = 4.8, 2H, 
porphyrin-H), 8.86 (s, 4H, porphyrin-H), 8.23 (AA’BB’, J = 8.3, 2H, C(2’, 6’)-H), 8.10 
(d, 6H, C(2’’, 6’’, 2’’’, 6’’’)-H), 7.56 (d, 6H, C(3’’, 5’’, 3’’’, 5’’’)-H), 7.46 (AA’BB’, J 
= 8.3, 2H, C(3’, 5’)-H), 3.60 (s, 3H, NCH3), 3.53 (s, 3H, NCH3), 2.71 (s, 9H, ArCH3), -
2.76 (s, 2H, porphyrin-NH) 
MALDI-TOF-MS: 760.3 [M+1] 
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ESI-MS (CH2Cl2/MeOH): 760 [M+H]+, 782 [M+Na]+ 
 
5-(p-S-dimethylcarbamylphenyl)-10,15,20-tri(p-methylphenyl)-porphyrin 77 
 
N
N
H
NH
N
S
5
10
15
20
2'
6'
2''
6''
2'''
6'''
2''
6''
C
O
N(CH3)2
 
 
A flask which had been purged with argon was charged with porphyrin 78 (5mg, 
6.62μmol). It was heated in a boiling glycerin-bath for 30min. Column chromatography 
(SiO2, CH2Cl2/hexane = 3:1 to 4:1) gave the title compound (4.97mg, 99%) as purple 
solid. 
 
TLC (ethyl acetate/hexane = 1:2): Rf = 0.48 
UV/Vis (CH2Cl2 + 1% Et3N, λ): 419 (100, Soret), 516 (4) 
1H-NMR (500MHz, CDCl3): 8.90-8.88 (m, 8H, porphyrin-H), 8.26 (AA’BB’, J = 8.2, 
2H, C(2’, 6’)-H), 8.12 (d, 6H, C(2’’, 6’’, 2’’’, 6’’’)-H), 7.90 (AA’BB’, J = 8.2, 2H, 
C(3’, 5’)-H), 7.57 (m, 6H, C(3’’, 5’’, 3’’’, 5’’’)-H), 3.25 (s, 3H, NCH3), 3.19 (s, 3H, 
NCH3), 2.72 (s, 6H, ArCH3), 2.71 (s, 3H, ArCH3), -2.77 (s, 2H, porphyrin-NH) 
13C-NMR (125MHz, CDCl3): 167.18 (C=O), 143.31 (C(1’)), 139.40 (C(1’’’)), 139.35 
(C(1’’)), 137.50 (C(4’’)), 137.48 (C(4’’’)), 135.15 (C(2’, 6’)), 134.66 (C(2’’, 6’’, 2’’’, 
6’’’)), 133.90 (C(3’, 5’)), 131 (brs, C(2, 3, 7, 8, 12, 13, 17, 18)), 128.57 (C(4’)), 127.58 
(C(3’’, 5’’)), 127.55 (C(3’’’, 5’’’)), 120.55 (C(15)), 120.41 (C(10, 20)), 118.85 (C(5)), 
37.25 (NCH3), 21.68 (ArCH3) 
MALDI-TOF-MS: 759.9 [M+1] 
ESI-MS (CH2Cl2/MeOH): 760 [M+H]+, 781.9 [M+Na]+ 
 
 
 
 
 99
β-Carbonyl [5-(p-hydroxyphenyl)-10,15,20-tri(p-methylphenyl)-porphyrinato] 
ruthenium 81 
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To a suspension of porphyrin 57 (178mg, 0.265mmol) in dry, degassed decalin (90ml) 
was added trirutheniumdodecacarbonyl (254mg, 0.40mmol). The reaction was heated 
under reflux for 4h in argon. Decalin was removed in high vacuo and the resulting 
crude product was purified by column chromatography (SiO2, hexane/ethyl acetate = 
3:1) to give the title compound (201.6mg, 95%) as red solid. 
 
TLC (ethyl acetate/hexane = 1:2): Rf = 0.35  
UV/Vis (CH2Cl2, λ): 413 (100, Soret), 530 (11) 
IR (KBr, ν/cm-1): 1941.2 (νCO), 1008.4 [Ru (II) oxidation state marker band] 
HPLC (LiChrospher® 100 RP-18 (5μm) 250×4, 80% MeOH to 100% MeOH in 13min, 
then @ 100% MeOH till 30min, flow 1ml/min, λdet = 413nm, T = 40oC): Rt = 14.59min 
1H-NMR (500MHz, CDCl3/MeOH-D4): 8.69 (d, J = 4.9, 2H, porphyrin-H), 8.66 (d, 2H, 
porphyrin-H), 8.65 (s, 4H, porphyrin-H), 8.07 (dd, J = 7.6, 1.8, 3H, C(2’’, 2’’’ or 6’’, 
6’’’)-H), 8.01 (dd, J = 8.2, 2.2, 1H, C(2’ or 6’)-H), 7.96 (dd, J = 7.6, 1.8, 3H, C(2’’, 
2’’’ or 6’’, 6’’’)-H), 7.92 (dd, J = 8.2, 2.2, 1H, C(2’ or 6’)-H), 7.49 (m, 6H, C(3’’, 5’’, 
3’’’, 5’’’)-H), 7.14 (m, 2H, C(3’, 5’)-H), 2.66 (s, 9H, ArCH3) 
13C-NMR (125MHz, CDCl3/MeOH-D4): 181.0 (CO), 156.1 (C(4’)), 144.3 (C(1, 9)), 
144.02 (C(4, 6)), 144.0 (C(11, 14, 16, 19)), 139.6 (C(1’’, 1’’’)), 136.9 (C(4’’, 4’’’)), 
135.4/134.9 (C(2’, 6’)), 134.3/133.7 (C(2’’, 6’’, 2’’’, 6’’’)), 134.2 (C(1’)), 
131.54/131.47 (C(2, 3, 7, 8, 12, 13, 17, 18)), 127.3/127.1 (C(3’’, 5’’, 3’’’, 5’’’)), 
121.7/121.6 (C(5,10,15,20)), 113.4/113.3 (C(3’, 5’)), 21.5 (ArCH3) 
ESI-MS (CH2Cl2/MeOH): 823.0 [M+Na]+, 800.0 [M]+  
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β-Carbonyl [5-(p-O-dimethylthiocarbamylphenyl)-10,15,20-tri(p-methylphenyl)- 
porphyrinato] ruthenium 82 
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To a solution of porphyrin 81 (50mg, 0.062mmol) in dry, degassed DMF (5ml) was 
added NaH (60% in oil, 5.1mg, 0.125mmol). The suspension was stirred vigorously at 
room temperature for 30min and then dimethylthiocarbamylphenyl chloride (15.7mg, 
0.125mmol) was added. The reaction was heated at 80oC in argon for 3h and then 
quenched with saturated NaHCO3 (aq. 10ml). The mixture was extracted with CH2Cl2 
and the combined extractions were washed with brine, dried over Na2SO4 and 
evaporated in vacuo. Column chromatography (SiO2, CH2Cl2) gave the title compound 
(39.2mg, 71%) as red solid together with reclaimed porphyrin 81 (14mg, 28%). 
 
TLC (CH2Cl2): Rf = 0.38 
UV/Vis (CH2Cl2, λ): 413 (100, Soret), 529 (10) 
HPLC (LiChrospher® 100 RP-18 (5μm) 250×4, 80% MeOH to 100% MeOH in 13min, 
then @ 100% MeOH till 30min, flow 1ml/min, λdet = 413nm, T = 40oC): Rt = 15.86min 
1H-NMR (400MHz, CDCl3): 8.68-8.64 (m, 8H, porphyrin-H), 8.22 (m, 1H, C(2’ or 6’)-
H), 8.10 (m, 4H, C(2’ or 6’)-H and C(2’’, 2’’’ or 6’’, 6’’’)-H), 7.99 (m, 3H, C(2’’, 2’’’ 
or 6’’, 6’’’)-H), 7.53-7.49 (m, 6H, C(3’’, 5’’, 3’’’, 5’’’)-H), 7.41-7.38 (m, 2H, C(3’, 5’)-
H), 3.58 (s, 3H, NCH3), 3.51 (s, 3H, NCH3), 2.68 (s, 9H, ArCH3) 
MALDI-TOF-MS: 859.04 [M-CO] 
ESI-MS (CH2Cl2/MeOH): 910.1 [M+Na]+ 
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β-Carbonyl [5-(p-S-dimethylcarbamylphenyl)-10,15,20-tri(p-methylphenyl)- 
porphyrinato] ruthenium 76 
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Method 1: A flask which had been purged with argon was charged with porphyrin 82 
(13.8mg, 15.6μmol). It was heated in a boiling glycerin-bath for 50min. (reaction 
should be controlled by HPLC) Column chromatography (SiO2, CH2Cl2 and then 
CH2Cl2/acetone = 100:1) gave the title compound (3.5mg, 25%) as red solid. 
Method 2: The solution of porphyrin 82 (29.5mg, 33.3μmol) in dry, degassed sulfolane 
(4ml) was heated in a boiling glycerin-bath under argon for 35min. (reaction should be 
controlled by HPLC) After evaporation of sulfolane in high vacuo, the resulting residue 
was dissolved in CH2Cl2/hexane (1:1) (50ml) and washed with water to remove 
residual sulfolane. Column chromatography (SiO2, CH2Cl2 and then ethyl 
acetate/hexane = 1:3) gave the title compound (25.6mg, 87%) as red solid. 
 
TLC (ethyl acetate/hexane = 1:2): Rf = 0.28 
UV/Vis (CH2Cl2, λ): 413 (100, Soret), 529 (10) 
IR (neat, ν/cm-1): 1924.8 (νCO), 1006.8 [Ru (II) oxidation state marker band] 
HPLC (LiChrospher® 100 RP-18 (5μm) 250×4, 90% MeOH to 100% MeOH in 15min, 
then @ 100% MeOH till 30min, flow 1ml/min, λdet = 413nm, T = 30oC): Rt = 14.35min 
(This method was also used for reaction control. Rt (porphyrin 82) = 13.27min) 
1H-NMR (500MHz, CDCl3/MeOH): 8.58 (m, 8H, porphyrin-H), 8.14 (dd, J = 7.8, 1.9, 
1H, C(2’ or 6’)-H), 8.04 (dd, J = 7.8, 1.9, 1H, C(2’ or 6’)-H), 8.0-7.98 (m, 3H, C(2’’, 
2’’’ or 6’’, 6’’’)-H), 7.90-7.88 (m, 3H, C(2’’, 2’’’ or 6’’, 6’’’)-H), 7.75 (dd, J = 7.8, 1.8, 
1H, C(3’ or 5’)-H), 7.72 (dd, J = 7.8, 1.8, 1H, C(3’ or 5’)-H), 7.44-7.40 (m, 6H, C(3’’, 
5’’, 3’’’, 5’’’)-H), 3.16 (s, 3H, NCH3), 3.06 (s, 3H, NCH3), 2.59 (s, 9H, ArCH3) 
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13C-NMR (125MHz, CDCl3/MeOH): 180.81 (CO), 167.94 (C=O), 
144.11/144.023/144.017/143.49 (C(1, 4, 6, 9, 11, 14, 16, 19)), 143.87 (C(1’)), 139.63 
(1’’’)), 139.61 (1’’)), 136.87 (C(4’’, 4’’’)), 134.75/134.41 (C(2’, 6’)), 134.21/133.75 
(C(2’’, 6’’, 2’’’, 6’’’)), 133.60/133.56 (C(3’, 5’)), 131.68/131.51/131.47/131.24 (C(2, 3, 
7, 8, 12, 13, 17, 18)), 127.48 (C(4’)), 127.26 (C(3’’ or 5’’)), 127.24 (C(3’’’ or 5’’’)), 
127.06 (C(3’’ or 5’’)), 127.04 (C(3’’’ or 5’’’)), 121.95 (C(15)), 121.81 (C(10, 20)), 
120.27 (C(5)), 37.06 (NCH3), 21.34 (ArCH3)  
MALDI-TOF-MS: 858.91 [M-CO] 
ESI-MS (CH2Cl2/MeOH): 910.1 [M+Na]+, 918.3 [M+CH3O]- 
 
Ruthenium porphyrin-β-CD complex 83 
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To a solution of porphyrin 76 (9.42mg, 10.6μmol) in dry, degassed THF (2ml) was 
added LiAlH4 (1M in THF, 31.9μl) at 0oC. The reaction mixture was then heated at 
reflux in argon for 2h. At room temperature, dry and degassed MeOH (1ml) was added 
to quench the reaction. After evaporation of solvent in vacuo under argon at room 
temperature, to the resulting residue was added the solution of 6-mono-tosyl-β-CD 
(27.4mg, 21.3μmol) and pyridine (85.5μl, 1.05mmol) in dry, degassed DMF (2ml). The 
reaction mixture was heated at 70oC for 24h in argon and then quenched with saturated 
NH4Cl (aq.) at room temperature. After removal of the solvent in vacuo, the resulting 
crude product was purified by semi-preparative HPLC (LiChrospher® 100 RP-18 (10 
μm) 250×10, 60% MeOH to 90% MeOH in 15min, then to 100% MeOH in 10min, @ 
100% MeOH for 10min, flow 5ml/min, λdet = 412nm, T = 40oC) to give the title 
compound (11.7mg, 56.8%) as a red solid. 
 
TLC (RP-18, MeOH/H2O = 9:1): Rf = 0.17 
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UV/Vis (MeOH, λ): 410 (100, Soret), 530 (9) 
HPLC (LiChrospher® 100 RP-18 (5μm) 250×4, 60% MeOH to 90% MeOH in 15min, 
then to 100% MeOH in 10min, @ 100% MeOH for 10min, flow 1ml/min, λdet = 412nm, 
T = 40oC): Rt = 19.91min 
1H-NMR (600MHz, DMSO-D6): 8.61-8.56 (m, 8H, prophyrin-H), 8.07 (m, 4H, C(2’, 
2’’, 2’’’ or 6’, 6’’, 6’’’)-H), 7.95 (m, 4H, C(2’, 2’’, 2’’’ or 6’, 6’’, 6’’’)-H), 7.75 (m, 2H, 
C(3’, 5’)-H), 7.58 (m, 6H, C(3’’, 3’’’ and 5’’, 5’’’)-H), 5.86-5.74 (m, 14H, CD-C(2, 3)-
OH), 5.02-4.81 (m, 7H, CD-C(1)-H), 4.61-4.36 (m, 6H, CD-C(6)-OH), 3.8-3.35 (m, 
heavily overlapped together with H2O), 2.65 (s, 9H, ArCH3) 
ESI-MS (MeOH): 1955.3 [M+Na]+, 989.2 [M+2Na]2+/2, 1931.4 [M-H]- 
 
Ruthenium porphyrin-bis-β-CD complex 58 
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To a solution of porphyrin 76 (6.52mg, 7.4μmol) in dry, degassed THF (2ml) was 
added LiAlH4 (1M in THF, 22.1μl) at 0oC. The reaction mixture was heated at reflux in 
argon for 2h. At room temperature, dry and degassed MeOH (1ml) was added to 
quench the reaction. After evaporation of solvent in vacuo under argon at room 
temperature, to the resulting residue was added the solution of 6-mono-tosyl-β-CD 
dimer 56 (37.52mg, 14.7μmol) and pyridine (59.2μl, 0.74mmol) in dry, degassed DMF 
(2ml). The reaction mixture was heated at 70oC in argon for 24h and then quenched 
with saturated NH4Cl (aq.). After removal of the solvent in vacuo, the resulting crude 
product was purified by semi-preparative HPLC (LiChrospher® 100 RP-18 (10 μm) 
250×10, 60% MeOH to 90% MeOH in 15min, then to 100% MeOH in 10min, @ 100% 
MeOH for 10min, flow 5ml/min, λdet = 412nm, T = 40oC) to give the title compound 
(15.7mg, 68%) as red solid. 
 
 104
TLC (RP-18, MeOH/H2O = 10:1): Rf = 0.49 
UV/Vis (MeOH, λ): 410 (100, Soret), 530 (8) 
HPLC (LiChrospher® 100 RP-18 (5μm) 250×4, 60% MeOH to 90% MeOH in 15min, 
then to 100% MeOH in 10min, @ 100% MeOH for 10min, flow 1ml/min, λdet = 412nm, 
T = 40oC): Rt = 19.69min 
ESI-MS (MeOH/H2O): 1620.3 [M+2Na]2+/2, 1596.3 [M-2H]2-/2 
 
Heptakis(6-O-tert.-butyldimethylsilyl)-β-CD 50[105] 
 
O
OO
HO OH
OTBMDS
7
1
2
3
4
56
 
 
To a solution of dry β-CD (1g, 0.88mmol) in dry pyridine (20ml) was added the 
solution of TBDMSCl (1.19g, 7.5mmol) in pyridine (10ml) dropwise by syringe over 
90min at 0oC. The reaction mixture was stirred at room temperature for 20h and then 
poured into ice-water and stirred vigorously for 10min. The resulting precipitates were 
filtered, washed with ice-water and dissolved in ethyl acetate. The organic solution was 
washed with 1M HCl (aq.), saturated NaHCO3 (aq.) and then brine, dried over Na2SO4 
and evaporated in vacuo. The resulting crude product was purified by column 
chromatography (SiO2, ethyl acetate/EtOH/H2O = 50:4:2) to give the title compound 
(1.31g, 76.9%) as white solid. 
 
TLC (ethyl acetate/EtOH/H2O = 50:7:4): Rf = 0.38  
1H-NMR (400MHz, Toluene-D8): 7.25 (s, 7H, C(3)-OH), 5.83 (s, 7H, C(2)-OH), 4.93 
(d, J = 3.3, 7H, C(1)-H), 4.31 (t, J = 9.1, 7H, C(3)-H), 4.07 (dd, J = 11, 3, 7H, C(6b)-H), 
3.88 (d, J = 11, 7H, C(6a)-H), 3.78 (d, J = 9.5, 7H, C(5)-H), 3.72 (dd, J = 9.6, 3.5, 7H, 
C(2)-H), 3.63 (t, J = 9.1, 7H, C(4)-H), 1.02 (s, 63H, CH3C), 0.2-0.18 (42H, CH3Si)  
13C-NMR (100MHz, Toluene-D8): 102.8 (C(1)), 82.69 (C(4)), 74.36 (C(2)), 74.13 
(C(3)), 73.02 (C(5)), 62.49 (C(6)), 26.26 (CH3C), 18.71 (CH3C), -4.66 (CH3Si), -4.84 
(CH3Si) 
ESI-MS (CH2Cl2/MeOH): 1956.1 [M+Na]+, 989.7 [M+2Na]2+/2 
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1,6-Bis[(p-tolylsulfonyl)oxy]hexane 90[100] 
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To a solution of 1,6-hexanediol (3.26g, 27.3mmol) in dry pyridine (200ml) was added 
p-tosyl chloride (31g, 0.159mol) in portions over a period of 1h at 0oC. The resulting 
suspension was stirred at 4oC overnight. The reaction mixture was poured into ice-
water (1L) and concentrated HCl (50ml) to give a white solid, which was purified by 
column chromatography (SiO2, ethyl acetate/hexane = 1:3) to give the title compound 
(8.3g, 71.3%) as white solid. 
 
mp: 72-73oC (Lit. [100]: 70-71.5oC) 
TLC (ethyl acetate/hexane = 1:2): Rf = 0.22  
1H-NMR (400MHz, CDCl3): 7.78 (AA’BB’, J = 8.3, 4H, C(2’, 6’)-H), 7.35 (AA’BB’, J 
= 8.3, 4H, C(3’, 5’)-H), 3.98 (t, J = 6.3, 4H, C(1, 6)-H), 2.45 (s, 6H, ArCH3), 1.61-1.57 
(m, 4H, C(2, 5)-H), 1.29-1.25 (m, 4H, C(3, 4)-H) 
13C-NMR (100MHz, CDCl3): 145.2 (C(1’)), 133.5 (C(4’)), 130.3 (C(2’, 6’)), 128.3 
(C(3’, 5’)), 70.7 (C(1, 6)), 29.0 (C(2, 5)), 25.2 (C(3, 4)), 22.1 (ArCH3) 
ESI-MS (CH2Cl2/MeOH): 875 [2M+Na]+, 449 [M+Na]+ 
 
1,6-Bis[[heptakis(6-O-tert-butyldimethylsilyl)-β-CD]-2-oxy]hexane 91 
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To a solution of dry TBDMS-β-CD 50 (9g, 4.65mmol) in dry THF (120ml) was added 
LiH (55.4mg, 6.62mmol). The mixture was stirred for 1h at room temperature and then 
heated under reflux for 2h. A solution of 90 (0.79g, 1.86mmol) in THF (40ml) was 
added and heating under reflux was continued for 5 days. The solvent was removed in 
vacuo and ethyl acetate was added. The solution was washed with saturated NaHCO3 
(aq.), brine, dried over Na2SO4 and evaporated in vacuo. The resulting crude product 
was purified by column chromatography (SiO2, ethyl acetate/EtOH/H2O = 50:4:2) 
followed by charcoal column chromatography (ethyl acetate/CH2Cl2 = 2:1) to give the 
title compound (2g, 27.2%) as white solid. 
 
TLC (ethyl acetate/EtOH/H2O = 50:7:4): Rf = 0.30  
1H-NMR (500MHz, CDCl3): 6.2 (brs, 2H, C(3A)-OH), 5.56-5.3 (m, C(2)-OH), 5.19 
(brs, 2H, C(2G)-OH), 5.1 (brs, 2H, C(2B)-OH), 4.99 (d, J = 3, 2H, C(1A)-H), 4.92 (d, J 
= 3.3, 2H, C(1B)-H), 4.91-4.88 (m, 10H, C(1)-H), 4.54 (brs, 2H, C(3B)-OH), 4.2-3.9 (m, 
26H, C(3)-14H, C(6)-10H, C(1’, 6’)-2H), 3.8-3.5 (m, 58H, C(2)-12H, C(4)-12H, C(5)-
14H, C(6)-18H, C(1’, 6’)-2H), 3.36 (m, 2H, C(4A)-H), 3.16 (dd, J = 9.6, 3, 2H, C(2A)-
H), 1.85 (m, 2H, C(3’, 4’)-H), 1.60 (m, 2H, C(2’, 5’)-H), 1.46 (m, 2H, C(2’, 5’)-H), 
1.08 (m, 2H, C(3’, 4’)-H), 0.88-0.86 (m, 126H, CH3C), 0.03-0.02 (m, 84H, CH3Si) 
13C-NMR (125MHz, CDCl3): 102.66 (C(1B)), 102.27 (C(1G)), 102.02, 101.98, 101.87, 
99.89 (C(1A)), 83.38 (C(4A)), 81.94, 81.84, 81.68, 81.23, 79.45 (C(4B)), 77.11, 74.0 
(C(2B)), 73.79, 73.70, 73.53 (C(3A)), 73.46, 73.40, 73.33, 73.20, 72.84 (C(5B)), 72.52, 
72.50, 72.43, 72.25, 72.05, 71.52 (C(1’, 6’)), 71.45 (C(3B)), 62.25 (C(6A)), 61.73, 61.68, 
61.64, 61.57, 61.48, 61.24, 30.03 (C(2’, 5’)), 25.92, 25.90, 25.80, 23.46 (C(3’, 4’)), 
18.38, 18.28, 18.15, -5.04, -5.08, -5.21, -5.23, -5.35 
ESI-MS (CH2Cl2/MeOH): 1997.7 [M+2Na]2+/2, 1973.8 [M-2H]2-/2 
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1,6-Bis[(β-CD)-2-oxy]hexane 93 
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To a solution of protected dimer 91 (1.65g, 0.42mmol) in THF (50ml) was added 
TBAF (1M in THF, 8.2mmol). The reaction was heated under reflux for 18h. The 
solvent was removed in vacuo and the residue was dissolved in water. Purification by 
amberlite CG-50 ion-exchange resin (weak acid, H+-form, 100-200mesh, H2O/t-butanol 
= 10:1) followed by reversed phase column chromatography (RP-18, gradient elution 
with H2O/MeOH=5:1 and then 2:1) gave the title compound (951mg, 97%) as white 
solid. 
 
TLC (ethyl acetate/i-PrOH/NH3(aq., 33%)/H2O =7:7:5:4): Rf = 0.04  
1H-NMR (500MHz, D2O): 5.17 (d, J = 3.6, 2H, C(1A)-H), 5.06 (m, 12H, C(1)-H), 4.03-
3.55 (m, 86H, C(2, 3, 4, 5, 6, 1’, 6’)-H), 3.47 (dd, J = 9.9, 3.6, 2H, C(2A)-H), 1.62 (m, 
4H, C(2’, 5’)-H), 1.38 (m, 4H, C(3’, 4’)-H) 
13C-NMR (125MHz, D2O): 102.58, 102.52, 102.46, 102.43, 100.75 (C(1A)), 82.12 
(C(4B)), 81.94 (C(4A)), 81.80, 81.75, 81.72, 80.81(C(2A)), 73.69, 73.19 (C(1’, 6’)), 73.0 
(C(3A)), 72.68, 72.66, 72.47, 72.41, 72.28, 72.19, 60.88, 29.41 (C(2’, 5’)), 25.25 (C(3’, 
4’)) 
ESI-MS (MeOH/H2O): 2373.9 [M+Na]+, 1198.4 [M+2Na]2+/2, 2350 [M-H]-, 1174.5 
[M-2H]2-/2 
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6-O-Mono-tosyl-β-CD dimer 94 
 
O
O OTs
 
 
To a solution of β-CD dimer 93 (308mg, 0.131mmol) in dry pyridine (14ml) was added 
p-tosyl chloride (28mg, 0.144mmol) at 0oC. The reaction was stirred for 1h at 0oC and 
then for 5h at room temperature. Water (3ml) was added to quench the reaction. 
Solvents were removed in vacuo and the resulting foam was stirred vigorously in 
acetone (100ml). The resulting white precipitate was collected and purified by reversed 
phase column chromatography (RP-18, gradient elution with 10% MeCN and then 15% 
MeCN) to afford the title compound (112mg, 34%) as white solid together with 
reclaimed educt 93 (163.5mg, 53%) 
 
TLC (RP-18, MeCN/H2O=3:10): Rf = 0.33  
HPLC (LiChrospher® 100 RP-18 (5μm) 250×4, 20% MeCN, flow = 1ml/min, λdet = 
220nm, T=40oC): Rt = 2.64min 
ESI-MS (MeOH/H2O): 2527.8 [M+Na]+, 1274.9 [M+2Na]2+/2, 2503.9 [M-H]-, 1251.4 
[M-2H]2-/2 
 
Ruthenium porphyrin-bis-β-CD complex 89 
 
N
N
N
N
S
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O O
 
 
To a solution of porphyrin 76 (6.84mg, 7.7μmol) in dry, degassed THF (2ml) was 
added LiAlH4 (1M in THF, 23.1μl) at 0oC. The reaction mixture was heated under 
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reflux in argon for 2h. At room temperature, dry and degassed MeOH (2ml) was added 
to quench the reaction. After evaporation of solvent in vacuo under argon at room 
temperature, to the resulting residue was added the solution of 6-mono-tosyl-β-CD 
dimer 94 (38.7mg, 15.4μmol) and pyridine (62.1ul, 0.77mmol) in dry, degassed DMF 
(2ml). The reaction mixture was heated at 70oC for 21h in argon. After removal of the 
solvent in vacuo, the resulting crude product was purified by reversed phase column 
chromatography (RP-18, gradient elution with MeOH/H2O = 1:1, then 10:1) to give the 
title compound (6.4mg, 26.4%) as red solid. 
  
TLC (RP-18, MeOH/H2O=10:1): Rf = 0.41  
HPLC (LiChrospher® 100 RP-18 (5μm) 250×4, 60% MeOH to 90% MeOH in 15min, 
then to 100% MeOH in 10min, @100% MeOH for 10min, flow = 1ml/min, λdet = 
412nm, T = 40oC): Rt = 18.64min 
UV/Vis (H2O, λ): 412 (100, Soret), 533 (11) 
ESI-MS (MeOH/H2O): 3171 [M+Na]+, 1597.3 [M+2Na]2+/2, 1573.9 [M-2H]2-/2, 
1048.7 [M-3H]3-/3 
 
(E)-4-(2,6-dimethylphenyl)3-buten-2-one 96[88] 
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To a solution of 2,6-dimethylbenzaldehyde (3.98g, 28.8mmol) in acetone (36ml) was 
added 2M NaOH (aq., 4.8ml) over 1h at 0oC. The mixture was stirred for 3h at 0oC and 
then for 18h at room temperature. The reaction solution was then poured into aqueous 
H2SO4 (2M, 80ml) and extracted with CH2Cl2. The combined extractions were washed 
with saturated NaHCO3 (aq.), brine, dried over Na2SO4 and evaporated in vacuo at 
room temperature. Column chromatography (SiO2, ethyl acetate/hexane = 1:20) gave 
the title compound (3.98g, 77%) as yellowish oil. 
 
TLC (ethyl acetate/hexane = 1:9): Rf = 0.23  
UV/Vis (hexane, λ): 216 (100), 276 (78) 
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1H-NMR (400MHz, CDCl3): 7.68 (d, J = 16.7, 1H, (C7)-H), 7.2-7.1 (m, 3H, C(2, 3, 4)-
H), 6.34 (d, J = 16.7, 1H, C(8)-H), 2.4 (s, 3H, C(12)-H), 2.35 (s, 6H, C(10,11)-H)  
13C-NMR (100MHz, CDCl3): 198.4 (C(9)), 142 (C(7)), 136.58 (C(1, 5)), 133.95 (C(6)), 
133.02 (C(8)), 128.46 (C(3)), 128.31 (C(2), C(4)), 27.5 (C(12)), 21.05 (C(10, 11)) 
EI-MS: 174.1 [M]+. (10), 159.1 (100), 115.1 (19), 91.1 (10) 
ESI-MS (CH2Cl2/MeOH): 175.0 [M+H]+, 197.0 [M+Na]+, 370.9 [2M+Na]+ 
 
Ethyl 3-methyl-5-(2,6-dimethylphenyl)penta-2,4-dienoate 97 
 
COOCH2CH3
1
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To a suspension of NaH (60 % in mineral oil, 155mg, 3.9mmol) in dry ether (2ml) was 
added a solution of triethylphosphonoacetate (0.77g, 3.36mmol) in dry ether (3ml) 
dropwise at room temperature. After being stirred for 2h at room temperature, the 
mixture was added with a solution of 96 (540mg, 3mmol) in ether (4ml) and reacted at 
room temperature overnight. The next morning additional triethylphosphonoacetaten 
(0.24g, 1.0mmol) was reacted with NaH (46.5mg) and added to the reaction. On the 
next day, the reaction was quenched with water and the aqueous phase was extracted 
with ether. The combined extractions were washed with water, dried over Na2SO4 and 
evaporated in vacuo at room temperature. Column chromatography (SiO2, ethyl 
acetate/hexane = 1:20) gave the title compound (470.4mg, 62.8%) as yellowish oil. 
(1H-NMR: 80% all-E). 
 
TLC (ethyl acetate/hexane = 1:9): Rf = 0.42  
1H-NMR (all-E isomer) (400MHz, CDCl3): 7.1-7.03 (m, 3H, C(2, 3, 4)-H), 6.98 (d, J = 
16.2, 1H, C(7)-H), 6.32 (d, J = 16.2, 1H, C(8)-H), 5.8 (s, 1H, C(10)-H), 4.20 (q, J = 7, 
2H, CH2CH3), 2.43 (d, J = 1.3, 3H, C(14)-H), 2.3 (s, 6H, ArH), 1.3(t, J = 7, 3H, 
CH2CH3) 
ESI-MS (CH2Cl2/MeOH): 267.1 [M+Na]+ 
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(all-E)-3-methyl-5-(2,6-dimethylphenyl)penta-2,4-dien-1-ol 98 
 
CH2OH
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To a solution of 97 (637mg, 2.61mmol) in dry ether (20ml) at 0oC was added DIBALH 
(1M in hexane, 5.2ml). After being stirred for 5h at room temperature, the reaction was 
diluted with ether (20ml) and quenched by careful addition of brine at 0oC, followed by 
dropwise addition of 3M HCl (aq. 10ml). The mixture was extracted with ether and the 
combined extractions were washed with saturated NaHCO3 (aq.), brine, dried over 
Na2SO4 and evaporated in vacuo at room temperature. Column chromatography (basic 
alox, hexane/TBME=2:1) gave title compound (297mg, 56.3%) as yellowish oil. 
 
TLC (basic alox, ethyl acetate/hexane = 1:2): Rf = 0.26  
UV/Vis (CH2Cl2, λ): 269 (100), 229 (80) 
IR (neat, ν/cm-1): 3317 (brs), 2916.17, 1465.8 
1H-NMR (400MHz, CDCl3): 7.05 (s, 3H, C(2, 3, 4)-H), 6.57 (d, J = 16.4, 1H, C(7)-H), 
6.28 (d, J = 16.4, 1H, C(8)-H), 5.71 (t, J = 6.8, 1H, C(10)-H), 4.35 (d, J = 6.8, 2H, 
C(11)-H), 2.3 (s, 6H, ArH), 1.95 (s, 3H, C(14)-H) 
13C-NMR (100MHz, CDCl3): 138.47 (C(8)), 137.5 (C(6)), 136.9 (C(9)), 136.4 (C(1), 
C(5)), 130.6 (C(10)), 128.21 (C(2, 4)), 126.95/126.7 (C(3, 7)), 59.9 (C11)), 21.41 (C(12, 
13)), 12.9 (C(14)) 
EI-MS: 202.1 [M]+. (48), 171.1 (46), 157.1 (100), 119.1 (52) 
 
(all-E)-3-methyl-5-(2,6-dimethylphenyl)penta-2,4-dienal 99 
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To a solution of 98 (577mg, 2.9mmol) in hexane (80ml) was added activated MnO2 
(5.5g, 58mmol). The reaction mixture was stirred at room temperature for 2h. MnO2 
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was filtered off and washed with CH2Cl2. The combined filtrate was concentrated in 
vacuo at room temperature. Purification by column chromatography (SiO2, 
hexane/TBME = 4:1) to give the title compound (335.5mg, 58.7%) as yellowish oil. 
 
TLC (ethyl acetate/hexane = 1:2): Rf = 0.46  
UV/Vis (CH2Cl2, λ): 313 (100), 250 (shoulder, 38) 
IR (neat, ν/cm-1): 1658.7, 1612.4, 1465.8, 1380.9 
HPLC (YMC C30 (3μm) 250×4.6, @MeOH/H2O (9:1) (100%) for 5min, to 
MeOH/TBME (7:3) (100%) in 30min, then @MeOH/TBME (7:3) for 17min, flow: 
1ml/min, λdet = 313nm, T = 25oC): Rt = 4.55 
1H-NMR (400MHz, CDCl3): 10.19 (d, J = 8.1, 1H, C(11)-H), 7.15 (d, J = 16.5, 1H, 
C(7)-H), 7.12-7.02 (m, 3H, C(2, 3, 4)-H), 6.44 (d, J = 16.5, 1H, C(8)-H), 6.01 (d, J = 
8.1, 1H, C(10)-H), 2.42 (d, J = 1.4, 3H, C(14)-H), 2.3 (s, 6H, C(12, 13)-H) 
13C-NMR (100MHz, CDCl3): 191.7 (C(11)), 154.5 (C(9)), 137.4 (C(8)), 136.6 (C(1, 5)), 
136 (C(6)), 134.7 (C(7)), 130.3 (C(10)), 128.6 (C(2, 4)), 128.1 (C(3)), 21.4 (C(12, 13)), 
13.4 (C(14)) 
EI-MS: 200.1 [M]+. (58), 185.1 (49), 157.0 (100), 142.1 (88), 115.1 (57) 
 
(all-E) 6-methyl-8-(2,6-dimethylphenyl)octa-3,5,7-trien-2-one 85 
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To a solution of aldehyde 99 (18.7mg, 0.093mmol) in acetone (1ml) was added 2M 
NaOH (aq., 14.3μl) at 0oC. The reaction solution was stirred for 3h at 0oC, 18h at room 
temperature and then diluted with ether (10ml). The organic layer was washed with 
brine, dried over Na2SO4 and evaporated in vacuo at room temperature. Column 
chromatography (SiO2, hexane/TBME = 4:1) gave the title compound (19mg, 84.7%) 
as yellowish oil. 
 
TLC (hexane/TBME = 2:1): Rf = 0.34  
UV/Vis (CH2Cl2, λ): 340 (100) 
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IR (neat, ν/cm-1): 1658.7, 1589.2 
HPLC (YMC C30 (3μm) 250×4.6, @MeOH/H2O (9:1) (100%) for 5min, to 
MeOH/TBME (7:3) (100%) in 30min, then @MeOH/TBME (7:3) for 17min, flow 
1ml/min, λdet = 340nm, T = 25oC): Rt = 5.28 
1H-NMR (400MHz, CDCl3): 7.6 (dd, J = 15.4, 12.0, 1H, C(11)-H), 7.1-7.0 (m, 3H, 
C(2,3,4)-H), 6.84 (d, J = 16.4, 1H, C(7)-H), 6.41 (d, J = 16.4, 1H, C(8)-H), 6.25 (d, J = 
12.0, 1H, C(10)-H), 6.22 (d, J = 15.4, 1H, C(12)-H), 2.33 (s, 6H, C(14, 15)-H), 2.32 (s, 
3H, C(17)-H), 2.17 (d, J = 1.4, 3H, C(16)-H) 
13C-NMR (100MHz, CDCl3): 198.6 (C(13)), 145 (C(9)), 139 (C(11)), 138 (C(8)), 136.5 
(C(6)), 136.2 (C(1, 5)), 130.19 (C(7)), 130.13 (C(12), 129.2 (C(10)), 128.1 (C(2, 4)), 
127.2 (C(3)), 28 (C(17)), 21.2 (C(14, 15)), 13.3 (C(16)) 
EI-MS: 240.2 [M]+. (21), 225.1 (51), 207.1 (27), 197.1 (100), 182.1 (69), 43 (32) 
 
β-Carbonyl [5-p-(((4’-(1,3-dioxo-1,3-dihydro-isoindol-2-ylmethyl)biphenyl)-4-yl) 
methoxyphenyl)-10,15,20-tri(p-methylphenyl)-porphyrinato] ruthenium 105 
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The suspension of Cs2CO3 (169mg, 0.52mmol) and phenol porphyrin 81 (40.5mg, 
0.051mmol) in dry, deagssed DMF (3ml) was stirred at room temperature for 2h, then 
the solution of 2-(4’-bromomethyl-biphenyl-4-yl-methyl)-isoindole-1,3-dione 104 
(105.6mg, 0.260mmol) in dry, degassed DMF (6ml) was added. The reaction mixture 
was heated at 80oC in argon for 3.5h and then diluted with ethyl acetate. The resulting 
organic layer was washed with water, dried over Na2SO4 and concentrated in vacuo. 
The crude product was purified by column chromatography (SiO2, ethyl acetate/hexane 
= 1:3) to give the title compound (48.63mg, 85%) as red solid. 
 
TLC (ethyl acetate/hexane=1:2): Rf = 0.33  
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UV/Vis (CH2Cl2, λ): 413 (100, Soret), 530 (11) 
IR (neat, ν/cm-1): 1934.5 (CO), 1716.5 (νC=O), 1008.7 [Ru (II) oxidation state marker 
band] 
1H-NMR (500MHz, CDCl3/MeOH-D4): 8.71 (d, J = 4.8, 2H, porphyrin-H), 8.692 (d, 
2H, porphyrin-H), 8.687 (s, 4H, porphyrin-H), 8.14 (dd, J = 8.3, 2.3, 1H, C(2’ or 6’)-H), 
8.10 (dd, J = 7.6, 1.9, 3H, C(2’’, 2’’’ or 6’’, 6’’’)-H), 8.04 (dd, J = 8.3, 2.3, 1H, C(2’ or 
6’)-H), 8.0 (dd, J = 7.6, 1.9, 3H, C(2’’, 2’’’ or 6’’, 6’’’)-H), 7.85 (dd, J =5.5, 3,  2H, 
phthalimide-α-H), 7.73 (dd, J = 5.5, 3, 2H, phthalimide-β-H), 7.69 (s, 4H, C(II, III, V, 
VI)-H), 7.62 (AA’BB’, J = 8.2, 2H, C(II’, VI’)-H), 7.56-7.50 (m, 8H, C(3’’, 5’’, 3’’’, 
5’’’)-H and C(III’, V’)-H), 7.37 (dd, J = 8.3, 2.7, 1H, C(3’ or 5’)-H), 7.33 (dd, J = 8.3, 
2.7, 1H, C(3’ or 5’)-H), 5.38 (s, 2H, OCH2), 4.92 (s, 2H, CH2N), 2.69 (s, 9H, ArCH3) 
13C-NMR (125MHz, CDCl3/MeOH-D4): 207.0 (could be CO), 168.17 (NCO), 158.26 
(C(4’)), 144.15/143.99 (C(1, 4, 6, 9, 11, 14, 16, 19)), 140.52/140.38 (C(I, I’)), 139.73 
(could be C(1’)), 139.56 (C(1’’, 1’’’)), 136.83 (C(4’’, 4’’’)), 136.15 (C(IV)), 
135.43/134.78 (C(2’, 6’)), 135.31 (C(IV’)), 134.23/133.69 (C(2’’, 6’’ and 2’’’, 6’’’)), 
134.06 (phthalimide-β-C), 132.02 (CCON), 131.51/131.48/131.43 (C(2, 3, 7, 8, 12, 13, 
17, 18)), 129.07 (C(III’, V’)), 128.23 (C(III, V)), 127.42/127.36 (C(II, VI and II’, VI’)), 
127.27/127.03 (C(3’’, 3’’’ and 5’’, 5’’’)), 123.38 (phthalimide-α-C), 121.71 (C(10, 20)), 
121.69 (C(15)), 121.25 (C(5)), 112.87/112.69 (C(3’, 5’)), 70.03 (ArCH2O), 41.27 
(ArCH2N), 21.42 (ArCH3) 
ESI-MS (CH2Cl2/MeOH): 1147.8 [M+Na]+, 1124.9[M]+  
 
β-Carbonyl [5-p-(((4’-amino-biphenyl)-4-yl)methoxyphenyl)-10,15,20- tri(p-
methylphenyl)-porphyrinato] ruthenium 106 
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The solution of porphyrin 105 (21.4mg, 0.019mmol) and hydrazine monohydrate 
(0.2ml, 4mmol) in EtOH/toluene (2:1, 8ml, degassed) was heated under reflux in argon 
for 3h. At room temperature, the reaction mixture was diluted with ethyl acetate, and 
then washed with water, dried over Na2SO4 concentrated in vacuo. The resulting crude 
product was dissolved in CH2Cl2/pyridine to give a solution, which was subjected to 
column chromatography (SiO2, CH2Cl2/MeOH=20:1 + 1% Et3N) to give the title 
compound (15.7mg, 83%) as red solid. 
 
TLC (CH2Cl2/MeOH=5:1 + 1% Et3N): Rf = 0.53  
UV/Vis (CH2Cl2, λ): 415 (100, Soret), 535 (8) 
IR (neat, ν/cm-1): 1940 (CO), 1006.8 [Ru (II) oxidation state marker band] 
1H-NMR (500MHz, CDCl3/pyridine-D5): 8.72 (d, J = 4.8, 2H, porphyrin-H), 8.70 (d, J 
= 4.8, 2H, porphyrin-H), 8.69 (s, 4H, porphyrin-H), 8.12 (dd, J = 8.3, 2.3, 1H, C(2’ or 
6’)-H), 8.08 (m, 3H, C(2’’, 2’’’ or 6’’, 6’’’)-H), 8.01 (dd, J = 8.3, 2.3, 1H, C(2’ or 6’)-
H), 7.96 (m, 3H, C(2’’, 2’’’ or 6’’, 6’’’)-H), 7.72-7.68 (m, 4H, biphenyl-H), 7.63 (m, 
2H, C(II’, VI”)-H), 7.50-7.43 (m, 8H, C(3’’, 3’’’, 5’’, 5’’’)-H and C(III’, V’)-H), 7.36 
(dd, J = 8.3, 2.3, 1H, C(3’ or 5’)-H), 7.32 (dd, J = 8.3, 2.3, 1H, C(3’ or 5’)-H), 5.34 (s, 
2H, ArOCH2), 3.94 (s, 2H, CH2NH2), 2.64 (s, 9H, ArCH3)  
13C-NMR (125MHz, CDCl3/pyridine-D5): 179.6 (CO), 157.8 (C(4’)), 
143.3/143.2/143.15/143.14 (C(1, 4, 6, 9, 11, 14, 16, 19)), 141.5 (C(IV’)), 140.2 (C(I)), 
139.1 (C(1’’, 1’’’)), 138.7 (C(I’)), 136.2 (C(4’’, 4’’’)), 135.5 (C(IV)), 135.3 (C(1’)), 
134.7/134.4 (C(2’, 6’)), 133.6/133.3 (C(2’’, 6’’, 2’’’, 6’’’)), 131.21/131.18/131.14 (C(2, 
3, 7, 8, 12, 13, 17, 18)), 127.7 (C(III, V)), 127.2 (C(III’, V’)), 126.72/126.68 (C(II, VI, 
II’, VI’)), 126.64/126.47 (C(3’’, 5’’, 3’’’, 5’’’)), 120.99 (C(10, 20)), 120.97 (C(15)), 
120.6 (C(5)), 112.3/112.2 (C(3’, 5’)), 69.4 (ArOCH2), 45.4 (ArCH2NH2), 20.8 (ArCH3) 
ESI-MS (CH2Cl2/MeOH): 1017.9 [M+Na]+, 995.9 [M+1]+  
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β-Carbonyl [5-p-(((4’-bromo-biphenyl)-4-yl)-methoxyphenyl)-10,15,20-tri(p-methyl 
phenyl)-porphyrinato] ruthenium 111 
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To a solution of phenol porphyrin 81 (24.9mg, 0.031mmol) in dry, degassed THF (2ml) 
was added NaH (60% in oil, 2.5mg, 0.062mmol). The resulting suspension was stirred 
at room temperature in argon for 18h, then the degassed solution of dibromide 110 
(52.8mg, 0.155mmol) in THF (3ml) was added at 0oC. After being stirred at room 
temperature in argon for 18h, the reaction mixture was diluted with ethyl acetate (30ml) 
and quenched with slow addition of ice-water. The organic layer was separated, washed 
with water, dried over Na2SO4 and concentrated in vacuo. The crude product was 
purified by column chromatography (SiO2, ethyl acetate/hexane = 1:4) to give the title 
compound (26.9mg, 82%) as red solid. 
 
TLC (ethyl acetate/hexane=1:2): Rf = 0.43  
UV/Vis (CH2Cl2, λ): 413 (100, Soret), 530 (10) 
IR (neat, ν/cm-1): 1928.7 (CO), 1006.8 [Ru (II) oxidation state marker band] 
1H-NMR (500MHz, CDCl3/MeOH-D4): 8.64-8.58 (m, 8H, porphyrin-H), 8.07 (dd, J = 
8.2, 2.3, 1H, C(2’ or 6’)-H), 8.03 (m, 3H, C(2’’ , 2’’’ or 6’’, 6’’’)-H), 7.97 (dd, J = 8.2, 
2.3, 1H, C(2’ or 6’)-H), 7.92 (m, 3H, C(2’’, 2’’’ or 6’’, 6’’’)-H), 7.64 (m, 4H, C(II, III, 
V, VI)-H), 7.58 (AA’BB’, J = 8.2, 2H, C(II’, VI”)-H), 7.47-7.44 (m, 8H, C(3’’, 3’’’, 5’’, 
5’’’)-H and C(III’, V’)-H), 7.3 (dd, J = 8.3, 2.3, 1H, C(3’ or 5’)-H), 7.26 (dd, 1H, H-
C(3’ or 5’)), 5.32 (s, 2H, ArOCH2), 4.51 (s, 2H, CH2Br), 2.62 (s, 9H, ArCH3) 
13C-NMR (125MHz, CDCl3/MeOH-D4): 181 (CO), 158.27 (C(4’)), 144.19/144.04 (C(1, 
4, 6, 9, 11, 14, 16, 19)), 140.97 (C(I’)), 140.31 (C(I)), 139.69 (C(1’’, 1’’’)), 137.0 
(C(IV’)), 136.88 (C(4’’, 4’’’)), , 136.47 (C(IV)), 135.50 (C(1’)), 135.36/134.87 (C(2’, 
6’)), 134.27/133.78 (C(2’’, 2’’’, 6’’, 6’’’)), 131.52/131.49/131.42 (C(2, 3, 7, 8, 12, 13, 
17, 18)), 129.59 (C(III’, V’)), 128.34 (C(III, V)), 127.55 (C(II’, VI’)), 127.42 (C(II, 
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VI)), 127.30/127.09 (C(3’’, 3’’, 5’’, 5’’’)), 121.74 (C(10, 15, 20)), 121.25 (C(5)), 
112.96/112.77 (C(3’, 5’)), 70.10 (ArOCH2), 33.35 (CH2Br), 21.42 (ArCH3) 
ESI-MS (CH2Cl2/MeOH): 1080.7 [M+Na]+, 1088.9 [M+MeO]- 
 
Protected ruthenium porphyrin-mono-β-CD complex 114 
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To a solution of TBDMS-β-CD 50 (520.5mg, 0,27mmol) in dry, deagssed THF (4ml) 
was added LiH (15.8mg, 1.9mmol). The suspension was stirred at room temperature for 
1h and then heated under reflux for 2h in argon. At room temperature, the degassed 
solution of mono-bromo-porphyrin 111 (28.5mg, 0.027mmol) in THF (6ml) was added. 
The resulting reaction mixture was heated under reflux in argon for 40h. At 0oC, the 
reaction was diluted with ethyl acetate, followed by slow addition of saturated NH4Cl 
(aq.). The organic layer was separated, washed with water, dried over Na2SO4 and 
concentrated in vacuo. The residue was separated by column chromatography (SiO2, 
ethyl acetate/EtOH/H2O = 50:2:1) to afford the title compound (49.9mg, 64%) as red 
solid. 
 
TLC (ethyl acetate/EtOH/H2O=50:7:4): Rf = 0.48  
UV/Vis (MeOH, λ): 410 (100, Soret), 530 (8) 
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IR (neat, ν/cm-1): 1930.6 (CO), 1035.7 (νC-O), 1006.8 [Ru (II) oxidation state marker 
band] 
1H-NMR (600MHz, toluene-D8/MeOH-D4): 8.92 (d, J = 4.8, 2H, C(3, 7)-H), 8.89 (d, J 
= 4.8, 2H, C(2, 8)-H), 8.86 (s, 4H, C(12, 13, 17, 18)-H), 8.13 (dd, J = 8.2, 2.3, 1H, C(2’ 
or 6’)-H), 8.11-8.05 (m, 7H, C(2’, 2’’, 2’’’ or 6’, 6’’, 6’’’)-H), 7.63 (m, 4H, C(II, VI, II’, 
VI’)-H), 7.60 (d, J = 8.3, C(III, V)-H), 7.54 (d, J = 8.3, C(III’, V’)-H), 7.35 (m, 3H, 
C(3’’, 5’’ or 3’’’, 5’’’)-H), 7.31 (m, 3H, C(3’’, 5’’ or 3’’’, 5’’’)-H), 7.25 (dd, J = 8.3, 
2.8, 1H, C(3’ or 5’)-H), 7.18 (dd, J = 8.3, 2.8, 1H, C(3’ or 5’)-H, 5.10 (m, 7H, CD-
C(1B-G)-H and CD-O-CH2), 5.0 (s, 2H, Ar-O-CH2-Ar), 4.97 (d, J = 3, 1H, CD-C(1A)-H), 
4.86 (d, 1H, CD-O-CH2), 4.48 (t, J = 9.1, 1H, CD-C(3A)-H), 4.3-3.57 (Heavily 
overlapped together with MeOH): 4.08 (CD-C(6A)-H), 3.86 (CD-C(6A)-H), 3.81 (CD-
C(5A)-H), 3.71 (CD-C(4A)-H), 3.57 (CD-C(2A)-H), 2.45 (s, 6H, C(7’’)-H), 2.44 (s, 3H, 
C(7’’’)-H), 0.97-0.94 (m, 63H, CH3C), 0.17-0.10 (m, 42H, CH3Si) 
13C-NMR (125MHz, toluene-D8/MeOH-D4): 181.6 (CO), 159.0 (C(4’)), 145.1, 144.9 
(C(1, 9, 11, 14, 16, 19)), 141.3 (C(I’)), 140.8 (C(I)), 140.6 (C(1’’, 1’’’)), 137.1 (C(IV, 
IV’)), 137.0 (C(4’’, 4’’’)), 136.1 (C(1’)), 136.0/135.4 (C(2’, 6’)), 134.9/134.4 (2’’, 6’’, 
2’’’, 6’’’)), 132.1 (C(2, 3, 7, 8, 12, 13, 17, 18)), 130.1 (C(III’, V’)), 128.5 (III, V)), 
127.9/127.5 (C(3’’, 5’’, 3’’’, 5’’’)), 127.6 (C(II, VI, II’, VI’)), 122.4 (C(10, 15, 20)), 
122.1 (C(5)), 113.4/113.2 (C(3’, 5’)), 103.7/103.45/103.4/103.2 (could be CD-C(1B-G)),  
101.9 (CD-C(1A)), 82.4 (CD-C(4A)), 82.3/82.1/82.0 (could be CD-C(4B-G)), 80.3 (CD -
C(2A)), 74.3 (CD-O-CH2), 74.1, 73.9, 73.2 [73.3 = (CD-C(3A)) was overlapped inside], 
73.0 (CD-C(5A)), 70.4, 70.1 (Ar-O-CH2-Ar), 62.6 (CD-C(6)), 26.2 (CH3C), 21.4 
(ArCH3), 18.7 (CH3C), -4.71/-4.77/-4.85 (CH3Si) 
ESI-MS (MeOH): 2934.8 [M+Na]+, 1478.6 [M+2Na]+/2, 2911.1 [M-H]- 
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Ruthenium porphyrin-β-CD complex 113 
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To a solution of protected ruthenium porphyrin-mono-β-CD complex 114 (7.4mg, 
2.6μmol) in dry, degassed THF (2ml) was added TBAF (1M in THF, 25μl, 25μmol). 
The reaction solution was heated under reflux in argon for 19h. After evaporation of 
solvent in vacuo, the resulting residue was treated with Amberlite CG-50 (weakly 
acidic, H+-form, 100-200 mesh, MeOH) to removed excess of TBAF, then purified by 
reversed phase column chromatography (RP-18, MeOH/H2O = 20:1) to afford the title 
compound (4.3mg, 80%) as red solid. 
 
TLC (ethyl acetate/i-PrOH/NH3 (aq., 33%)/H2O = 7:7:5:4): Rf = 0.51; (RP-18, 
MeOH/H2O = 20:1): Rf = 0.43 
UV/Vis (MeOH, λ): 410 (100, Soret), 530 (8) 
HPLC (LiChrospher® 100 RP-18 (5μm) 250×4, 80% MeOH to 100% MeOH in 5min, 
@100% MeOH for 15min, flow = 1ml/min, λdet = 412nm, T=40oC): Rt = 7.83min 
1H-NMR (500MHz, DMSO-D6/D2O): 8.59 (d, J = 4.8, 2H, porphyrin-H), 8.56 (d, J = 
4.8, 2H, porphyrin-H), 8.55 (s, 4H, porphyrin-H), 8.1-8.08 (m, 1H, C(2’ or 6’)-H), 
8.04-8.02 (m, 3H, C(2’’, 2’’’ or 6’’, 6’’’)-H), 7.98-7.96 (m, 1H, C(2’ or 6’)-H), 7.93-
7.92 (m, 3H, C(2’’, 2’’’ or 6’’, 6’’’)-H), 7.8 (d, J = 8.2, 2H, C(II, VI)-H), 7.75-7.71 (m, 
4H, C(III, V, II’, VI’)-H), 7.59-7.55 (m, 6H, C(3’’, 5’’’, 3’’, 5’’’)-H), 7.52 (d, J = 8.2, 
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2H, C(III’, V’)-H), 7.45-7.39 (m, 2H, C(3’, 5’)-H), 5.39 (s, 2H, Ar-O-CH2-Ar), 4.94 (d, 
J = 3, CD-C(1A)-H), 4.89-4.80 (m, 8H, CD-C(H1B-G)-H and CD-O-CH2), 3.7-3.28 
(heavily overlapped together with H2O), 2.63 (s, 9H, ArCH3) 
ESI-MS (MeOH): 2135.5 [M+Na]+, 1079.3 [M+2Na]2+/2, 2111.0 [M-H]-, 1054.9 [M-
2H]2-/2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 121
5.3 Enzyme mimic reaction 
Gereral procedure for the cleavage reactions: A round bottomed flask. which had been 
purged with argon and fitted with an appropriately sized egg shaped magnetic stir bar, 
was charged with a solution of catalyst in H2O or MeOH/H2O (1:9) according to the 
property of catalyst. TBHP (70% in water) (300 eq. to catalyst) was added. β,β-
carotene or synthetic carotenoid (10 or 3.5 eq. to catalyst) was added to the reaction 
flask as a solution in chloroform/hexane (9:1) to produce a biphasic system. The 
reaction was closed, heated in 31-32oC water bath and stirred vigorously to ensure good 
mixing of two phases. At time points during the reaction, stirring was stopped to allow 
phase separation. Aliquots (20μl) of the organic phase were taken and subjected to 
HPLC analysis.  
 
HPLC methods:  
1. For β,β-carotene 2 as substrate 
LiChrospher 100 RP-18 (5μm, length × ID = 125mm × 4.6mm), 25°C, 1ml/min, 
gradient: acetonitrile/1% NH4OAc(aq) (1:1) to  acetonitrile/i-PrOH (1:1) in 10min, 
@ acetonitrile/i-PrOH (1:1) for 5min, then acetonitrile/i-PrOH (1:1) to 
acetonitrile/1% NH4OAc(aq) (1:1) in 2min. Detection was by diode array detector 
(λdet = 340nm, 380nm, 405nm, 426nm, 450nm). Rt retinal = 10.39min, Rt 12’-apo = 
12.05min, Rt 10’-apo = 12.20min. Quantification was by means of external curves.  
 
For LC-MS analysis, the same column was used: 25oC, 0.3ml/min, gradient: 
[acetonitrile/0.05% NH4OAc(aq) (1:1)/acetonitrile/i-PrOH (1:1)] (1:1) to  
acetonitrile/i-PrOH (1:1) in 20min, @ acetonitrile/i-PrOH (1:1) for 20min, then 
acetonitrile/i-PrOH (1:1) to acetonitrile/1% NH4OAc(aq) (1:1) in 2min. Temperature 
of ESI-MS was 300oC. 
 
2. For 17,17’-dinor-φ,φ-carotene 84 as substrate 
YMC C30 (3 μm particle size, 4.6×250 mm), 25°C, 1ml/min, gradient: @ 
MeOH/H2O (9:1) for 5min, then to MeOH/TBME (7:3) in 30min, @ MeOH/TBME 
(7:3) for 17min. Detection was by diode array detector (λdet = 340nm, 380nm, 
405nm, 426nm, 450nm). Rt retinal = 8.88min, Rt 12’-apo = 19.85min. 
Quantification was by means of external curves. 
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5.4 Detailed parameters of X-ray structure 
 
Table 2 - Crystal and Structure Refinement Data for Compound 55 
 
Compound       55 
Formula 
Composition 
FW   
Crystal size (mm) 
Morphology  
Cryst color  
Wavelength (Å) 
Crystal system 
Space group 
T, K 
a/Å 
b/Å 
c/Å 
α, deg 
β, deg  
γ, deg 
V, Å3 
Z 
θ (min, max) 
h, k, l (min, max) 
no. of refln measured 
no. of unique reflns 
no. of parameters 
ρcalc (g/cm3) 
μ, mm-1 
F(000) 
R indexes 
   [I > 3.00σ(I)]  
R (all data) 
 
GoF 
C92H144N2O70   
C92H146N2O70 . 1.5 C3H6O . 15.5 H2O 
2721.14 
0.24×0.24×0.15 
plate 
colorless  
0.71073 
monoclinic  
P21 
173  
17.5185(2) 
19.6595(2) 
18.5663(2) 
90.00 
99.0029(7) 
90.00 
6315.55(12) 
2 
2.944, 27.504 
(-22,18), (-25,24), (-22,24) 
19224 
15477 
1774 
1.431 
0.129 
2860 
R1 = 0.0516a 
   wR2 = 0.0608b 
R1 = 0.0704 
   wR2 = 0.0774 
1.0828 
                    a R = ∑(Fo - Fc)/∑(Fo). b wR2 ={∑[w(Fo2 – Fc2)2]/∑[w(Fo2)2]}1/2. 
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Structure (mercury view) and atoms coordination for compound 55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Atom          X/ Y/ Z/ Uiso 
 
C1      0.6889(2)/ 0.5501(3)/ 0.6980(3)/ 0.0895  
C2      0.68588(18)/ 0.5898(2)/ 0.7667(2)/ 0.0575  
C3      0.76177(17)/ 0.59164(17)/ 0.8187(2)/ 0.0420  
C4      0.75166(17)/ 0.62419(16)/ 0.89046(19)/ 0.0392  
C5      0.6841(2)/ 0.59323(17)/ 0.9210(3)/ 0.0530  
C6      0.6123(2)/ 0.59046(17)/ 0.8648(3)/ 0.0547  
C7      0.4488(2)/ 0.60524(18)/ 0.74514(17)/ 0.0450  
C8      0.45861(19)/ 0.67446(16)/ 0.78035(17)/ 0.0383  
C9      0.50997(16)/ 0.67643(15)/ 0.85458(17)/ 0.0340  
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C10     0.51213(18)/ 0.74701(15)/ 0.88711(15)/ 0.0343  
C11     0.43140(19)/ 0.77232(16)/ 0.88852(17)/ 0.0385  
C12     0.38201(18)/ 0.76569(16)/ 0.81350(17)/ 0.0368  
C13     0.2932(3)/ 0.7753(2)/ 0.6331(2)/ 0.0586  
C14     0.34707(19)/ 0.83573(18)/ 0.64304(17)/ 0.0420  
C15     0.36529(19)/ 0.85757(17)/ 0.72281(17)/ 0.0389  
C16     0.4096(2)/ 0.92427(17)/ 0.73198(18)/ 0.0481  
C17     0.3680(2)/ 0.97810(18)/ 0.68069(19)/ 0.0463  
C18     0.35022(18)/ 0.95106(18)/ 0.60384(18)/ 0.0412  
C19     0.36724(19)/ 0.86793(19)/ 0.43534(19)/ 0.0453  
C20     0.43721(17)/ 0.91271(17)/ 0.45371(17)/ 0.0372  
C21     0.42590(17)/ 0.96925(17)/ 0.50586(18)/ 0.0392  
C22     0.49311(18)/ 1.01937(17)/ 0.5163(2)/ 0.0437  
C23     0.50287(19)/ 1.04531(18)/ 0.4410(2)/ 0.0460  
C24     0.51319(17)/ 0.98711(17)/ 0.39075(18)/ 0.0403  
C25     0.58552(19)/ 0.8318(2)/ 0.3183(2)/ 0.0502  
C26     0.65377(17)/ 0.86928(19)/ 0.36036(17)/ 0.0411  
C27     0.63918(16)/ 0.94511(18)/ 0.36833(16)/ 0.0375  
C28     0.71260(17)/ 0.98230(17)/ 0.40161(17)/ 0.0380  
C29     0.77753(17)/ 0.9655(2)/ 0.35924(17)/ 0.0432  
C30     0.78753(17)/ 0.8895(2)/ 0.35364(16)/ 0.0450  
C31     0.79709(19)/ 0.7165(2)/ 0.3849(2)/ 0.0530  
C32     0.84386(18)/ 0.74680(19)/ 0.45300(18)/ 0.0435  
C33     0.87248(17)/ 0.81791(19)/ 0.43932(17)/ 0.0416  
C34     0.92450(18)/ 0.84402(18)/ 0.50707(18)/ 0.0416  
C35     0.98871(17)/ 0.79379(19)/ 0.53414(17)/ 0.0419  
C36     0.95668(17)/ 0.72211(18)/ 0.53930(17)/ 0.0401  
C37     0.8493(2)/ 0.5804(2)/ 0.5728(2)/ 0.0516  
C38     0.86254(17)/ 0.61974(18)/ 0.64423(18)/ 0.0406  
C39     0.93063(17)/ 0.66923(17)/ 0.65137(17)/ 0.0382  
C40     0.94492(16)/ 0.70263(16)/ 0.72678(17)/ 0.0360  
C41     0.95269(17)/ 0.64735(17)/ 0.78584(18)/ 0.0398  
C42     0.88511(17)/ 0.59759(17)/ 0.77300(18)/ 0.0387  
C43     0.70729(19)/ 1.01258(17)/ 0.6784(2)/ 0.0425  
C44     0.7312(2)/ 0.95164(17)/ 0.7240(2)/ 0.0458  
C45     0.6926(3)/ 0.9312(2)/ 0.7802(3)/ 0.0701  
C46     0.7145(3)/ 0.8728(2)/ 0.8194(3)/ 0.0809  
C47     0.7779(3)/ 0.83420(19)/ 0.8033(3)/ 0.0666  
C48     0.8172(2)/ 0.85575(18)/ 0.74785(19)/ 0.0455  
C49     0.7946(2)/ 0.91357(17)/ 0.70903(18)/ 0.0428  
C50     0.8854(2)/ 0.81640(17)/ 0.72873(18)/ 0.0410  
C101    0.7110(2)/ 1.1904(3)/ 0.9611(2)/ 0.0655  
C102    0.6635(2)/ 1.1266(2)/ 0.9564(2)/ 0.0521  
C103    0.5925(2)/ 1.12738(18)/ 0.89736(18)/ 0.0442  
C104    0.5417(2)/ 1.06507(16)/ 0.90073(17)/ 0.0405    
C105    0.5258(2)/ 1.05237(18)/ 0.97910(19)/ 0.0464    
C106    0.6010(2)/ 1.05623(19)/ 1.03304(19)/ 0.0506    
C107    0.7761(2)/ 1.04193(19)/ 1.1408(2)/ 0.0500    
C108    0.7585(2)/ 0.97214(19)/ 1.11164(18)/ 0.0469    
C109    0.6739(2)/ 0.95654(18)/ 1.08173(17)/ 0.0445    
C110    0.6658(2)/ 0.8844(2)/ 1.0529(2)/ 0.0553    
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C111    0.7014(2)/ 0.83462(19)/ 1.11122(19)/ 0.0477    
C112    0.78305(19)/ 0.85632(18)/ 1.14194(16)/ 0.0417    
C113    0.9725(3)/ 0.9126(2)/ 1.1690(2)/ 0.0669   
C114    0.9675(2)/ 0.86270(18)/ 1.10709(18)/ 0.0453   
C115    0.90011(19)/ 0.81436(17)/ 1.10007(16)/ 0.0401   
C116    0.90171(19)/ 0.76656(17)/ 1.03657(18)/ 0.0406   
C117    0.97955(19)/ 0.73036(16)/ 1.04365(17)/ 0.0394   
C118    1.04587(19)/ 0.78103(16)/ 1.05800(17)/ 0.0379  
C119    1.1679(5)/ 0.9303(3)/ 1.0514(3)/ 0.1526   
C120    1.1380(3)/ 0.9074(2)/ 0.97311(19)/ 0.0666   
C121    1.1206(2)/ 0.83140(16)/ 0.97164(17)/ 0.0415   
C122    1.11495(18)/ 0.80369(15)/ 0.89421(17)/ 0.0372   
C123    1.18826(19)/ 0.82245(18)/ 0.86377(19)/ 0.0437   
C124    1.1999(2)/ 0.89885(19)/ 0.8682(2)/ 0.0515   
C125    1.1820(4)/ 1.0773(2)/ 0.8524(3)/ 0.0878   
C126    1.1327(2)/ 1.04844(18)/ 0.7847(2)/ 0.0495   
C127    1.15557(19)/ 0.97640(18)/ 0.76702(18)/ 0.0434   
C128    1.11130(18)/ 0.95170(17)/0.69465(17)/ 0.0396   
C129    1.11890(19)/ 1.0048(2)/ 0.63649(19)/ 0.0515   
C130    1.0940(2)/ 1.0744(2)/ 0.6590(2)/ 0.0539   
C131    1.0033(2)/ 1.2115(2)/ 0.7398(2)/ 0.0565   
C132    0.9410(2)/ 1.1710(2)/ 0.6929(2)/ 0.0502   
C133    0.96621(19)/ 1.1272(2)/ 0.63447(19)/ 0.0476   
C134    0.8970(2)/ 1.0937(2)/ 0.5901(2)/ 0.0511   
C135    0.8361(2)/ 1.1448(2)/ 0.5602(2)/ 0.0502   
C136    0.81818(19)/ 1.1924(2)/ 0.6203(2)/ 0.0492   
C137    0.7760(3)/ 1.2696(2)/ 0.7740(4)/ 0.0809/   
C138    0.7227(2)/ 1.20821(18)/ 0.7638(2)/ 0.0507   
C139    0.70983(19)/ 1.18263(17)/ 0.6854(2)/ 0.0445   
C140    0.64832(19)/ 1.12655(17)/ 0.67355(19)/ 0.0413   
C141    0.57569(19)/ 1.15146(18)/ 0.7015(2)/ 0.0445   
C142    0.59339(19)/ 1.18071(17)/ 0.7779(2)/ 0.0461   
C170    0.6458(3)/ 0.7736(3)/ 0.6221(3)/ 0.0953  
C171    0.6683(5)/ 0.8218(3)/ 0.5677(3)/ 0.1201   
C172    0.5829(5)/ 0.8002(6)/ 0.6578(5)/ 0.0908   
C173    0.5678(6)/ 0.7604(7)/ 0.6302(8)/ 0.1243   
C180    0.8778(7)/ 1.0431(6)/ 0.8934(6)/ 0.1135   
C181    0.8529(9)/ 0.9863(9)/ 0.9343(8)/ 0.1259   
C182    0.9388(6)/ 1.0220(8)/ 0.8560(7)/ 0.1092   
N1      0.88207(15)/ 0.74895(14)/ 0.73804(14)/ 0.0386   
N2      0.67588(16)/ 1.06368(14)/ 0.71116(15)/ 0.0399   
O1      0.81746(12)/ 0.63208(12)/ 0.78693(12)/ 0.0405   
O2      0.71418(18)/ 0.4827(2)/ 0.7123(3)/ 0.1173   
O3      0.82076(14)/ 0.61501(13)/ 0.93972(14)/ 0.0478   
O4      0.66963(16)/ 0.62852(14)/ 0.98440(18)/ 0.0614   
O5      0.62741(14)/ 0.55747(15)/ 0.8016(2)/ 0.0745   
O6      0.58783(12)/ 0.65899(12)/ 0.84717(15)/ 0.0454   
O7      0.42276(15)/ 0.55452(12)/ 0.79033(13)/ 0.0475   
O8      0.55421(14)/ 0.74341(12)/ 0.95973(12)/ 0.0453   
O9      0.43308(16)/ 0.84203(13)/ 0.90986(14)/ 0.0535   
O10     0.38228(12)/ 0.69792(11)/ 0.78833(12)/ 0.0391   
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O11     0.41457(13)/ 0.80932(11)/ 0.76474(12)/ 0.0393   
O12     0.2771(2)/ 0.75562(17)/ 0.55974(17)/ 0.0869   
O13     0.4150(2)/ 0.94879(13)/ 0.80443(14)/ 0.0652   
O14     0.41389(17)/ 1.03789(12)/ 0.68281(15)/ 0.0543   
O15     0.30794(12)/ 0.89037(13)/ 0.60090(12)/ 0.0441   
O16     0.42068(12)/ 0.94140(12)/ 0.57690(12)/ 0.0404   
O17     0.29896(15)/ 0.90688(19)/ 0.41317(19)/ 0.0772   
O18     0.47694(15)/ 1.07576(13)/ 0.55928(15)/ 0.0534   
O19     0.56383(15)/ 1.09333(13)/ 0.44445(17)/ 0.0570   
O20     0.45075(12)/ 0.94194(12)/ 0.38506(12)/ 0.0400   
O21     0.58408(11)/ 0.95389(12)/ 0.41712(12)/ 0.0378   
O22     0.59653(16)/ 0.76033(16)/ 0.3249(2)/ 0.0745   
O23     0.69620(13)/ 1.05371(13)/ 0.40000(14)/ 0.0494   
O24     0.84723(12)/ 0.99873(15)/ 0.39242(13)/ 0.0521   
O25     0.71787(12)/ 0.85937(14)/ 0.32000(11)/ 0.0450   
O26     0.80912(12)/ 0.86481(13)/ 0.42593(11)/ 0.0406   
O27     0.76681(15)/ 0.65057(15)/ 0.39866(16)/ 0.0615   
O28     0.95654(15)/ 0.90838(15)/ 0.49005(16)/ 0.0587   
O29     1.03057(13)/ 0.81441(14)/ 0.60238(12)/ 0.0464   
O30     0.90924(13)/ 0.70285(13)/ 0.47360(12)/ 0.0452   
O31     0.91422(12)/ 0.72207(12)/ 0.59829(11)/ 0.0394   
O32     0.91854(17)/ 0.54819(16)/ 0.56000(17)/ 0.0681   
O33     1.02030(12)/ 0.60816(12)/ 0.78314(15)/ 0.0464   
O34     0.87522(12)/ 0.57018(12)/ 0.70173(12)/ 0.0413   
O35     0.71664(16)/ 1.01374(13)/ 0.61324(14)/ 0.0520   
O36     0.93892(15)/ 0.84641(13)/ 0.70685(14)/ 0.0521   
O37     0.16077(16)/ 0.66332(14)/ 0.75417(16)/ 0.0576   
O38     0.8260(2)/ 0.3636(2)/ 0.5194(2)/ 0.0900   
O39     0.8540(2)/ 0.41805(18)/ 0.7406(3)/ 0.1136   
O40     0.9422(2)/ 0.3710(2)/ 0.6378(2)/ 0.0923   
O41     1.02360(17)/ 0.49915(16)/ 0.67175(18)/ 0.0675   
O42     0.67804(18)/ 0.62847(15)/ 0.26710(18)/ 0.0723   
O43     0.59758(19)/ 0.70597(16)/ 1.15273(19)/ 0.0722   
O44     0.4195(3)/ 0.7113(2)/ 0.4847(2)/ 0.1026   
O45     0.5152(3)/ 0.3090(2)/ 0.8718(2)/ 0.1104   
O46     0.1526(3)/ 0.6562(3)/ 0.6090(2)/ 0.1052   
O48     0.6525(3)/ 0.5082(3)/ 1.0495(3)/ 0.0471   
O52     1.0490(5)/ 0.5676(4)/ 0.9346(5)/ 0.1034   
O53     0.5108(4)/ 0.4385(4)/ 0.8233(8)/ 0.1345   
O70     0.6690(6)/ 0.7152(4)/ 0.6310(5)/ 0.1209   
O71     0.7009(5)/ 0.7424(4)/ 0.6622(5)/ 0.1123   
O80     0.8497(6)/ 1.1014(6)/ 0.8951(6)/ 0.1326   
O101    0.6675(3)/ 1.2559(2)/ 0.9705(3)/ 0.0525   
O102    0.47142(15)/ 1.07586(12)/ 0.85350(13)/ 0.0481   
O103    0.49120(19)/ 0.98896(14)/ 0.98476(15)/ 0.0628   
O104    0.63976(16)/ 1.11744(13)/ 1.02622(13)/ 0.0520   
O105    0.64724(16)/ 0.99974(13)/ 1.02049(13)/ 0.0546   
O106    0.73272(15)/ 1.05780(13)/ 1.19761(14)/ 0.0516   
O107    0.58534(16)/ 0.86888(13)/ 1.03070(16)/ 0.0611   
O108    0.70355(15)/ 0.76764(13)/ 1.08189(14)/ 0.0498   
O109    0.78450(15)/ 0.92354(13)/ 1.16814(12)/ 0.0483   
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O110    0.82810(13)/ 0.84935(12)/ 1.08569(11)/ 0.0425   
O111    1.0303(3)/ 0.9626(2)/ 1.1671(3)/ 0.1252   
O112    0.84215(14)/ 0.71647(14)/ 1.03461(14)/ 0.0514   
O113    0.98734(13)/ 0.69263(12)/ 0.97919(13)/ 0.0435   
O114    1.03802(13)/ 0.82366(12)/ 1.11797(11)/ 0.0417   
O115    1.04737(14)/ 0.81949(11)/ 0.99393(11)/ 0.0410   
O116    1.2431(3)/ 0.8867(3)/ 1.0806(2)/ 0.1219   
O117    1.10513(14)/ 0.73194(12)/ 0.89370(13)/ 0.0457   
O118    1.18759(14)/ 0.79891(13)/ 0.79236(13)/ 0.0475   
O119    1.20512(19)/ 0.92164(14)/ 0.94032(14)/ 0.0665   
O120    1.13851(12)/ 0.93029(11)/ 0.82203(11)/ 0.0383   
O121    1.2610(2)/ 1.07311(18)/ 0.8476(2)/ 0.1090   
O122    1.14343(13)/ 0.88881(13)/ 0.67908(12)/ 0.0462   
O123    1.07555(18)/ 0.98370(17)/ 0.56878(15)/ 0.0727   
O124    1.14129(14)/ 1.09274(13)/ 0.72484(16)/ 0.0562   
O125    1.01592(13)/ 1.07215(14)/ 0.66665(14)/ 0.0521   
O126    1.03991(15)/ 1.25865(15)/ 0.69918(16)/ 0.0584   
O127    0.91997(17)/ 1.0573(2)/ 0.53008(19)/ 0.0808   
O128    0.76734(14)/ 1.11300(16)/ 0.52578(14)/ 0.0569   
O129    0.88657(14)/ 1.22126(13)/ 0.65861(14)/ 0.0521   
O130    0.77866(13)/ 1.15466(12)/ 0.66759(13)/ 0.0452   
O131    0.7497(3)/ 1.3210(2)/ 0.7365(3)/ 0.0675   
O132    0.54110(15)/ 1.20554(15)/ 0.65567(15)/ 0.0572   
O133    0.65069(14)/ 1.23108(12)/ 0.78385(17)/ 0.0544   
O134    0.61667(14)/ 1.12608(11)/ 0.82667(12)/ 0.0427   
O201    0.7880(4)/ 1.1679(3)/ 1.0060(4)/ 0.0762   
O470    0.6677(5)/ 0.6341(5)/ 0.5011(5)/ 0.0981   
O471    0.6396(4)/ 0.6811(4)/ 0.4611(4)/ 0.0669   
O490    0.6524(6)/ 0.3898(4)/ 0.8344(6)/ 0.0901   
O491    0.6567(5)/ 0.4130(5)/ 0.7942(4)/ 0.0812   
O500    0.9133(5)/ 0.5086(4)/ 0.9579(5)/ 0.0848   
O501    0.9575(3)/ 0.5509(3)/ 0.9655(3)/ 0.0589   
O510    0.6469(4)/ 0.4193(3)/ 0.9821(3)/ 0.0669   
O511    0.6293(5)/ 0.3453(6)/ 0.9767(4)/ 0.1005   
O1310   0.7832(4)/ 1.3047(4)/ 0.8282(4)/ 0.0547   
H1      0.8352/ 0.7330/ 0.7416/ 0.0500   
H2      0.6770/ 1.0692/ 0.7599/ 0.0474      
H3      0.8279/ 0.6476/ 0.9745/ 0.0500    
H7      0.3746/ 0.5541/ 0.7984/ 0.0500    
H8      0.5673/ 0.7805/ 0.9837/ 0.0500    
H14     0.3831/ 1.0712/ 0.6924/ 0.0500    
H18     0.4635/ 1.0561/ 0.5998/ 0.0500   
H19     0.6071/ 1.0692/ 0.4512/ 0.0500    
H23     0.7295/ 1.0769/ 0.4307/ 0.0500   
H24     0.8703/ 0.9853/ 0.4358/ 0.0500    
H27     0.7225/ 0.6480/ 0.4184/ 0.0500   
H29     0.9982/ 0.8192/ 0.6346/ 0.0500    
H33     1.0633/ 0.6300/ 0.7767/ 0.0500   
H103    0.4844/ 0.9583/ 0.9504/ 0.0500   
H106    0.7477/ 1.0959/ 1.2173/ 0.0500   
H108    0.6819/ 0.7395/ 1.1084/ 0.0500   
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H113    0.9852/ 0.6536/ 1.0006/ 0.0500   
H117    1.0687/ 0.7155/ 0.9165/ 0.0500   
H118    1.1653/ 0.8258/ 0.7579/ 0.0500   
H120    0.2501/ 0.7891/ 0.5381/ 0.0500   
H123    1.0252/ 0.9818/ 0.5723/ 0.0892   
H126    1.0046/ 1.2873/ 0.6777/ 0.0698   
H127    0.9670/ 1.0435/ 0.5326/ 0.0500   
H128    0.7550/ 1.0881/ 0.5621/ 0.0500   
H130    0.4240/ 0.9148/ 0.8369/ 0.0500   
H220    0.5514/ 0.7400/ 0.3171/ 0.0500   
H1020   0.4622/ 1.0373/ 0.8317/ 0.0500   
H1120   0.7977/ 0.7389/ 1.0347/ 0.0500   
H1210   1.2755/ 1.0814/ 0.8923/ 0.0500   
H1220   1.1096/ 0.8704/ 0.6445/ 0.0500   
H11     0.6363/ 0.5495/ 0.6679/ 0.1023    
H12     0.7257/ 0.5734/ 0.6694/ 0.1023    
H21     0.6692/ 0.6379/ 0.7533/ 0.0690    
H31     0.7818/ 0.5441/ 0.8273/ 0.0504    
H41     0.7415/ 0.6741/ 0.8822/ 0.0487    
H51     0.6987/ 0.5455/ 0.9353/ 0.0643    
H61     0.5710/ 0.5654/ 0.8847/ 0.0701    
H71     0.4102/ 0.6091/ 0.6997/ 0.0538    
H72     0.4998/ 0.5907/ 0.7325/ 0.0538   
H81     0.4807/ 0.7057/ 0.7470/ 0.0465    
H91     0.4896/ 0.6434/ 0.8883/ 0.0417    
H101    0.5390/ 0.7784/ 0.8569/ 0.0418   
H111    0.4069/ 0.7441/ 0.9240/ 0.0455   
H121    0.3278/ 0.7796/ 0.8161/ 0.0449   
H131    0.2431/ 0.7880/ 0.6496/ 0.0678   
H132    0.3170/ 0.7365/ 0.6636/ 0.0678   
H141    0.3962/ 0.8243/ 0.6244/ 0.0487   
H151    0.3161/ 0.8625/ 0.7434/ 0.0457   
H161    0.4627/ 0.9165/ 0.7194/ 0.0543   
H171    0.3180/ 0.9897/ 0.6977/ 0.0547   
H181    0.3190/ 0.9859/ 0.5728/ 0.0495   
H191    0.3752/ 0.8362/ 0.3951/ 0.0540   
H192    0.3602/ 0.8404/ 0.4796/ 0.0540   
H201    0.4826/ 0.8845/ 0.4750/ 0.0431   
H211    0.3771/ 0.9940/ 0.4873/ 0.0459   
H221    0.5415/ 0.9958/ 0.5387/ 0.0513   
H231    0.4540/ 1.0694/ 0.4207/ 0.0542   
H241    0.5163/ 1.0064/ 0.3414/ 0.0480   
H251    0.5793/ 0.8456/ 0.2661/ 0.0601   
H252    0.5379/ 0.8448/ 0.3390/ 0.0601   
H261    0.6674/ 0.8486/ 0.4098/ 0.0486   
H271    0.6184/ 0.9651/ 0.3197/ 0.0442   
H281    0.7277/ 0.9672/ 0.4533/ 0.0456   
H291    0.7632/ 0.9841/ 0.3089/ 0.0506   
H301    0.8297/ 0.8794/ 0.3243/ 0.0529   
H311    0.8316/ 0.7126/ 0.3468/ 0.0593   
H312    0.7534/ 0.7482/ 0.3670/ 0.0593   
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H321    0.8112/ 0.7483/ 0.4927/ 0.0503   
H331    0.9014/ 0.8172/ 0.3969/ 0.0501   
H341    0.8926/ 0.8510/ 0.5471/ 0.0487   
H351    1.0252/ 0.7929/ 0.4976/ 0.0497   
H361    1.0006/ 0.6891/ 0.5502/ 0.0480   
H371    0.8088/ 0.5447/ 0.5754/ 0.0602   
H372    0.8312/ 0.6122/ 0.5320/ 0.0602   
H381    0.8146/ 0.6457/ 0.6490/ 0.0479   
H391    0.9779/ 0.6441/ 0.6431/ 0.0447   
H401    0.9944/ 0.7287/ 0.7319/ 0.0423   
H411    0.9552/ 0.6688/ 0.8353/ 0.0468   
H421    0.8959/ 0.5594/ 0.8086/ 0.0466   
H451    0.6488/ 0.9588/ 0.7923/ 0.0917   
H461    0.6868/ 0.8576/ 0.8586/ 0.1131   
H471    0.7943/ 0.7927/ 0.8315/ 0.0833   
H491    0.8229/ 0.9287/ 0.6692/ 0.0522   
H1011   0.7335/ 1.1953/ 0.9147/ 0.0795   
H1012   0.7536/ 1.1872/ 1.0031/ 0.0795   
H1021   0.6978/ 1.0874/ 0.9473/ 0.0612   
H1031   0.5615/ 1.1694/ 0.9020/ 0.0532   
H1041   0.5679/ 1.0242/ 0.8839/ 0.0481   
H1051   0.4898/ 1.0887/ 0.9913/ 0.0524   
H1061   0.5877/ 1.0534/ 1.0834/ 0.0604   
H1071   0.7630/ 1.0754/ 1.1005/ 0.0594   
H1072   0.8322/ 1.0449/ 1.1610/ 0.0594   
H1081   0.7892/ 0.9645/ 1.0716/ 0.0544   
H1091   0.6406/ 0.9632/ 1.1204/ 0.0525   
H1101   0.6935/ 0.8802/ 1.0096/ 0.0620   
H1111   0.6697/ 0.8342/ 1.1515/ 0.0547   
H1121   0.8037/ 0.8250/ 1.1830/ 0.0512   
H1131   0.9839/ 0.8861/ 1.2168/ 0.0789   
H1132   0.9207/ 0.9352/ 1.1679/ 0.0789   
H1141   0.9649/ 0.8894/ 1.0608/ 0.0519   
H1151   0.9023/ 0.7875/ 1.1459/ 0.0465   
H1161   0.8936/ 0.7933/ 0.9900/ 0.0470   
H1171   0.9836/ 0.6984/ 1.0860/ 0.0455   
H1181   1.0953/ 0.7549/ 1.0695/ 0.0433   
H1191   1.1783/ 0.9809/ 1.0520/ 0.1514   
H1192   1.1251/ 0.9226/ 1.0824/ 0.1514   
H1201   1.0920/ 0.9346/ 0.9495/ 0.0752   
H1211   1.1621/ 0.8067/ 1.0050/ 0.0481   
H1221   1.0693/ 0.8251/ 0.8630/ 0.0427   
H1231   1.2327/ 0.8007/ 0.8955/ 0.0504   
H1241   1.2491/ 0.9103/ 0.8502/ 0.0573   
H1251   1.1675/ 1.1266/ 0.8572/ 0.0934   
H1252   1.1709/ 1.0520/ 0.8962/ 0.0934   
H1261   1.0774/ 1.0479/ 0.7916/ 0.0556   
H1271   1.2125/ 0.9746/ 0.7649/ 0.0493   
H1281   1.0554/ 0.9455/ 0.6991/ 0.0464   
H1291   1.1749/ 1.0072/ 0.6307/ 0.0596   
H1301   1.1010/ 1.1083/ 0.6203/ 0.0616   
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H1311   0.9797/ 1.2368/ 0.7776/ 0.0643   
H1312   1.0431/ 1.1788/ 0.7650/ 0.0643   
H1321   0.9139/ 1.1416/ 0.7251/ 0.0558   
H1331   0.9940/ 1.1551/ 0.6019/ 0.0547   
H1341   0.8737/ 1.0609/ 0.6225/ 0.0605   
H1351   0.8572/ 1.1725/ 0.5233/ 0.0597   
H1361   0.7834/ 1.2300/ 0.5978/ 0.0572   
H1371   0.7844/ 1.2826/ 0.8269/ 0.1012   
H1372   0.8272/ 1.2558/ 0.7601/ 0.1012   
H1381   0.7448/ 1.1708/ 0.7975/ 0.0592   
H1391   0.6932/ 1.2217/ 0.6519/ 0.0524   
H1401   0.6349/ 1.1171/ 0.6201/ 0.0488   
H1411   0.5380/ 1.1129/ 0.7007/ 0.0517   
H1421   0.5451/ 1.2014/ 0.7911/ 0.0536   
H1711   0.6399/ 0.8643/ 0.5700/ 0.1552   
H1712   0.6508/ 0.7996/ 0.5175/ 0.1552   
H1713   0.7237/ 0.8267/ 0.5762/ 0.1552   
H1721   0.5743/ 0.8485/ 0.6432/ 0.1157   
H1722   0.5371/ 0.7724/ 0.6448/ 0.1157   
H1723   0.6020/ 0.7980/ 0.7121/ 0.1157   
H1731   0.5334/ 0.7885/ 0.5945/ 0.1477   
H1732   0.5574/ 0.7118/ 0.6233/ 0.1477   
H1733   0.5618/ 0.7747/ 0.6813/ 0.1477   
H1811   0.8865/ 0.9482/ 0.9288/ 0.1688    
H1812   0.8001/ 0.9814/ 0.9199/ 0.1688   
H1813   0.8658/ 1.0039/ 0.9881/ 0.1688   
H1821   0.9504/ 0.9732/ 0.8671/ 0.1320   
H1822   0.9226/ 1.0285/ 0.8026/ 0.1320   
H1823   0.9865/ 1.0500/ 0.8727/ 0.1320   
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